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 Thesis Abstract 
 
My doctoral thesis aims at the development of molecular tweezers with increased affinity and 
specificity for amyloidogenic proteins. A particular focus lies on the amyloid-β protein, a major 
pathological hallmark of Alzheimer’s disease. In Klärner group, a molecular tweezer called the 
phosphate tweezer was developed which selectively binds to the amino acid lysine and arginine 
both in peptides and proteins, and thereby inhibits the aggregation and toxicity of amyloid 
proteins. However, the symmetrical prototype which carries two phosphate anions at its 
periphery, does not distinguish between well-accessible lysines on a protein surface. In my thesis 
I try to develop symmetrical and unsymmetrical molecular tweezers with new recognition sites, 
which become selective for a given protein/epitope. 
 
In the first part of the work, I explored the chemical and biological effects of replacing the 
phosphate anions by other anionic groups of biological relevance.  For this purpose, I synthesized 
the sulfate tweezer and carried out comparative binding studies among the phosphate, 
phosphonate, sulfate and methyl carboxylate tweezers with basic amino acids and relevant 
peptide guests. Using NMR, fluorescence, ITC, and molecular simulation, I observed substantial 
differences in the binding characteristics of all the four tweezer types toward their peptide guests. 
 
In collaboration, we studied the inhibition potential of the phosphate tweezer against the 
pathologic aggregation of the islet amyloid polypeptide (IAPP), a protein involved in the type II 
diabetes. For more structural insight, I carried out an investigation about complexes between the 
tweezer and IAPP fragments by NMR, fluorescence and ITC experiments. Biological 
experiments and QM/MM calculations were performed in collaborations.  
 
In the second part of my work, I synthesized several unsymmetrical molecular tweezers that carry 
a phosphate group on one side and several different linkers on the other side of tweezer’s central 
benzene ring. These tweezers with attached linker units display varying affinities for lysine and 
arginine derivatives from milimolar to micromolar. Biological experiments of these 
unsymmetrical tweezers are currently underway in Prof. Bitan’s lab (neurology, UCLA). Lastly, I 
developed an even more general and potent synthetic route for the synthesis of unsymmetrical 
molecular tweezers which keep both the phosphate groups on the tweezer. One of the two 
phosphate groups is substituted with an alkyne or an ester linker unit. The alkyne linker tweezer 
can be coupled with an azide containing recognition site via alkyne-azide click reaction, whereas, 
 the ester linker tweezer can be coupled with an amine containing recognition site to synthesize 
more powerful unsymmetrical molecular tweezer. 
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1 Introduction 
 
Proteins constitute an essential part in organisms and nearly participate in all the cellular 
processes. Regulation of cellular growth, cell signaling, immune re1sponse, trafficking of 
molecules and cell differentiation are important protein functions.[1] Proteins are synthesized in 
the ribosome as linear heteropolymers or polypeptides of amino acids which share a common 
molecular backbone but differ in their variable side chains.[2] These linear molecules are folded 
into highly specific compact three dimensional structures. The position of all atoms and their 
collective motion determines the properties of the proteins. A number of factors are assisting 
protein folding, but particularly molecular chaperones which are present in all type of cellular 
compartments, provide a favorable environment which helps to correct conformational errors.[3,4] 
Only correctly folded proteins can selectively and specifically interact with other molecules. 
Therefore, for the proper functioning of a protein, it has to be ensured that it is correctly folded 
into its thermodynamically most stable native state. Failure of proteins to fold correctly or remain 
correctly folded often is the origin of pathological diseases.[5] Amyloids are proteins whose 
misfolding causes several so-called amyloidogenic diseases including Alzheimer’s disease and 
type-II diabetes etc. To date there is no cure for these diseases, therefore, the development of 
small molecule therapeutics for the treatment of these amyloid related diseases is a prime 
objective. Similarly, this thesis aims at developing molecular tweezers against Alzheimer’s 
disease, which are able to prevent amyloid-β (Aβ) peptide misfolding and aggregation, and 
secondly, molecular tweezers against type II diabetes, which are able to counteract islet amyloid 
polypeptide (IAPP) misfolding and aggregation. 
1.1 Alzheimer’s disease  
 
Alzheimer’s disease (AD) is a progressive neurodegenerative disease that initially appears as 
temporary memory loss and difficulty with daily tasks, and gradually causes decline of mental 
faculties, dementia, and finally to death.[6,7] This is a disease of old age, typically affecting people 
in the eighth or ninth decade of life with incidence numbers rising steeply after age 65. Currently, 
AD has no cure. Whereas, several major diseases are decreasing gradually, AD is sharply 
increasing. In 2009, the Alzheimer’s Association has reported that current estimates of AD 
prevalence worldwide is 29.4 million,[8] with the US contributing the highest number of 5.3 
million.[9]  The life span of patients with AD is eight years on average and may extend up to 20 
years from the onset of symptoms.[10] During the long years of illness, the patients, families, 
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caretakers, and society in general suffer emotionally and financially. Current cost estimates of 
care for patients with AD in the US are > $148 billion a year and worldwide estimates are > 315 
billion a year.[11]  If no cure is found in the near future, AD will become an epidemic.[12,13] 
 1.2 Amyloid proteins involved in pathology of Alzheimer’s disease 
 
The protein associated with Alzheimer disease is a 37-42 amino acid residue peptide called 
amyloid-β (Aβ). The original source of Aβ is the abnormal proteolysis of the amyloid precursor 
protein (APP), an integral membrane protein whose primary function is not well known.[14] In the 
AD patient, Aβ42 and Aβ40 accumulate into Aβ fibrils and deposit as senile plaques into the 
brain and have been considered the major cause of neurotoxicity and neuronal cell death.[15] 
Today, however, it is generally accepted that pre-fibrillar soluble oligomers are the primary 
neurotoxic agents.[16,17,18] A pictorial sketch of the amyloid cascade is depicted in Figure 1.1 and a 
stepwise cascade outline is found in Figure 1.2. 
 
 
Figure 1.1 Putative amyloid cascade.[7] 
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Figure 1.2 A hypothetical sequence of pathologenic step of familial form of Alzheimer’s diseases.[6] 
 
Due to the metastable and non-crystalline nature of Aβ aggregates, structural studies of Aβ have 
been difficult.[19,20] However, in recent years, significant progress has been made in obtaining 
high-resolution NMR structures of both Aβ fibrils[21,22], and pre-fibrillar assemblies of Aβ.[23] 
Using solid-state NMR techniques, Lührs et al. have reported that in amyloid fibrils, Aβ 
molecules are organized in parallel β-sheets.[24] In these β-sheets each monomer is folded into 
two β-strands connected by a turn (U-turn) in the region Aβ (22-30) as shown in Figure 1.3.  
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Figure 1.3 Left: Aβ (17–42) peptide in which a salt bridge between K28 and D23 is highlighted by the black circle. 
Right: Lühr’s structure of amyloid-β fibril, indicating a β-sheet shown by cyan arrows.[24] 
 
Within this turn, a salt-bridge between the side chains of Asp-23 and Lys-28 has been identified 
as a key stabilizing interaction.[25,26,27]  Because this turn appears to be the first structural element 
observed along the pathway of Aβ folding, Lazo et al. suggested that it nucleates Aβ folding and 
assembly.[28]    
 
In principle, a salt-bridge may also be formed between Lys-28 and Glu-22.[29] The NMR data of 
Lazo et al. could not distinguish between these two possibilities and suggested that both could 
co-exist. Follow up modeling studies suggested that a Glu22–Lys28 salt bridge actually 
predominated over Asp23–Lys28 in the initial turn (Figure 
1.4).[30]  
 
Apart from participating in electrostatic interactions, the alkyl 
chain of the Lys-28 side-chain forms hydrophobic 
interactions with the side chain of Val-24, which were 
reported to be crucial for stabilization of the initial turn in 
Aβ.[28,31,32] Similarly, the alkyl chain of Lys-16 can contribute 
in hydrophobic interactions with residues in the central 
hydrophobic cluster of Aβ (CHC, residues 17–21) and 
thereby stabilize intra- and/or intermolecular contacts 
involved in β-sheet formation and aggregation. Therefore, the two Lys residues in Aβ, and in 
particular Lys-28, appear to be crucial in Aβ folding and self-assembly. With this information in 
mind, Bitan et al. hypothesized that a reagent capable of interacting specifically with Lys residues 
might inhibit the crucial electrostatic and hydrophobic interactions the Lys side chains participate 
 
Figure 1.4 Model of central turn in Aβ. 
The model is based on NMR data and 
molecular dynamic simulations.[29] 
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in and thereby inhibit Aβ folding, assembly, and toxicity. 
 
 1.3 Protein recognition by artificial synthetic receptors 
 
Most of the biological processes rely on the association of two or more proteins which is a highly 
precise molecular recognition phenomenon. Therefore, synthetic receptor molecules that can bind 
or interact with proteins can be of great importance. In particular, those receptor molecules are 
valuable that operate in aqueous solution, bind selectively to a target protein through noncovalent 
interactions and can modulate or alter protein activities. However, a number of challenges are 
associated with the design of small molecular receptors that can efficiently control or regulate the 
activity of a protein.[33,34]  Some of these comprise (1) the complex irregular topology of most 
protein surfaces rendering many surface-exposed residues sterically inaccessible, (2) the large 
contact area which is usually required for efficient competition with natural protein-protein 
interactions (> 1000 Å2), (3) the high number of identical amino acid residues on a protein 
surface, among which only few are suited for protein inhibition by external complexation, and (4) 
the high degree of solvation of polar surface-bound amino acid residues in proteins. On the other 
hand, supramolecular chemistry has gone a long way since the Nobel Prize was awarded to Cram, 
Lehn and Pedersen in 1987. Today we can calculate with reasonable precision all kinds of 
noncovalent interactions and we know how to construct receptor molecules for almost any given 
target. 
 
In recent years several pioneering supramolecular systems have been developed that were used to 
stimulate or retard protein activities. These have been summarized in several excellent 
reviews.[34,35,36,37,38,39] Some of the first approaches have been developed in the Hamilton group: 
initial efforts focused on hot spots of basic proteins around the active site. Porphyrins, calixarenes 
and cyclodextrins were chosen as molecular platforms with attached peripheral arms for lateral 
recognition of charged amino acid residues. Among the above supramolecular host molecules, 
cone shaped calix[n]arenes can accommodate functional groups in their hydrophobic cavities and 
have great potential in protein surface recognition.[40,41,42,43,44] In most of these early examples, 
multiple electrostatic interactions towards charged amino acids were combined with dispersive 
interactions towards the unpolar ligand platform, further enhanced by the hydrophobic effect 
(exclusion of solvent molecules). Impressive results have been obtained when the artificial 
inhibitors were complementary in shape and charge distribution to the respective protein epitope.  
In my thesis I summarize recent work and progress in the direction of rational design of small 
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molecule receptors that efficiently interfere with the biological function of a protein–some of 
which are therapeutically relevant.  
 
1.3.1 Inhibition of potassium channels 
 
 In a rational approach to design small molecule inhibitors of proteins, Trauner et al developed 
synthetic inhibitors of potassium channels.[45] The latter are gated membrane pores for the 
regulated flux of metal cations which are essential for organisms as diverse as archaebacteria and 
humans.[46] Potassium channels control transmembrane potential and thereby vital cellular 
functions such as excitability, proliferation secretion and volume regulation. Each channel is 
formed by four protein subunits which self-assemble into a central pore. Some simple organic 
molecules are known to block these pores, such as the tetraethylammonium cation. A number of 
natural inhibitors have also been identified from scorpions, snakes, spiders and other organisms, 
but none of them takes advantage of the four-fold symmetry of the homotetrameric ion channels. 
 
       
 
Figure 1.5 (A) Tetraphenylporphyrin derivatives, designed to block hot spots in potassium channels (R = -NH2+-
(CH2)n-NH3+); (B) tetraphenylporphyrin (violet) docked onto its preferred binding site on the channel entrance.[45]   
 
In their seminal work, Trauner et al. proposed that fourfold symmetrical porphyrin scaffolds may 
be able to bind all four channel subunits simultaneously, resulting in a strong polyvalency effect. 
As a consequence his group synthesized and tested several cationic tetraphenylporphyrin (TPP) 
derivatives which bind to the four subunits of voltage-gated potassium channels of the Kv1.x 
class such as “Shaker” and “Kv1.3”. From a competitive binding assay with a hongotoxin (125I-
HgTX1A19Y/Y37F), a number of TPP derivatives, all decorated with a positively charged 
periphery, were found to bind to these potassium channels with nanomolar affinities (e. g., for 
compound 3, Ki = 20 nM). On the other hand, porphyrins with negatively charged groups did not 
B A 
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compete with hongotoxin binding, suggesting that the high affinity originates from specific 
interactions between cationic groups on the porphyrins and negatively charged (aspartate) 
residues located on the hot spots of each channel subunit. Electrophysiological experiments 
demonstrated, that cationic compounds indeed significantly inhibites the “Shaker” current in a 
reversible manner; however, complete inhibition was not attained even at high concentrations, 
raising the question whether the porphyrin really binds to all four channel subunits 
simultaneously, as proposed in the binding model (Figure 1.5). 
 
The putative binding mode of TPP derivatives on potassium channels has been the subject of 
further mechanistic studies.[47] Solid state NMR spectroscopy was combined with 
electrophysiological and pharmacological experiments in order to investigate structural 
alterations of the K+ channels. However, in contrast to the Trauner model, all structural data 
according to Ader pointed to deep penetration of the porphyrin into the channel pore with 
simultaneous insertion of one of its positively charged arms along the channel axis where the 
protonated amine group interacts with K+ ion binding sites. It was argued that although the 
synthetic porphyrin fulfilled the 4-fold symmetry requirement it did not utilize it, because its flat 
structure did not fit the conical shape of the channel pore and thus only partially inhibited the 
channel current in a nonspecific way. 
 
In another combined effort to design and synthesize more selective ligands for this job, Trauner 
and de Mendoza later reported about a family of multivalent calix[4]arene ligands which bind to 
the surface of Kv1.x channels in a reversible manner.[48] In contrast to flat porphyrins, these 
calix[4]arenes possess a conical C4-symmetry which is perfectly complementary to the shape of 
the Kv channels’ outer vestibule, thus providing features for optimal binding. Trauner and de 
Mendoza synthesized and evaluated a large number of calix[4]arenes with neutral, positively or 
negatively charged upper rims and free-OH or crown ether loops at their lower rims. 
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Figure 1.6 Calix[4]arene docked on the crystal structure of human valtage dependent Kv1.2 potassium channel. The 
Asp-379 side chains are represented, showing the 4-ion-pair, hydrogen-bonded contacts with the guanidinium 
residues of the calix[4]arene.[48] 
 
Molecular dynamics and electrophysiological experiments were performed to investigate the 
structural and functional aspects of the interaction between these calix[4]arene derivatives and 
potassium channels. Ligands with cationic (guanidine and arginine) substituents at the upper rims 
bind the protein with high affinity by interacting with an anionic Asp-379 residue, which is 
conserved in all the potassium channels of the Kv1.x subfamily. Simultaneously, the lower rim 
adorned with free hydoxyls is embedded inside the channel pore where it establishes a cyclic 
array of four hydrogen bonds in the turret loop (Figure 1.6).  
 
By contrast, calixarene ligands substituted with carboxylate, neutral or ammonium groups at the 
upper rims do not show significant inhibition effects on the “Shaker” ion current. Thus, simple 
guanidinylated phenols shows no inhibition effect even at 50 µM, strongly indicating the 
importance of multivalency and preorganization present in the active calix[4]arenes. 
 
1.3.2 Control over the tetramerization domain of mutant P53-R337H protein 
 
Protein P53 is also called the tumor suppressor protein or the “genome guardian”. It is a 
transcription factor, responsible for mediating cell cycle arrest or apoptosis when its DNA is 
damaged.[49] Mutations in P53 were found to initiate around 50% of all kinds of human cancer. 
Human P53 protein contains 393 amino acids and is structurally as well as functionally divided 
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into four domains. Two identical protein chains, each consisting of an α-helix and a β-strand, fold 
into an intertwined secondary structure called “dimer”, stabilized through a major ion-pair 
interaction between Arg-337 and Asp-352 (Figure 1.7A). The active form of the protein is a 
tetramerization domain in which two of these dimers are held together by strong hydrophobic and 
hydrogen bonding interactions. In the mutant P53-R337H, Arg-337 is replaced by histidine which 
is unable to form the ion pair bridge with Asp-352 because the histidine is not fully protonated at 
physiological conditions. This mutation destabilizes the whole tetramerization domain and 
renders the organism susceptible to tumor setup. 
 
Further, the development of effective synthetic P53 ligands came from the Giralt and de Mendoza 
groups, who again used the shape complementary of a calixarene platform to the conical cavity of 
a self-assembled protein.[50] It was reasoned that combination of the calixarene’s cone 
conformation with appropriately positioned positively charged groups would efficiently 
complement the hydrophobic environment inside the protein tetramer and the negatively charged 
glutamate residues located on its outer surface. 1H-STD NMR, 15N-1H-HSQC NMR, Differential 
Scanning Calorimetry (DSC), and MD simulations were all used to characterize this protein-
ligand binding process.  
 
Intriguingly, already the simple conical calix[4]arene ligand (Figure 1.7B)  meets the above 
mentioned criteria. Two of these calix[4]arene molecules sit like corks in the hydrophobic clefts 
of the protein, which recovers its tetramer integrity and thus protein begins to work again (Figure 
1.7C). The four guanidiniomethyl groups at the upper rim of this calix[4]arene undergo 
electrostatic and hydrogen bonding interactions with Glu-336 and Glu-339 and the calixarene’s 
hydrophobic surface together with both crown ether loops at lower rim fit nicely and 
cooperatively into the hydrophobic pocket of the P53 tetramer assembly, stabilizing the whole 
ensemble. 
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Figure 1.7 Protein p53TD and docking of ligand 1. (A) Primary p53 dimer showing the two major R337–D352 
interactions. (B) Tetraguanidiniomethylcalix[4]arene ligand. (C) Two calix[4]arene molecules with guanidiniomethyl 
groups stabilizes the mutated tetramerization domain of the tumor suppressor P53 protein. [50] 
 
1.3.3 Protein camouflage in cytochrome c–calixarene complexes 
 
Recently, Crowley et al. were successful to generate a crystal structure of p-
sulfonatocalix[4]arene complexing the surface of cytochrome c.[51] Cytochrome c is known as a 
pseudospecific binder to its protein partners involved in redox processes and apoptosis. NMR 
titration data revealed that the binding process involves two or more binding sites; however, 
binding affinities were estimated only in the range of 0.8-1.6 mM. In the crystal structure is 
shown that three sulfonatocalix[4]arene molecules bind to three different lysine residues (Lys89, 
Lys4 and Lys22) in two crystallographically separate molecules of Cyt c (Figure 1.8). Clearly, the 
ligand binds to lysine by encapsulating the amino acid side-chain and by forming at least one 
hydrogen bond between its peripheral sulfonate anions and the ammonium cation of lysine. 
Electrostatic contributions were investigated by varying the ion concentration. In the absence of 
50 mM NaCl the binding affinities increased by a factor of 1.6, indicating the decrease in 
electrostatic screening effects of ions. Though, the effects of sulfonatocalix[4]arene on the 
reactivity of Cyt c have not yet been carried out, these crystal structures are first of its kind and 
very encouraging towards the supramolecular approaches of biological interference.  
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Figure 1.8 Crystal structure of sulfonatocalix[4]arene complexed at three different lysines on two different 
molecules of cytochrome c (Cyt c).[51] 
 
All the above examples showed how rationally designed molecules can use non-covalent 
interactions to bind to selected residues on the surface of large proteins.  
 1.4 Receptor molecules for amino acids  
 
Most of the artificial receptor molecules utilize the multivalency to bind proteins and to date no 
receptor molecule is reported which is amino acid specific and interferes with biological process 
of proteins. Amino acid specific receptors can be of great importance in modern medicinal 
chemistry. For example, there are only a few amino acids or sequences of amino acids that 
contribute most to the structural and functional aspects of a protein or enzyme. The group of 
these key amino acids is called hot spot.[52] Therefore, such key residues in a protein could be 
attractive targets for amino acid specific receptors. The artificial receptors can be modified and 
developed to interact with a specific region in a protein and therefore, become protein selective.  
 
In the supramolecular chemistry community, a number of artificial receptor molecules have been 
developed for amino acids. Pioneering work came from Cram (binaphthyl crown ethers),[53] 
Sessler (sapphyrins),[54,55,56] Chin (coordination complexes),[57] de Mendoza (chiral bicyclic 
guanidines)[58,59] and Sanders (zinc porphyrins).[60] Later amino acid specificity was achieved by 
crown ethers adorned with a “recognition unit” (lysine, H.-J. Schneider, B. König),[61,62] glycoluril 
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clips (aromatic amino acids, R. Nolte),[63,64] polycyclic pyridines (arginine, T. Bell),[65] 
macrocyclic Tröger’s base derivatives (lysine/arginine, D. Dougherty),[66] zinc and copper chelate 
complexes (histidine, B. König, E. V. Anslyn),[67,68] boronic acids (homocysteine, R. Strongin),[69] 
guanidiniopyrroles (aspartate, glutamate, C. Schmuck),[70,71] cucurbit [7]uril (phenylalanine, A. R. 
Urbach)[72]  etc. All represent powerful mono- or ditopic host molecules with functionalities 
complementary to the side chains of proteinogenic amino acids. Some of these also operate in 
water, but very few cases have been reported where these receptor molecules are able to interfere 
with biological processes.  
 
In particular, basic amino acids lysine and arginine play vital role in biological processes.[73] 
Histones are specifically acetylated and deacetylated at side chain ammonium group of lysine to 
activate or repress gene regulation (transcription).[74,75] RNA binding proteins are arginine rich 
and bind through specific electrostatic interactions with phosphate anions in the neucleotide 
backbone, for example; arginine rich transcriptional activator Tat and Rev are involved in the 
replication step of human immunodeficiency visus type 1 (HIV-1).[76,77] Further, KAA sequence 
is an important building block in the bacterial cell walls.[78] Lysine peptide KLVFF is associated 
with Aβ aggregation in Alzheimer’s disease.[79] The RGD sequence is another important 
recognition element found in many proteins that interact with integrins on cell surface.[80] 
 
Though basic amino acids are crucial in protein’s structures and functions, there are only selected 
potential artificial receptors for these amino acids. For example, apart from our research group, 
two receptors are known for amino acid lysine and arginine. Polycyclic pyridines developed by 
Bell et al. is an interesting example that bind guanidinium group of arginine through multiple 
arrays of hydrogen bonds and known as Bell’s arginine cork (Figure 1.9), however, in aqueous 
solution only 1100 µM affinity (Kd) is achieved.  
 
Figure 1.9 Structures of Bell’s arginine cork[65] (left) and Dougherty’s cylcophane receptor for arginine.[66] 
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Substituted cyclophanes, developed by Dougherty group, are another class of potential receptors 
(Figure 1.9) having the best affinity of 200 µM for arginine. These carboxylic cyclophane 
receptors are arginine selective over lysine and form complexes by utilizing the cation-л, 
electrostatic and hydrophobic interactions. Certain calix[4]- and -[5]arenes have also been 
identified that binds to lysine and arginine.[41,42,44] König et al. attached two crown ethers via a 
suitable linker to bind diammonium lysine, however, in aqueous buffer solutions the binding was 
almost immeasurable (Ka < 10 M-1).[62]  
 
In the below example is shown how the strong binding of lysine is achieved in proteins. 
Methylated lysine histone (for example; H3K4me3) is associated with transcription start site of 
active genes. Crystal structures of histone H3K4me3 bound by plant homeodomain (PHD) finger 
of human BPTF are obtained (Figure 1.10).[81] Interestingly, in the crystal structure, a cage of 
aromatic amino acids of the protein BPTF is formed surrounding the trimethylated lysine side-
chain of histone. An affinity of 3 µM was estimated for BPTF binding to H3(1-15)K4me3 using 
calorimetric measurements. This is an interesting example where only one lysine residue play 
critical role in biological recognition through hydrophobic and cation-л interactions. 
 
 
 
Figure 1.10 Crystal structure of protein BPTF bound to H3K4me3. In yellow is shown trimethylated lysine and in 
cyan aromatic residues of PHD  domain of protein BPTF.[81] 
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1.5 Molecular tweezers 
 
In recent years, our group has explored new mechanisms of supramolecular interference with 
protein and peptide activity by means of molecular clips and tweezers.[82,83,84,85] Molecular clips 
draw the biologically active part of the respective cofactor (NAD+ or NADP+) into their cavities 
and are able to reversibly inhibit enzymatic processes.[83,86] On the other hand, molecular 
tweezers encapsulate the side chain of Lys and Arg amino acids[87] and prevent the protein 
aggregation events.[88] The phosphonate tweezer was the first water soluble artificial receptor that 
bind to lysine with the dissociation constant, Kd = 200 µM in neutral phosphate buffer. Later on, 
even much higher affinity was achieved by the phosphate analog that binds to lysine in neutral 
phosphate buffer with 20 µM affinity[83]. Therefore, the phosphate tweezer was proved to be more 
water soluble and highly selective artificial receptor molecule for lysine. The structures of the 
two tweezers and electrostatic potential surface of the phosphate tweezer are shown in Figure 
1.11. 
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Figure 1.11 Structures of the phosphonate and the phosphate tweezers developed in the Schrader and the Klärner 
groups, and electrostatic potential surface of the phosphate tweezer showing high electron density cavity (right).[89]  
 
These molecular tweezers adorned with anionic phosphate or phosphonate groups on the central 
benzene ring feature electron-rich and torus-shaped cavity. The exquisite selectivity for lysine or 
arginine is achieved through threading the amino acid side-chain into the cavity and locking the 
phosphate/phosphonate and ammonium/guanidinium ions by the salt-bridge formation.  NMR 
and ITC titrations showed the enthalpy driven complex formation between the tweezers and 
lysine/arginine which results from van-der Waals and electrostatic interactions. Molecular 
modeling studies provided structural insights of a complex formed by these molecular tweezers 
with lysine or arginine guests (Figure 1.12).[87] 
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Figure 1.12 Left: schematic drawing of lysine/arginine binding to phosphonate tweezer; Middle: calculated structure 
of the phosphonate tweezer- AcLysOMe complex;[87] Right: calculated structure of the phosphate tweezer-
AcLysOMe complex.[89] Both the structures were calculated using conformational search (Macro Model, 
Amber*/water, 5000 steps). 
 
Given the low micromolar affinities in aqueous solution towards basic amino acids, the 
phosphate tweezer possesses high potential to interfere with the biologically relevant peptide or 
proteins in which lysine or arginine residues play crucial roles. This hypothesis was explored by 
Prof. Bitan at UCLA who work on the structure-based inhibitors of amyloid proteins involved in 
Alzheimer’s disease and type II diabetes etc. Prof. Bitan in collaboration with our group 
investigated the inhibition potential of the molecular tweezers against aggregation and toxicity of 
the amyloid proteins.[88] Biophysical and cell assays studies suggested that the phosphate tweezer 
is capable of inhibiting the aggregation and toxicity of multiple amyloidogenic proteins. Using 
the mass spectrometry and solution-state NMR it was shown that the phosphate tweezer binds to 
the lysine residues in the amyloid-β protein and disrupts the hydrophobic and electrostatic 
interactions which are thought to be crucial for the nucleation of aggregation process. With its 
great potential, the phosphate tweezer was named CLR01. 
 
Bitan et al. investigated the inhibition of aggregation processes of Aβ42 by the phosphate tweezer 
using Thioflavin T (ThT), circular dichroism (CD), electron microscope (EM) etc techniques. The 
decrease or no change in ThT fluorescence in the presence of the phosphate tweezer indicated the 
prevention of protein aggregation (Figure 1.13b). The same samples of ThT experiments were 
analyzed into electron microscope which showed long needle shaped fibrils of amyloid proteins 
in absence of CLR01, while only amorphous structures in the presence of CLR01 were observed 
(Figure 1.13e). 
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Figure 1.13 (b) CLR01 inhibition of Aβ42 aggregation measured by ThT fluorescence. (e) Morphological analysis 
of Aβ42 in the absence or presence of phosphate tweezer (CLR01) was examined at the end of each aggregation 
reaction. Phosphate spacer (CLR03) was used as a negative control.[88] 
 
 
 
 
Figure 1.14 Dose-dependent inhibition of toxicity of amyloidogenic proteins by CLR01. (a) Increasing 
concentrations of CLR01 were incubated with differentiated PC-12 cells for 24 h. (c) Oligomers of protein Aβ42 
were added to differentiated PC-12 or RIN5fm cells in the absence or presence of increasing CLR01 concentrations. 
Cell viability were measured using the MTT reduction assay.[88] 
 
The toxicity and rescue effects of CLR01 on the cells in the presence of amyloid aggregates were 
tested in cell viability assays. The results indicated that CLR01 is not toxic upto a high 
concentration of 200 µM and only at about 400 µM little toxicity of CLR01 was observed (Figure 
1.14a). On the other hand, CLR01 rescued the cell viability from the toxicity of various proteins 
aggregates. At about 100 µM concentration of CLR01 cells were rescued and restored into fully 
functioning state (Figure 1.14c).  
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These intriguing results lead to further develop the molecular tweezers into more powerful and 
selective receptors. To understand the importance of the phosphate groups, it is necessary to 
replace them with other different anions of similar nature and investigate the role of each anion in 
the binding process and inhibition potency of the respective tweezers. Since the diphosphate 
tweezer is symmetrical and cannot be selective to a particular protein target, it is also necessary to 
transform at least one of the phosphate groups into an additional protein specific or amino acid 
sequence specific binding unit. 
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2 Goal of the work 
 
My doctoral thesis aims at the development of molecular tweezers with increased affinity and 
specificity for amyloidogenic proteins. A particular focus lies on the amyloid-β protein. The 
molecular tweezer 133 with two phosphate groups operates in aqueous medium and selectively 
binds to the amino acids lysine and arginine both in peptides and proteins.[89,90] Recently this 
tweezer was reported to inhibit the aggregation and toxicity of amyloid proteins.[88] It is evident 
that the strong binding of the phosphate tweezer 133 to lysine or arginine resulted from specific 
hydrophobic, electrostatic and cation-л interactions. The development of molecular tweezers will 
be approached in two parts. 
2.1 Role of different peripheral anions 
 
The phosphate groups on tweezer 133 not only render the tweezer water-soluble, but are also 
essential to lock the ammonium or guanidinium cations of basic amino acids into an internal ion 
pair. Therefore, replacing the phosphate anions with other anionic groups of biological relevance 
would be an interesting study which may result in improved tweezer design, if the differences in 
the binding characteristics of anionic groups can be explored. Phosphates, carboxylates and 
sulfates are ubiquitous in biological structure, function and regulation. The sulfate group has 
pulled more attention in developing new substances with pharmacological 
importance.[91,92,93,94,95,96,97] Despite the similar structure and pyramidal shape of phosphate and 
sulfate, they are highly specific in biological systems. For example; phosphate-binding protein 
(PBP) selectively transport the phosphate anions in biological process, while unable to recognize 
other polyanionic groups such as sulfate.[98] On the other hand, sulfate-binding protein, involved 
in the active transport of sulfate, is highly specific for sulfate and do not bind to phosphate.[99] 
Another interesting example is the heparin binding to antithrombin-III (AT-III). This binding is 
achieved through AT-III interactions with sulfate groups in sugar units of heparin. Boeckel et al 
showed that the replacement of a particular sulfate group by a phosphate group resulted in the 
inactive analog of pentasaccharide domain.[100]  
Apart from the biological systems, many groups have explored the functional aspects of artificial 
receptors that are substituted with these anionic groups. Klärner et al. studied the supramolecular 
properties of several molecular clips substituted with phosphate, phosphonate and sulfate anions 
(Figure 2.1).[101] Interestingly, they found substantial difference in the binding characteristics of 
these clips as shown in Table 2.1. The phosphate clip 18h binds substantially stronger to caffeine 
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and SAM compared to the sulfate clip 36 and the phosphonate clip 18g. On the other hand, the 
sulfate clip 36 binds to NMNA and Kosower Salt more strongly compared to the clips 18h and 
18g. 
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Figure 2.1 Structures of the three anionic clips studied in the Klärner group.[101] 
 
In another example, Nilsson et al.[102] synthesized a series of O2-anion-substituted 
galactopyranosides and studied their binding to arginine-rich proteins galactins. In the 
comparison study of sulfate and phosphate substituted ligand, they found sulfated ligand were 
several fold superior over the phosphate substituted ligand. There could be several factors like; 
charge, resonance stabilization of charge and solvation of anions, etc that affect the selectivity 
and specificity of the ligands containing these anionic groups.  
 
Though, phosphate and phosphonate tweezers have already been synthesized and studied in 
Klärner and Schrader groups, the binding comparisons among the phosphate, phosphonate, 
sulfate and carboxylate anionic tweezers have not yet been investigated. These studies should be 
of great importance, in particular, when we would like to develop molecular tweezers as 
therapeutic candidates. Therefore, specific and selective binding characteristics and toxicity 
effects of these anionic tweezers should also be screened in biological system. 
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Table 2.1 comparisons among the dissociation constants of the sodium sulphate naphthalene clip 36, the tetralithium 
phosphate clip 18h and the dilithium phosphonate clip 18g in buffered water solution (pH= 7.2) measured by means 
of 1H NMR titration experiments at 25 ºC. 
 
Guest 
Host 
36 Kd [µM] 18h Kd [µM] 18g Kd [µM] 
N
N N
N
O
O
 
Caffeine 
345 23 105 
N
O O
I
 
Kosower Salt 
12a 53 1190 
N
NH2
O
I
 
NMNA 
6 30 88 
N
NN
N
NH2
O
OHOH
HH
HH
SH2N
CO2H
 
SAM  
1064 185 833 
a Measured in pure D2O[101]  
 
In the first part of this thesis, the effects of these anionic groups on the tweezer will be 
investigated (Figure 2.2). For this reason, the sulfate tweezer 161 will be synthesized for the first 
time to carry out comparative binding studies among phosphate, phosphonate, sulfate and 
carboxymethyl tweezers with derivatives of basic amino acids and relevant peptide guests such as 
KAA, KLVFF, RGDFV and IAPP fragments.  
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Figure 2.2 Structures of the four symmetrical anionic tweezers substituted with phosphonate, phosphate, sulphate 
and methylcarboxylate anions. 
 
Due to the difference in basicity, shape, charge, solvation and stereoelectronic properties of the 
four anions, these tweezers are supposed to provide substantial differences in the binding 
characteristics toward their peptide guests. Guest binding studies will be performed by NMR, 
fluorescence, ITC experiments and molecular modeling simulation. 
2.2 Role of different linker groups on monophosphate tweezers 
 
The symmetrical prototype which carries two phosphate anions at its periphery, does not 
distinguish between well-accessible lysine residues on a protein surface. To develop further their 
diagnostic as well as therapeutic potential these new lead structures must become protein- or 
peptide-specific, and thus avoid unwanted side effects. Since only one phosphate is used for 
ammonium- or guanidinium recognition, the other one may be replaced by a second binding site, 
connected to the parent tweezer by a suitable linker, which corresponds to the distance between 
both functional groups on the protein surface. Therefore, in the second part of this work, I will 
develop unsymmetrical tweezers which carry additional recognition sites and hence become 
selective for a given protein epitope.  
 
Earlier observations from substituted neutral tweezer derivatives in organic media quite often 
demonstrated self-inclusion of extended aliphatic side chains, with the result, that guest affinities 
remained very modest, if binding was not blocked at all. This unsatisfying behavior poses the 
open question, if also in buffered aqueous solution, certain linkers block the cavity entrance to 
our anionic phosphate tweezers, and prevent free access of amino acid and peptide guests?  
 
Common linkers which are often used in synthetic drug candidates to combine an alcohol with 
another active part of the molecule are mainly based on ether and ester functionalities. Ethers are 
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usually preferred over esters because of their greater hydrolytic stabilities. On the other hand, 
polar chains are considered to avoid unwanted hydrophobic clustering as well as increase water 
solubility of the resulting drug candidates.  
 
Several unsymmetrical molecular arginine and lysine tweezers which carry the above-mentioned 
linker units on one side and a phosphate anion on the other side of their central hydroquinone will 
be synthesized. These linkers which cover a broad range of polarities as well as anchor points for 
the covalent attachment of the secondary binding site will be attached to the parent hydroquinone 
by ester and/or ether junctions. The new unsymmetrical tweezers with attached linker units will 
be studied to evaluate the effects of their individual linker groups in complex formation. Only the 
best candidates will be equipped with recognition sites to achieve protein specificity.  
 
Our group has already established a close collaboration with Prof. Bitan’s laboratory (Department 
of Neurology, UCLA, U.S.A.) who will carry out biological studies of every new tweezer type 
about its influence on the aggregation of amyloidogenic proteins. The required chemical studies 
will be performed by myself.  
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3 Results and Discussion 
3.1 Synthesis 
3.1.1 Synthesis of the tweezer precursors  
 
The starting molecular tweezers required in this work are the dihydroxy tweezer 121 and the 
monohydroxy acetoxy tweezer 120, that were developed in the group of Prof. Klärner and were 
first synthesized by Kamieth.[103] The diacetoxy tweezer 119 served as the parent tweezer for both 
the starting precursors and was synthesized from the bisdienophile 107 (spacer) and the diene 115 
(side wall) through the Diels-Alder (DA) reaction.  
 
The Spacer 107 was synthesized in five steps as shown in Scheme 3.1 starting from p-
benzoquinone and cyclopentadiene. The DA-adduct 103 obtained in the first reaction was 
converted into the 1,4-hydroquinone intermediate 104 by triethylamine and subsequently was 
oxidized into the corresponding quinone derivative 105 by using p-benzoquinone as oxidizing 
agent. The syn and anti products were produced through the DA reaction of 105 and 
cyclopentadienes. The syn product 106 was purified by crystallization and converted into 
diacetoxy spacer 107 using acetic anhydride and DMAP in pyridine.  
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Scheme 3.1 Synthesis of the bisdienophile 107 (spacer). 
 
The diene 115 was synthesized in 7 steps (Scheme 3.2). The first step of the synthesis was the 
Diels-Alder reaction of indene and maleic anhydride. The reaction proceeds by refluxing the 
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reaction mixture at > 200 oC where indene converted into 1H-indene which undergoes a [4+2] 
cycloaddition with maleic anhydride and produced the adduct 110 in 20-40 % yield. In the next 
step, cis dimethylester 111 was produced by the estrification of anhydride 110 in the presence of 
acetyl chloride as acid catalyst. Then cis-dimethylester 111 was converted into 
thermodynamically more stable trans-dimethylester 112 using sodium methoxide. The trans 
diemethylster 112 was then reduced into trans diols 113 using LiAlH4. Chlorination of the trans 
diols 113 was carried out using the triphenylphosphine dichloride as a chlorinating agent and 
finally, the elimination of chlorides was conducted in alkaline media (KOH in THF) at 40oC to 
obtain the diene 115. 
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Scheme 3.2 Synthesis of the diene 115 (side wall). 
 
The most critical reaction in the synthesis of the tweezers is the coupling reaction of the diene 
115 and the bisdienophile 107 (Scheme 3.3). One molecule of the bisdienophile and two 
molecules of the diene were coupled by [4+2] cycloaddition. This reaction required high pressure 
and temperature and therefore was performed in the sealed ampoules at 170 oC under inert 
atmosphere for four days. The resulting adduct 118 was then oxidized into the corresponding 
diacetoxy tweezer 119 using DDQ as oxidizing agent in the refluxing toluene. The dihydroxy 
tweezer 121 was obtained by the reduction of acetoxy groups of the tweezer 119 using LiAlH4, 
whereas the monohydroxy acetoxy tweezer 120 was synthesized by selective removal of one 
acetyl group of 119 in alkaline NaOH. 
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Scheme 3.3 Synthesis of the dihydroxy tweezer 121 and the monohydroxy-acetoxy tweezer 120 
 
3.1.2 Synthesis of the phosphate tweezer 133 
 
The phosphate tweezer 133, was synthesized for the first time by Bastkowski[89] in the Klärner 
group (Scheme 3.4). The phosphate tweezer 133 was synthesized on a large scale to conduct 
more new experiments and to perform biological studies in several collaborations worldwide. 
Several projects were undertaken in collaboration on the tweezer 133, in particular with Prof. 
Bitan at UCLA. Prof. Bitan is responsible for biophysical and biological studies of the tweezers. 
The phosphate tweezer 133 was synthesized by the phosphorylation of the dihydroxy tweezer 
121 with phosphoroxy chloride. The intermediate tetrachloride 122 was washed several times 
with diluted aqueous HCl followed by hydrolysis in THF/H2O. The resulting crude product 123 
was washed several times with aqueous HCl solution. Neutralization of the tweezer 123 was 
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performed with aqueous NaOH in methanol to produce sodium salt of the phosphate tweezer 133. 
After washing the solid crude with minimum amount of dichloromethane or acetonitrile pure 
phosphate tweezer 133 was obtained. 
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Scheme 3.4 Synthesis of the phosphate tweezer 133. 
 
3.1.3 Synthesis of the sulfate tweezer 161 
The sulfate tweezer 161 was synthesized as shown in Scheme 3.5 using the optimized protocol by 
Cartagena.[101] To incorporate the sulfate groups into the tweezer, the dihydroxy tweezer 121 was 
treated with sulfur trioxide pyridinium complex in refluxing anhydrous pyridine. Initially, 4 eq. of 
SO3.Py complex were added and after 24 hour 3 eq. of the complex were additionally added to 
the reaction mixture. Basic work up by NaHCO3 furnished the sodium salt of sulfate tweezer 161. 
The final product was then purified by redissolving the crude in ethanol and subsequent filtration. 
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Scheme 3.5 Synthesis of the sulfate tweezer 161. 
 
3.1.4 Synthesis of 1st generation unsymmetrical linker tweezers 
Possible pathways 
In the past years, our group has been interested in designing and modifying the symmetrical 
tweezers to the unsymmetrical tweezers to make them more selective and specific. Usually, in the 
unsymmetrical tweezers one phosphate group is replaced by some other auxiliaries or recognition 
units. The recognition units are required to read a protein sequence or make additional 
interactions with a target protein. The other phosphate group on the tweezer is required for the 
tweezer’s water solubility and ion pair interactions with the cationic ammonium or guanidinium 
groups of a guest. 
 
There can be several pathways to make unsymmetrical tweezers. Three possible paths are shown 
in the schemes below. In the path 1 (Scheme 3.6), starting material is the dihydroxy tweezer 121. 
The first step of the path 1 can either be a nucleophilic substitution reaction of tweezer’s 
phenoxide with acyl or alkyl halides in the presence of an alkali base such as K2CO3 or a coupling 
reaction with a carboxylic group using PyBOP and N-Methylmorpholine. The latter conditions 
have been employed by Talbiersky.[90] The first step of path 1 is uncontrolled with respect to the 
reaction of two hydroxyl groups of the tweezer 121 and therefore, the disubstituted tweezer 136 
is also formed along with the required mono substituted tweezer 135. In the second step, 
phosphorylation of the second hydroxy group of the tweezer 135 was achieved using 
phosphoroxy chloride but the yield of the product in the first step is less than 50 % which makes 
this approach less suitable. 
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Scheme 3.6 Synthetic scheme for the preparation of unsymmetrical phosphate tweezers starting from the 
dihydroxy tweezer 121 through path 1. 
 
The phosphodichloride intermediate can be directly hydrolyzed by water to produce the required 
phosphate tweezer. However, when the phosphorylation did not work completely, the separation 
of unreacted starting material and product was very difficult due to the highly polar free 
phosphate group on the tweezer. Even more, the phosphate group was cleaved during the normal 
silica gel column chromatography. Therefore, instead of direct hydrolysis, the phosphodichloride 
intermediate was reacted with methanol to get dimethylphosphate precursor 137. After the 
column chromatography purification and removal of the protecting methyl groups by 
trimethylsilyl bromide pure product was obtained in good yield. 
 
The monohydroxy acetoxy tweezer 120 was synthesized to minimize the loss of the starting 
material by the formation of the disubstituted acyl or alkyl precursors.[103] However, excess of 
NaOH used in his protocol produced mixture of the monoacetoxy tweezer, the dihydroxy tweezer 
and the starting diacetoxy tweezer. Further, the product formation could not be monitored by TLC 
because all these tweezers were having same Rf value. Therefore, only one acetyl group was 
hydrolyzed by using 1.1 eq. NaOH, but allowing the reaction for longer time (20 hours). Though, 
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compared to path 1 there is one extra step in path 2 but good yield obtained by path 2 make it 
more suitable over path 1.  
 
Path 2 and 3 
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Scheme 3.7 Synthetic scheme for the preparation of unsymmetrical phosphate tweezer by path 2 and path 3. 
 
Path 3 was recognized during the synthesis of the acetoxy phosphate tweezer 193. As a 
convenience, esterification of the intermediate phosphoryl chloride with excess methanol also 
cleaved the acetyl group and directly furnished the tweezer 189. After column purification, the 
tweezer 189 was obtained in 65% overall yield. Product can also be purified by crystallization in 
methanol. Initial attempts to alkylate or acylate the tweezer 189 were successful and the protected 
phosphate group appeared stable under the basic conditions. Following the path 3, there are two 
advantages: 1) phosphorylation of each new tweezer will not be required as in other two paths; 2) 
in the same pot acetyl group can be cleaved to furnish the required monohydroxy 
dimethylphosphate tweezer 189.  Therefore, path 3 proved to be the convenient path, and 
majority of the new unsymmetrical tweezers were prepared following the path 3. 
 
3.1.4.1 Synthesis of the acetoxy phosphate tweezer 193 
 
To understand the effects of ester junction, we synthesized the acetoxy phosphate tweezer 193. 
Acetoxy group was attached to the hydroxyl group in the tweezer 189 using acetyl chloride and 
triethylamine (Scheme 3.8). In the next step, complete dealkylation on phosphorus using 
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trimethylsilylbromide TMSBr in CH2Cl2 leads to the acetoxy phosphate tweezer 193. For 
complete removal of both methyl esters on phosphorus, TMSBr qualified as a powerful reagent, 
which acts under mild conditions and leaves ester as well as ether links untouched. Due to acetyl 
group sensitivity towards sodium hydroxide, we used the acetoxy tweezer 193 without 
neutralization of its phosphate group by NaOH. 
 
THF, 0°C to RT, 5 h
             87%
CH3COCl, Et3N
192
O
O
P
O O
O
O
193
O
O
P
O OH
OH
O
1. TMSBr, CH2Cl2
    0°C to RT, 8 h
2. CH2Cl2/H2O (1:1)
    RT, 16 h
    97%
189
O
OH
P
O O
O
 
 
Scheme 3.8 Synthesis of the acetoxy phosphate tweezer 193 
 
3.1.4.2 Synthesis of the octyl phosphate tweezer 195 
 
To investigate the hydrophobic interactions in the unpolar region of Aβ, we synthesized the 
tweezer 195 substituted with a long octyl chain. The monohydroxy dimethylphosphate tweezer 
189 was deprotonated to generate the nucleophilic phenoxide anion, which reacted with 1-
bromooctane and produced the tweezer 182. Both the methyl esters on phosphorous were 
removed by TMSBr in the same way as for the tweezer 193. Treating the resulting free phosphate 
tweezer with 2 eq. of aqueous NaOH in methanol furnished the sodium phosphate salt of the 
octyl tweezer 195. Previously, initial attempts were made to prepare 195 according to path 2 but 
the phosphorylation followed by hydrolysis to generate directly free phosphate tweezer did not 
furnish pure product. Further, purification of the resulted crude was difficult as the free phosphate 
group (-OPO3H2) was cleaved during the silica gel column chromatography. 
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Scheme 3.9 Synthesis of the octyl phosphate tweezer 195. 
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3.1.4.3 Synthesis of the ethoxycarboxymethyl phosphate tweezer 196 
 
We designed the tweezer 196 to keep the ester group in the linker, but to avoid the more 
susceptible phenolic ester group we shifted the ester group one carbon farther and converted the 
phenolic ester into an alkyl ester.  With this molecule, we expect that due to the carboxylic ester 
group, the linker will avoid to interact with the cavity. Further, the ester group will make the 
linker soluble in the aqueous solution. Also, a recognition site can be easily coupled with the 
carboxylic group. The tweezer 196 was prepared in the similar way as the tweezer 195. Here, 
Finkelstein conditions were established by addition of KI in acetone, so that bromide was 
smoothly displaced from ethyl bromoacetate by the tweezer’s phenoxide. The reaction completed 
in 16 hour in refluxing acetone while at room temperature 4 days were required. After column 
chromatography purification the tweezer 191 was obtained in 73% yield.  
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Scheme 3.10 Synthesis of the ethoxycarboxymethyl phosphate tweezer 196. 
 
In the Next step, methyl groups on phosphorous were cleaved selectively using TMSBr and 
without affecting other functionality like the ethyl ester. Neutralization of the phosphate group 
with NaOH also partially hydrolyzed the ethyl ester group. Therefore, the tweezer 196 was used 
as such without the neutralization of its phosphate group by NaOH.  
 
3.1.4.4 Synthesis of the glycerol phosphate tweezer 198 
 
Epoxides are reactive towards a large number of nucleophiles (O, N, C and S).[104,105,106,107] To 
explore different type of linkers at the tweezer we chose to utilize epoxide chemistry. Herein, we 
designed an epoxide containing tweezer 164. Such epoxides can provide several advantages in 
the tweezer synthesis, such as: 1) epoxide group can be opened with a variety of nucleophiles; 2) 
depending on the acidic or basic conditions, epoxides can be opened to generate primary or 
secondary hydroxy group; 3) new hydroxy group generated will add to the tweezer’s solubility in 
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water; 4) hydroxy group can also participate in guest interactions and; 5) hydroxy group provides 
anchor point for further functionalization of the tweezer. 
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Scheme 3.11 Synthesis of the glycerol phosphate tweezer 198. 
 
Using this approach, the glycerol phosphate tweezer 198 was synthesized in which the linker is 
consists of a glycerol backbone (Scheme 3.11). Treatment of the monohydroxy precursor 120 
with glycidyl nosylate in the presence of caesium floride furnished the respective epoxide ether 
164. Following a protocol from Furukawa and Otera[108], a 6-fold excess of CsF was employed 
which serves a dual purpose: one equivalent deprotonates the phenol as a non-nucleophilic base 
and generates the highly nucleophilic caesium phenoxide, another equivalent binds the resulting 
sulfonic acid. The nitrobenzenesulfonate (Ns) derivative directs the nucleophilic attack 
exclusively to the C-1 position, so that no racemization occurs at C-3. During subsequent ring 
opening with excess sodium ethoxide, the acetoxy group was once more simultaneously cleaved, 
leading to the intermediate 172 with a phenolic and a secondary aliphatic hydroxy moiety. This 
reaction can later be used to introduce the second binding site from alcohols or amines. 
Phosphorylation with POCl3/Et3N takes place exclusively on the phenolic group of the tweezer 
172, and generates, after hydrolysis and neutralization, the mono sodium salt of the glycerol 
phosphate tweezer 198.   
 
All the new 1st generation linker tweezers as well as their intermediates have been fully 
characterized by spectroscopic methods. The existence of the phosphate moiety has been 
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unequivocally established by HRMS and 31P NMR spectroscopy. The unsymmetrical tweezers 
are all soluble in water (1-50 μM). However, for NMR measurements at millimolar 
concentrations, methanol was added to the aqueous buffer (CD3OD/D2O phosphate buffer). 
 
3.1.5 Synthesis of the 2nd generation unsymmetrical tweezers 
 
Recently, we designed a new approach to make unsymmetrical tweezers that can overcome the 
problems such as poor water solubility, low affinity and self inclusion of linker. We adopted 
synthetic route similar to DNA synthesis.[109,110] Installing one phosphate in its protected form on 
one side of the central benzene ring (189), a trivalent phosphorous was attached on the other side 
in order to obtain phosphoramide intermediate 246. This was achieved in 90% yield by reacting 
phenolic -OH group of the tweezer 189 with phosphorylating reagent, N,N-
Diisopropylmethylphosphonamidic chloride  in presence of DIPEA. To the intermediate 246, two 
different linkers were attached that can later be coupled with a recognition unit.  
 
2nd generation linker 1:  the tweezer 247 was synthesized with a linker unit that has a terminal 
carboxylic ester group. Such an ester group can be selectively hydrolyzed and coupled with 
alcohol- or amine-containing recognition units. In the last step, the protecting groups can be 
cleaved to furnish the desired unsymmetrical tweezer molecule. The reaction of phosphoramide 
tweezer 246 with alcoholic linker methyl glycolate and subsequent oxidation of trivalent 
phosphorous to pentavalent phosphorous by t-butyl hydroperoxide produced the fully protected 
product 247 in 50% yields (Scheme 3.12). For the lower yield of 247, it can be suspected that 
excess of alcoholic linker replaced with the tweezer on the trivalent phosphorous in 246. To 
examine the effect of oxidizing reagent, iodine can be used for the oxidation of the trivalent 
phosphorous. Initial attempts to deprotect the methyl ester of phosphate were made using LiBr 
and TMSBr. LiBr is a mild method for the cleavage of methyl group on phosphorous, but even 30 
eq. of LiBr partially cleaved the methyl ester groups and did not produced the final product 252. 
TMSBr, though, cleaved all the methyl groups, but the final product 251 was not obtained pure. 
In future, more elaboration of the deprotection step will be required to obtain the clean product. 
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Scheme 3.12 Synthesis of the carboxylic ester linker tweezer 251/252. 
 
Hydrolysis of phosphate diesters by suitably placed nucleophile has been reported.[111] Further, 
the hydrolysis rate could be enhanced by divalent metal ions such as Mg2+ and Zn2+. In the below 
depicted example, an intramolecular cyclic phosphate ester was formed by the exocyclic attack of 
a carboxylic oxygen on the phosphorous, liberating the phenoxide as a leaving group in a 
reversible manner. The similar hydrolysis mechanism can be expected in our case when we 
neutralized the deprotected tweezer with NaOH to obtain the tweezer 251. Therefore, to avoid 
such a highly favorable five or six membered ring formation, one could use a longer linker 
separating the ester and hydroxyl groups by three or more atoms. Another possibility could be 
that a recognition unit should be synthesized with a hydroxyl group that can react with 
phosphoramide 246.  
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2nd generation linker 2: a linker that has a terminal alkyne group can be more potent. A terminal 
alkyne provides the great advantage that a tweezer and a recognition unit can be coupled in water. 
A molecular tweezer such as 257 and a recognition unit with azide functionality can easily be 
prepared and then could be coupled by the famous cupper catalyzed click reaction. To explore 
further the synthetic utility of the trivalent phosphorous, the tweezer 248 was prepared in 50 % 
yield by the reaction of 246 and 3-butyn-1-ol (Scheme 3.13). Here, the deprotection of the methyl 
groups shall be carried out, for which TMSBr can be used as a potential reagent.  
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Scheme 3.13 Synthesis of the alkyne linker tweezer 248/257. 
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3.2 Binding Studies 
3.2.1 Binding studies of the anionic tweezers 
 
Rational design of the artificial receptor molecules for a given target lies in the heart of non-
covalent interactions between the two species. Therefore, in the proper designing of receptor 
molecules, it is essential to understand several aspects of the molecular interactions through the 
different techniques. In this chapter we investigated the self associations and the guest binding of 
the different anionic tweezers shown in Figure 3.1. 
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Figure 3.1 Structures of the four symmetrical anionic tweezers synthesized to date. 
 
The work discussed in this section was performed by several colleagues of our group and Klärner 
group and, I am very much thankful to them. Synthesis and studies of the tweezer 133 were 
performed by Frank Bastkowski[89], Peter Talbiersky[90] and me. The tweezers 161, 734 and 150 
were synthesized and studied by me, Michael Fokkens[112] and Constanze Wilch[113] respectively. 
 
3.2.1.1 Self association properties of the sulfate tweezer 161 - comparison with other anionic 
tweezers 
The tendency of an artificial receptor molecule to self-assemble can lower the receptor’s ability 
to complex a guest molecule. Therefore, a potential receptor should have low affinity to self-
assemble for optimum function under the desired conditions. It is known that the phosphate 
tweezer 133 weakly self assemble into the dimer (Kdm = 60 μM) in aqueous solution. Expectedly, 
the tweezer 161 also shows the different chemical shift patterns of aromatic protons in D2O and 
methanol-d4. The aromatic signals in methanol are sharp and split while the signals in D2O are 
broad and shifted. These changes indicate that distinct supramolecular assemblies are formed in 
37 
the two solvents. Concentration dependent 1H-NMR dilution titration of the tweezer 161 in 
aqueous phosphate buffer produces the dimerisation constant Kdm = 370 M-1 (Table 3.1).  
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Figure 3.2 Concentration dependent 1H-NMR signals of the sulfate tweezer 161 in phosphate buffer (10 mM, pH 
7.2) at 25oC.  
 
From the NMR titration it is obtained that the protons 2-H, 3-H, 13-H and 14-H are highly 
dependent on the tweezer concentration and influence most (Δδmax ~ 2.0 ppm) due to the 
magnetic anisotropy from the aromatic rings of the second tweezer molecule (Figure 3.2). Other 
aromatic protons are only weakly shifted (Δδmax ~ 0.3 ppm) and the chemical shifts of the non-
aromatic protons of 161 are independent of the tweezer concentration.  
 
Molecular modeling calculations were performed for the monomeric 161 and the dimeric 1612 
tweezers. The resulted minimum energy structures are listed in Figure 3.3. In the monomeric 
structure of the tweezer 161, both the anionic sulfate groups are pointed upward away from the 
electron rich cavity. The calculated structures of the dimer 1612 supports the chemical shift 
pattern observed by the 1H-NMR titration. The calculated entangled dimer 1612 is also quite 
similar to the calculated phosphate tweezer dimer 1332. 
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Figure 3.3 Molecular modeling structures of the sulfate tweezer 161 (left) and its dimer 1612 (right) obtained by the 
Monte-Carlo Simulation (Maestro 9.2, OPLS_2005, water, 5000 steps). 
 
Self association properties of the four anionic tweezers were compared to understand the effects 
of the different anions. Experimental data on the measured dimerisation constants (Kdm) and 
maximum chemical shift difference (Δδmax) are listed in the Table 3.1. Unexpectedly, 
dimerisation of the sulfate tweezer 161 is stronger than the dimerisation of the phosphate tweezer 
133. On the other hand, the phosphonate tweezer 734 and the carboxymethyl tweezer 150 do not 
self-assemble. Since the hydrophobic skeleton is common in all the tweezers, the difference in 
their dimerisation must arise due to the different anionic groups.  
 
The calculated structure of the tweezer 161 (Figure 3.4) shows that negatively charged sulfate 
groups pointed are upward away from the electron rich tweezer’s cavity, resulting into the 
completely opened cavity. On the other hand, the phosphate groups in the tweezer 133 can be 
expected partially protonated that can exist in -PO32- and -OPO3H- forms at the neutral pH. In 
addition, the phosphate groups can move freely up and down with a small difference in their 
conformational energy. The calculated minimum energy structure of the monoprotonated 
phosphate tweezer shows that the phosphate groups are pointed down and insert the hydrogen 
atoms of the phosphate groups into the tweezer’s cavity. This creates the partial steric hindrance 
at the cavity of the tweezers.  Furthermore, the phosphate groups are strongly solvated compared 
to the sulfate groups due to the more negative charge on the phosphate groups. Therefore the 
bigger size of the solvation shells of the phosphate groups can again create the steric hindrance at 
the cavity of the tweezers. All these observations suggest that the sulfate tweezer 161 has more 
opened cavity compared to the phosphate tweezer 133 that allow the former to self-assemble 
strongly compared to the later. Moreover, it is found that the sulfate tweezer 161 is slightly less 
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soluble in compared to the tweezer 133 in aqueous solutions because the tweezer 161 has higher 
aggregation tendency.  
 
Table 3.1 Self association constants Kdm [M-1] and association induced maximum chemical shifts Δδmax [ppm] of 
aromatic protons of the phosphate tweezer 133 and the sulfate tweezer 161 in phosphate buffer (10 mM, pH 7.2). 
Phosphonate and carboxymethyl tweezers do not show self association and therefore not listed here. 
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Figure 3.1 Molecular modeling structures of the four anionic tweezers obtained by conformational search (Maestro, 
OPLS_2005, water, 5000 steps). The structures of the tweezers 133, 734 and 150 were re-produced again.  
 
The molecular modeling structure of the phosphonate tweezer 734[112], shows that the methyl 
groups on phosphorous are pointed down into the tweezer’s cavity that can prevent the dimer 
formation by providing steric hindrance for the other molecule of the tweezer. Carboxymethyl 
tweezer 150 does not provide any significant concentration dependent chemical shift, and 
therefore, no dimerisation is expected for this tweezer. However, molecular modeling structures 
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do not show completely upward or downward orientation of carboxymethyl groups. But one 
thing might be expected that longer length and more flexibility of carboxymethyl groups create 
the steric impact at the cavity and on the dimmer formation of this tweezer.  
 
Overall, we have shown the effects of different anionic groups on the self association behavior of 
the tweezers. The sulfate tweezer (-OSO3-, 161) being the least bulky tends to aggregate strongly 
compared to the other tweezers. The dimerisation of the tweezers are substitution dependent (size 
of the anion) in the order; -SO3 (161) > -OPO3H-(133) > -OCH2CO2-(150) ≈ OPO2CH3 (734). It is 
important to note that the above mentioned factors about the different anionic tweezers can also 
affect their binding with the guests. Further, the dimerisation constants of all the tweezers are 
small and can be ruled out when strong complex can be formed with a guest molecule. 
 
3.2.1.2 Studies of the sulfate tweezer 161 complexes 
 
The most important parameter in the association of the two or more different molecular species is 
the association constant (Ka) or the dissociation constant (Kd). The dissociation constant is a 
measure of the binding affinity between a host and a guest that is influenced by the non-covalent 
intermolecular interactions. For all the guests, dissociation constants were obtained using 
fluorescence titration experiments. NMR titration and isothermal calorimetric titration 
experiments were performed for the selected guest molecules. Molecular modeling was 
performed to gain more structural insight into host-guest complexes. Since, until now no crystal 
structure of a tweezer and an amino acid or protein guest has been generated, all the above 
mentioned methodologies were performed to understand several chemical and structural aspects 
of the complexes formed by the tweezers. Although, the NMR titrations alone provides 
substantial structural information through chemical shift differences of host and guest protons, 
but the fluorescence spectrometry was used more routinely. Further, ITC measurements were 
performed to obtain thermodynamic data such as; enthalpy and entropy of a complex.  
 
3.2.1.2.1 Studies of the sulfate tweezer 161 complexes by 1H-NMR titration spectrometry 
 
The complex formation between a receptor molecule and a guest molecule can be easily detected 
by the 1H-NMR spectrum of the receptor-guest mixture. In a standard 1H-NMR titration 
experiment, complexation-induced chemical shifts (Δδobs) of the guest protons are measured with 
varied receptor concentrations and constant guest concentration. In an alternative method, called 
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the dilution titration method, complexation-induced chemical shifts (Δδobs) of the guest protons 
are measured in a 1:1 mixture of the receptor/guest at overall different concentrations. Using both 
the methods, complexation-induced maximum chemical shifts (Δδmax) of guest protons and 
association constant Ka can be calculated by the use of equation 3.1 and performing the program 
TableCurve.[114,115,116,117,118] 
 
 
     Equation 3.1 
 
∆δobs : Observed chemical shift difference 
∆δmax : Maximum complexation-induced chemical shifts of the guest protons  
[G]t : Total concentration of the guest 
[H]t : Total concentration of the host 
Ka : Association constant 
 
 
The NMR titration spectroscopy was used to study the host-guest complex formation for selected 
guests. Experimentally measured dissociation constants and complexation-induced maximum 
chemical shifts for the selected protons of the lysine and arginine derivatives are given in the 
Table 3.2. 
 
Table 3.2 Dissociation constants Kd [µM] of the sulfate tweezer 161 with lysine and arginine derivatives and 
complex induced chemical shift difference Δδmax [ppm] of guest protons in the phosphate buffer (10 mM, pH 7.2). 
 
Guest Δδmax [ppm] Kd [µM] 
Ac Lys OMe 3.75 (6-H), 4.41 (5-H), 2.64 (4-H), 1.29 (3-H),  0.37 (2-H) 12 ± 11 % 
Ac Arg OMe 3.86 (5-H), 2.51 (4-H), 1.32 (3-H), 0.42 (2-H) 88 ± 5 % 
 
The dissociation constants of the tweezer 161 for protected lysine and arginine are in low µM 
range. The tweezer 161 shows affinity of 12 µM to AcLysOMe while 7 times lower affinity to 
AcArgOMe. The complete titration spectra for complex 161@AcLysOMe are shown in Figure 
3.5. The spectra indicate almost complete saturation of the lysine signals at 3:1 stoichiometry of 
host/guest in which 6-H and 5-H protons of the lysine are shifted most (~ 3.7 ppm and ~ 4.3 ppm 
respectively). These strong upfield shifts of the lysine side-chain provide evidence for the 
inclusion of the alkyl side-chain into the tweezer’s cavity. 
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Figure 3.5 1H-NMR titration spectra of the sulfate tweezer 161 and AcLysOMe in phosphate buffer (10 mM, pH 7.2) 
at 25oC. The concentration of AcLysOMe was kept constant at 0.572 mM. The protons of guest are mentioned on the 
top spectrum. 
 
The complete titration spectra for complex 161@AcArgMe are shown in Figure 3.6. All the guest 
protons were shifted upfield and among them proton 5-H and proton 4-H are the most shifted 
protons (3.6 ppm and 2.3 ppm respectively). These shifts indicate the complex formation by the 
inclusion of the guanidinium side-chain of the arginine into the tweezer’s cavity. The lower 
affinity for arginine is attributed to the bigger size and desolvation penalty of guanidinium moiety 
inside the tweezer’s cavity.   
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Figure 3.6 1H-NMR titration spectra of the sulfate tweezer 161 and AcArgOMe in phosphate buffer (10 mM, 
pH 7.2) at 25oC. The concentration of AcArgOMe was kept constant at 0.560 mM. The protons of arginine are 
mentioned on the top spectrum. 
 
3.2.1.2.2 Studies of the sulfate tweezer 161 complexes by fluorescence spectrometry 
 
To measure the association/dissociation constants of a complex, fluorescence spectrometry is 
more efficient and convenient tool compared to 1H-NMR or ITC spectrometry. Less amount 
(micromolar concentration) of a receptor and the least time required compared to the other 
methods makes this technique most suitable. Binding affinities of the sulfate tweezer 161 for a 
large number of amino acid derivatives and peptide guests were measured using this 
methodology. The obtained dissociation constants (Kd) are listed in the Table 3.3. 
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Table 3.3 Dissociation constants Kd [µM] of the sulfate tweezer 161 with lysine and arginine derivatives and, 
peptides in the phosphate buffer as measured by the fluorescence titration spectroscopy. 
 
Guest Solvent, pH Kd [µM] 
Ac Lys OMe PB, 200 mM, pH 7.6 28 ± 2 % 
Ac Arg OMe PB, 200 mM, pH 7.6 178 ± 4 % 
Ac Lys OMe PB, 10 mM, pH 6.2 16 ± 3 % 
Ac Arg OMe PB, 10 mM, pH 6.2 69 ± 4 % 
Ac Lys OMe PB, 10 mM, pH 7.2 19 ± 3 % 
Ac Arg OMe PB, 10 mM, pH 7.2 77 ± 5 % 
Ac Lys OMe PB, 10 mM, pH 8.6 18 ± 5 % 
Ac Arg OMe PB, 10 mM, pH 8.6 88 ± 5 % 
H Lys OH PB, 10 mM, pH 7.6 227 ± 6 % 
H Lys OH PB, 10 mM, pH 6.2 173 ± 15 % 
H Arg OH PB, 10 mM, pH 7.6 699 ± 15 % 
H Arg OMe PB, 10 mM, pH 7.6 160 ± 6 % 
KAA PB, 10 mM, pH 7.6 303 ± 5 % 
KAA PB, 10 mM, pH 6.2 184 ± 12 % 
KLVFF PB, 10 mM, pH 7.6 38 ± 11% a 
IAPP(1-7) PB, 10 mM, pH 7.6 110 ± 6 % 
cRGDFV PB, 10 mM, pH 7.6 n.d. 
Ac Lys OMe PBS, 10 mM, pH 7.2 31 ± 4 % 
KAA PBS, 10 mM, pH 7.2 397 ± 3 % 
AcLysOMe Methanol 20 ± 6 % 
Ac Arg OMe Methanol 276 ± 7 % 
PB: phosphate buffer 
PBS: phosphate buffer saline with 150 mM NaCl  
n.d.: Not Determined. 
a: Strong shift of fluorescence maximum (∆λ ~ 20 nm, blue shift) and intensity of new maximum increase after 
addition of ~ 5 equivalent guests. 
 
The structures of all the amino acid derivatives and peptide guests discussed in this thesis are 
given in Figure 3.8 (lysine guests) and Figure 3.9 (arginine guests). The biological importance of 
all these peptides has been described in the section 1.3. The dissociation constants obtained by 
the 1H-NMR titration experiments and the fluorescence titration experiments are in good 
agreement. The small differences in the dissociation constants are apparently due to the different 
concentrations used in the two methods. Surprisingly, the tweezer 161 shows a wide range of 
affinities ranging from 700 µM to 16 µM for different guests. Under the similar conditions, the 
most differed binding behavior is observed among the protected and unprotected amino acids. 
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For example, the binding affinity for the unprotected lysine (HLysOH) is 227 µM which is about 
12-fold lower than the affinity for the protected lysine (AcLysOMe). 
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Figure 3.7 Selected guest concentration dependent emission spectra of the tweezer 161 (left) in aqueous phosphate 
buffer (10 mM, pH 7.6) and the non linear curves obtained by SigmaPlot[119] (right). 
 
Similar trends of the sulfate tweezer 161 binding are also observed for the arginine guests, for 
example; the tweezer 161 binds to HArgOH with about 9-fold lower affinity compared to 
AcArgOMe. In addition, it is found that the sulfate tweezer 161 binds strongly to the N/C-
protected amino acids and failed to bind comparably to the N/C-free amino acids or peptides 
(Table 3.3). For the longer peptide IAPP1-7, the tweezer 161 shows moderate, but still 6-fold 
lower affinity (110 µM) compared to AcLysOMe. Interestingly, protecting the C-terminus of the 
arginine, as in HArgOMe, increase the affinity by 4-fold compared to the N/C-free arginine.  
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Figure 3.8 Structures of the lysine- and cysteine-containing peptide guests. 
 
The structural differences between the protected and free amino acids are based only on their 
amine and carboxylate functional groups. Due to this reason, the differences in the tweezer 
binding affinity towards these guests is aroused through the electrostatic and hydrogen bonding 
interactions between the sulfate anion of the tweezer and the free or protected amine and 
carboxylic groups of the amino acid backbone. From the experimental and structural details, it is 
found that that the electrostatic repulsions between the anionic sulfate and the anionic carboxylate 
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reduce the strength of the complex. These data highlight the importance of the appropriate 
electrostatic and hydrogen bonding interactions between the tweezer’s anion and the backbone of 
an amino acid or a peptide in the formation of a strong complex. 
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Figure 3.9 Structures of the arginine derivatives and arginine-containing peptide guests. 
 
 
The effects of the pH, the buffer concentration, the ionic strength and the solvent on the complex 
stability were also investigated (Table 3.3). No substantial effects of the varied pH (6.2 to 8.5) are 
observed on the tweezer binding to the protected lysine and arginine; however, the effects are 
significant for the free amino acids and peptide KAA. When the pH is reduced from 7.6 to 6.2, 
the tweezer affinities for the N/C-free guests is increased almost by a factor of 2. The reduction in 
the pH increases the population of the protonated ammonium and carboxylate groups of the 
amino acid backbone and therefore, the electrostatic and hydrogen bonding interactions between 
the tweezer and the guest are enhanced.  
 
The effects of the buffer concentration and saline are similar on the complex stability. When the 
buffer concentration is increased from 10 mM to 200 mM, the binding affinities of the tweezer 
161 are reduced from 19 µM to 28 µM for the protected lysine and from 77 µM to 178 µM for 
the protected arginine. These results indicate the screening effects of the buffer ions. Obviously, 
the ionic interactions are not the major forces responsible for the stability of the complexes.  
Complex formations by the sulfate tweezer 161 in the solvents other than water were also 
investigated. Due to close similarity of methanol to water, methanol served as another good 
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solvent. Surprisingly, complex formed between the tweezer 161 and AcLysOMe in methanol has 
same affinity to the complex formed in aqueous buffer. The 1H-NMR spectra of a 1:1 mixture of 
the tweezer 161 and AcLysOMe in methanol-d4 showed almost the similar chemical shift pattern 
of AcLysOMe protons as in the aqueous buffer. The 4-fold low affinity of the complex 
161@AcArgOMe indicates different impact of methanol on this complex. The NMR chemical 
shifts of the guest protons are also not influenced as large as in the buffer solution. Surprisingly, 
in methanol, fluorescence of the tweezer 161 is increased with the guest addition and is reverse to 
the fluorescence quenching occurred in the aqueous solutions. Proper reasons for the fluorescence 
inversion in the methanol are not yet understood.  
3.2.1.2.3 Studies of the phosphate tweezer 133 complexes by fluorescence spectroscopy 
 
The binding of the tweezer 133 for the lysine, arginine and cysteine derivatives were investigated 
using fluorometric titration experiments (Table 3.4). The tweezer 133 shows about 2-3 times 
lower affinities to arginine derivative AcArgOMe compared to lysine derivative AcLysOMe. The 
effects of buffer ions concentrations on the guest binding of the phosphate tweezer 133 are 
similar to those of the tweezer 161. Binding of the tweezer 133 to cysteine (AcCysOMe), 
disulfide cystine (AcCysOMe)2 and IAPP peptide fragments were also investigated as a part of 
the project, “inhibition of aggregation and toxicity of IAPP protein by the molecular tweezer 
133”. Only 2-4 % change in the fluorescence of the tweezer 133 is observed with cysteine or 
cystine derivatives, indicating no binding of the tweezer 133 to these guests. The binding of the 
tweezer 133 with IAPP fragments will be discussed in the last section of this chapter. 
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Table 3.4 Dissociation constants Kd [µM] of the phosphate tweezer 133 with lysine, arginine and cysteine 
derivatives and, IAPP peptide fragments in phosphate buffer as measured by the fluorescence titration spectroscopy. 
 
Guest Solvent, pH Kd [µM] 
Ac Lys OMe PB, 200 mM, pH 7.6 17 ± 6 % [90] 
Ac Lys OMe PB, 10 mM, pH 7.6 9 ±  6 % 
Ac Arg OMe PB, 200 mM, pH 7.6 61 ± 2 % 
Ac Arg OMe PB, 10 mM, pH 7.6 20 ± 5 % 
AcCysOMe PB, 10 mM, pH 7.6 - 
(AcCysOMe)2 PB, 10 mM, pH 7.6 - 
IAPP(1-7) PB, 10 mM, pH 7.6 9 ± 6 % 
IAPP(2-14) PB, 10 mM, pH 7.6 104 ± 4 % 
AcLysOMe Methanol 66 ± 11 % 
-:  no binding, only 2-4 % changes in the tweezer’s fluorescence. 
3.2.1.2.4 Isothermal calorimetric titration (ITC) studies of the sulfate tweezer 161 complexes 
and the phosphate tweezer 133 complexes 
 
Isothermal titration calorimetry[120] is another important method from which we not only measure 
the association constants but also other  important thermodynamic parameters such as enthalpy, 
entropy and stoichiometry of the complex formation are measured in just a single experiment. In 
an ITC experiment, the heat evolved or absorbed is measured during the addition of a guest 
solution into a host solution. The thermodynamic data for the complexes of the tweezers 161 and 
133 with lysine- and arginine-containing guests determined by the VP-ITC[121] are listed in the 
Table 3.5. The binding affinities determined by the ITC measurements are in agreement with the 
data obtained by the fluorometric and the 1H-NMR titration experiments. The enthalpy 
determined for the complex 161@AcLysOMe formation is highly favorable (ΔH = -8.3 
kcal/mole) but the entropy of the complex formation is unfavorable (-TΔS = 2.1 kcal/mole), 
resulting in an overall decreased affinity. On the other hand, the entropy determined (-TΔS = 
0.387 kcal/mole) for the complex 161@AcArgOMe is only slightly unfavorable but the observed 
enthalpy (ΔH = -5.9 kcal/mole) is substantially lower than the enthalpy for the complex 
161@AcLysOMe. The more negative ΔH determined for AcLysOMe indicates that the tweezer 
161 binds enthalpically more tightly to AcLysOMe compared to AcArgOMe. These results 
suggest that the entropy loss by the association of the tweezer 161 and lysine or arginine guest is 
more than the entropy gain by the release of solvent molecules into the bulk solvent.[122] 
Obviously, the loss in the degree of freedom of the host and guest, in particular, by the restricted 
motion of the tightly complexed lysine, is responsible for the more entropy loss of the complex 
161@AcLysOMe.  
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Table 3.5 Dissociation constants (Kd), enthalpy (ΔH), entropy (ΔS), Gibbs free energy and stoichiometry (n) of the 
tweezers 161 and 133 complexes with lysine- or arginine-containing guests obtained by the isothermal titration 
calorimetry (ITC) in phosphate buffer (10 mM, pH 7.6). 
 
host@guest Kd [µM] n ΔH[kcal/mol] -TΔS[kcal/mol] ΔG[kcal/mol] 
161@AcLysOMe 28 ± 4 % 0.82 -8.17 1.96 -6.21 
161@AcArgOMe 88 ± 9 % 0.90 -5.92 0.39 -5.53 
133@AcLysOMe 14 ± 5 % 0.68 -5.55 -1.05 -6.60 
133@AcArgOMe 31 ± 3 % 0.62 -6.80 0.67 -6.14 
133@KLVFF 15 ± 4 % 1.02 -6.29 -0.28 -6.57 
133@IAPP(1-7) 7 ± 3 % 1.16  
-6.37 
 
-0.70 
 
-7.07 
 
133@IAPP(2-14) 157 ± 40% 1.00 -5.38 0.19 -5.19 
133@AcLysOMea 172 ± 17% 1.25 10.15 -15.31 -5.16 
a measured in methanol  
 
The entropies determined for the complexes of the tweezer 133 with all the lysine-containing 
guests are favorable, whereas, for all the arginine-containing guests are unfavorable. 
Interestingly, the tweezer 133 binds AcArgOMe enthalpically more tightly than any other guests, 
but entropy compensation lowers the overall affinity for the complex 133@AcArgOMe. More 
surprisingly, the complex 161@AcLysOMe has highest negative enthalpy among all the 
complexes of the two tweezers, but high unfavorable entropy (-TΔS = 2.1 kcal/mole) cause 
substantial decrease in the overall affinity of this complex. Surprisingly, the complex 
133@AcLysOMe is entropy driven (-TΔS = -15.31 kcal/mole) in methanol. The positive enthalpy 
(ΔH = 10.15 kcal/mole) indicate lack of the hydrophobic interactions.  
 
From the ITC data, it is observed that enthalpically lysine is bound much tighter to the tweezer 
161, whereas, arginine is bound much tighter to the tweezer 133 and, it is the entropy which play 
crucial role in deciding the net affinity the complex. The ITC results suggest that phosphate and 
sulfate anions are responsible for the difference in the enthalpy and the entropy of the complexes 
formed by the tweezers 133 and 161 with the same guest. Further, our results of large negative 
enthalpies of the complexes formed by the tweezers support the results obtained for host-guest 
complex formation in aqueous solutions that rely on the aromatic interactions, called the non-
classical hydrophobic effects.[123,124,125,126]  
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3.2.1.2.5 Molecular modeling of the sulfate tweezer 161 complexes 
 
In order to get structural information, the corresponding host-guest complexes were optimized by 
Monte-Carlo Simulations using the program Maestro 9.2. The resulted minimum energy 
structures for lysine and arginine guests are given in Figure 3.10. In the calculated structures of 
the sulfate tweezer 161 complexes with lysine and arginine, a combination of the hydrogen 
bonding interactions, the electrostatic interactions and the hydrophobic interactions is apparent. 
The ammonium cation of lysine and the guanidinium cation of arginine side-chains make 
hydrogen bonds and electrostatic interactions with one anionic sulfate group of the tweezer 161. 
In case of lysine, a cation-л interaction between the ammonium cation and electron rich aromatic 
cavity of tweezer 161 also likely occurs. Apart from these clearly observable interactions, close 
inspection of the complex structures suggest that two S=O…C=O dipolar interaction can also 
exist. All together these complex structures are in good agreements with 1H-NMR chemical shifts 
data.  
 
 
161@ AcArgOMe 
 
161@ AcArgOMe 
 
161@ AcLysOMe  161@ AcLysOMe 
 
Figure 3.10 Molecular modeling structures of the sulfate tweezer 161 complexes with AcLysOMe and AcArgOMe 
obtained by Monte-Carlo Simulation (Maestro 9.2, OPLS_2005, water, 5000 steps). 
 
Structural insights by molecular modeling were also investigated in case of low affinity guests 
HLysOH, HArgOH and KAA. The calculated minimum energy structures are listed in Figure 
3.11. Hydrogen bonding seems to be involved between tweezer’s sulfate anion and all the 
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protonated ammonium group of the guests. However, the anionic carboxylate group keeps apart 
from the anionic sulfate group. Moreover, calculated structure with unprotonated amine of the 
peptide KAA eliminated the possibility of any hydrogen bonding between the sulfate group and 
the peptide backbone. These structures indicate high repulsive interactions between the peptide 
and the sulfate group of the tweezer 161. Obviously, such repulsive interactions can be the 
dominating factor for the decrease affinities of these complexes. The lack of strong electrostatic 
and hydrogen bonding interactions probably do not allow the guest to bind tightly inside the 
tweezer’s cavity.  Definitely, these results highlight the importance of strong cooperative 
hydrogen bonding between a tweezer and the backbone of a peptide guest in order to form a 
strong complex. 
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161@HLysOH 
 
 
161@HLysOH 
 
161@HArgOH 
 
 
161@HArgOH 
 
161@KAA (doubly protonated) 
 
 
161@KAA (doubly protonated) 
 
161@KAA (singly protonated) 
 
161@KAA (singly protonated) 
 
Figure 3.11 Calculated structures of the sulfate tweezer 161 with HLysOH, HArgOH, KAA (doubly protonated) and 
KAA (singly protonated) obtained by Monte-Carlo Simulation (Maestro 9.2, OPLS_2005, water, 5000 steps). 
 
The Fluorescence emission spectra of the sulfate tweezer 161 on titration with KLVFF are 
surprising and unusual as shown in Figure 3.12 The fluorescence of the tweezer 161 is decreased 
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intiallly for ~ 5 equivalents of guest addition but thereafter slowly starts increasing with blue shift 
of the emission band. The exact reasons for the above mentioned effect are not clear, however, 
the resulted emission spectra indicates the presence of other strong interactions between the 
tweezer’s hydrophobic surface and peptide’s hydrophobic residues (Leu and Phe). A molecular 
modeling structure in different representation and from different angles is shown in Figure 3.13. 
It shows that the whole peptide adopts a concave conformation with the alignment of its amide –
NH groups at the inner surface and making a cluster of three hydrogen bonds with the sulfate 
group of the tweezer 161. Additionally, it shows the hydrophobic interactions between the 
hydrophobic phenyalanine and leucine residues of the peptide and the outer surface of the 
tweezer with lysine side-chain imbedded into the tweezer’s cavity. It is known that the presence 
of aromatic interactions (π-stacking, T-shaped orientation, partial displaced orientation) in a 
complex or excimer can change the fluorescence properties of the fluorophore.[127,128] Obviously, 
either these additional aromatic interactions have modified or changed the fluorescence properties 
of the tweezer 161 or the new emission band have developed due to the aromatic interactions 
among the three aromatic ring (two from the guest and one from the tweezer).  
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Figure 3.12 Left: peptide KLVFF concentration dependent emission spectra of the tweezer 161 (left) in aqueous 
phosphate buffer (10 mM, pH = 7.6), right: non linear binding isotherms obtained by the SigmaPlot (right). 
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161 and KLVFF in stick model 
 
 
 
161 in stick and KLVFF in CPK model 
 
 
161 (red) and KLVFF (blue) in CPK model  
 
 
 
161 (red) and KLVFF (blue) in CPK model  
 
 
Figure 3.13 Calculated structure of the complex 161@KLVFF in different views and model obtained by Monte-
Carlo Simulation (Maestro 9.2, OPLS_2005, water, 5000 steps). 
 
3.2.2 Binding comparisons among the four anionic tweezers 
 
The comparative study of the binding of anionic tweezers with lysine- and arginine-containing 
guests was made to understand and generalize the roles of different anions in the tweezers 
binding. The dissociation constants of the phosphate, phosphonate, sulfate and carboxylate 
tweezers for different guests measured by fluorometric titration experiments are summarized in 
Table 3.6. Surprisingly, there are substantial differences in the binding of all the four tweezers 
with respect to a particular guest. The phosphate tweezer 133 forms more stable complexes than 
the sulfate tweezer 161 followed by the phosphonate 734 and the carboxymethyl 150 tweezers.  
Surprisingly, the binding affinities of the tweezer 161 determined for the unprotected amino acids 
or peptides are about 10-fold lower than for the N/C-protected lysine and arginine guests. These 
are contrary to the very similar binding affinities of the tweezer 133 determined for these guests. 
The tweezer 734 also shows similar trends like sulfate tweezer 161 and binds strongly only to 
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AcLysOMe, but four times weaker than the tweezer 133 and two times weaker than the tweezer 
161.  
 
Table 3.6 Comparisons among the guest binding (Kd value in μM) of different anionic tweezers measured by 
fluorescence spectrometry.  
 
 
  a Phosphate buffer, 200 mM, pH=7.6; b phosphate buffer, 10 mM pH=7.6;  c phosphate buffer, 10 mM, pH=7.2. 
n.d.: Not Determined or with the error of more than 30%. 
* Strong shift of the fluorescence emission maxima (~ 20 nm blue shift) and intensity of new maximum increase after 
adding about 5 equivalent guests. 
 
The carboxymethyl tweezer 150 is also superior to AcLysOMe among all the guests examined, 
but surprisingly, with 13-fold lower affinity compared to the tweezer 133. From these data we 
have observed that the host-guest complex with high 1H-NMR chemical shift changes in the 
guest protons (Table 3.7) also showed strong complex formation by means of 1H-NMR and 
fluorometric titration experiments. On the other hand, where no significant chemical shift 
changes in the guest protons were observed, there the binding affinities measured by any method 
were also poor as in case of the tweezer 150.  
 
 
 
 
 
 
Guest Phosphate Phosphonate Sulfate Carboxymethyl
AcLysOMe 17 ± 6 %  a, [90,83] 
9 ±  6 % b 
68 ± 1% a, [90] 28 ± 2 % a 
19 ±  3 % c 
226 ± 14 % a, [113] 
643 ±  7% c, [113] 
HLysOH 21 ± 4 %  a, [90,83] 874 ± 1% a, [90] 227 ± 6 % b 1170 ± 20 % b, [113] 
KAA 30 ± 3 %  a, [90] 905 ± 1% a, [90]  303 ± 5 % b n.d. c, [113] 
KLVFF 20 ± 5 % a, [90]  38 ± 11 % b, * n.d. c, [113] 
KKLVFF 4 ±  1 % a, [90] 71 ± 1% a, [90]   
IAPP(1-7) 9 ± 6 % b  110 ±  6 % b  
AcArgOMe 60 ± 2 % a 
20 ±  5 % b 
 178 ± 4 % a 
77 ±  5 % c 
880 ± 26 % a, [113] 
281 ± 18% c, [113] 
HArgOH   699 ± 15 % b 609 ± 27 % c, [113] 
HArgOMe   160 ± 6 % b  
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Table 3.7 Dissociation constants Kd [µM] and complexation-induced maximum 1H-NMR chemical shifts 
(∆δmax[ppm]) of the guest protons determined for the host-guest complexes of the phosphate-, phosphonate-, sulfate-, 
and OCH2-carboxylate-substituted tweezers 133, 734, 161, and 150 with lysine- or arginine-containing amino acid 
and peptides derivatives by 1H NMR titration experiments in aqueous phosphate buffer at pH = 7.2. 
 
Host-Guest Complex Kd [µM] ∆δmax [ppm] 
133 • Ac Lys OMe 17 ± 0 % [89] 3.91 (6-H), 0.51 (2-H), -0.32 (NCOCH3) 
133 • H Lys OH 40 ± 7 % [89]  4.51 (6-H), 4.47 (5-H), 0.24 (2-H) 
133 • KAA 11 ± 9 % [89] 5.82, 5.92 (9-H)a, 3.22 (8-H), 2.28 (7-H) 
133 • Ac Arg OMe 22 ± 4 % 3.75 (5-H), 2.54 (4-H), 1.23 (3-H), 0.63 (2-H) 
734 • Ac Lys OMe 227 ± 22 % [87] > 4 (6-H)b, 1.45, 1.57 (5-H)a, 0.57 2-H) 
734 • H Lys OH 714 ±  8 % [87] > 4 (6-H)b 
734 • KAA 833 ± 14 % [87] 2.80 (6-H), 1.03 (5-H), 0.29 (2-H) 
161 • Ac Lys OMe 12 ± 11 % 3.75 (6-H), 4.41 (5-H), 2.64 (4-H), 1.29 (3-H),  0.37 (2-H) 
161 • Ac Arg OMe 88 ± 5 % 3.86 (5-H), 2.51 (4-H), 1.32 (3-H), 0.42 (2-H) 
150 • Ac Lys OMe 1164 ± 11% [113] 
0.94 (6-H), 0.54 (5-H), 0.40 (4-H), 
0.77, 0.52 (3-H)a 
150 • Ac Arg OMe 1393 ± 18% [113] 0.96 (5-H), 0.62, 0.48 (4-H)a, 0.52 (3-H) 
 
a The diastereotopic methylene protons show two separate signals in the complex. b The signal broadening does not 
allow the exact 1H NMR chemical shift determination of the complex. 
 
In case of the strong complex formation, the chemical shift changes in the guest protons are very 
high (~ 3.5 – 5 ppm) which indicate that the stable complex is formed by the guest side-chain 
inclusion into the tweezer’s hydrophobic cavity. The inclusion of a guest into the tweezer’s cavity 
is a result of hydrophobic dispersive interactions between the CH2-groups of the guest side-chain 
and π-electron rich tweezer’s cavity. In a similar way, the fluorescence of the tweezer is partially 
quenched when a complex is formed by the inclusion of a guest into the tweezers’s cavity. The 
quenching in the tweezer’s fluorescence is higher when the tight complex is formed. So, 
combining the fluorescence and NMR data, it can be generalized that when the chemical shift 
changes in guest protons are smaller, the fluorescence quenching are also smaller and resulted 
binding affinities are also lower and vice versa. Now, the obvious question arise that though the 
cavity of all the tweezers are same and all the four anions are capable to interact strongly with 
ammonium or guanidinium cations of guest molecules, why there are very much differences in 
the binding of different tweezers, and how can we understand them?  
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In literature, several groups have investigated the complex formation of the calixarenes 
substituted by these anionic groups with lysine or arginine guests, however, comparative binding 
studies have not been made among them. Desrorsies and coworkers showed that in phosphate 
buffer solution the calix[4]arenesulphonate binds 2-fold strongly to the free arginine (Kd = 667 
µM) compared to the free lysine.[129] Other report from Rachoń et al showed that the 
calix[4]arenephosphonate binds almost with the same affinity (Kd = 1667 µM) to these amino 
acids in the phosphate buffer.[130] In both calixarenes, the inclusion of the side-chains of both the 
amino acid were observed by 1H-NMR chemical shifts which indicate that the complex was 
formed by the hydrophobic and electrostatic interactions. In case of arginine, a π-π interaction 
between the guanidinium moiety of arginine and the aromatic rings of calixarene is expected 
responsible for the higher affinity for arginine compared to lysine. Noticeably, our first three 
tweezers are more superior to the lysine or arginine compared to the above mentioned 
calixarenes. 
Nilsson and coworker[102] synthesized and investigated several galactopyranoside sugar 
derivatives substituted with the phosphate, phosphonate and sulfate moiety for the binding to 
arginine rich galectin proteins. In their study they found that the sulfated ligands bound stronger 
to most of the galectins compared to the phosphate and phosphonate analogs. The dissociation 
constants for galectin-1, 3 and 9N correlated negatively with the calculated partial charge {PO32- 
>P(OMe)O2- >SO3-} of the anionic oxygens of the ligands. These results suggested the role of the 
desolvation penalty that depends on the magnitude of charge of anions. Contrary to the above 
examples our results partially correlate with them but in an inverse order. 
 
When the two molecular species interact to form complex there are substantial modification in 
the degree of freedom of host and/or guest, the hydrophobic interactions, the electrostatic 
interactions, hydrogen bonding interactions, the π-π interactions etc. In a complex formation 
some of these interactions could be favorable and some unfavorable. Therefore, the net result of 
these contributions decides the stability of a complex. Understanding each single contribution 
would be very demanding, but this is not possible to evaluate them in our case, however, the 
general nature of these forces towards enthalpy and entropy of a host-guest complex formation in 
water are known (Table 3.8). 
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Table 3.8 Different factors involved in a host-guest complex formation and their contributions to the enthalpy or 
entropy in aqueous solution.  
 
Interaction Contribution to ΔH Contribution to TΔS 
Electrostatic interactions Negative  
Hydrophobic interactions  positive 
π-π interactions Negative  
Desolvation of ionic groups Positive positive 
Loss of degree of freedom  negative 
 
All the above listed interactions are likely to be involved in our receptor-guest complexes. To 
understand the effects of electrostatic interactions on the stability of a complex of a tweezer and a 
guest, the Lewis structures of the different anions and their partial charge at about neutral pH in 
aqueous buffer solution are drawn below-  
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The phosphate group (in tweezer 133) can have both fully deprotonated and partially protonated 
forms with -2 and -1 charge respectively and distributed over three oxygen atoms with the partial 
charges of -2/3 and -1/2. The phosphonate group (in tweezer 734) and the carboxylate group (in 
tweezer 150) have one negative charge distributed over two oxygen atoms and therefore -1/2 
partial charges. Sulfate group has -1 charge distributed over three oxygen atoms and therefore -
1/3 partial charges (in tweezer 161). Therefore, the statistical partial charge of these anions are in 
the order: -OPO32- > -OP(OMe)O2- ≥ -OCH2CO2- > -OSO3-. Based on the partial charge, the 
phosphate tweezer 133 can be expected to make the strongest electrostatic interaction among all 
the tweezers. Indeed, the phosphate tweezer 133 has the highest affinity among the four tweezers 
for any guest, supporting the role of the electrostatic interactions. But, the other three tweezers do 
not show correlation between their partial charge and binding affinity, as the sulfate tweezer 161 
has the lowest partial charge but shows higher affinities than the phosphonate tweezer 734 and 
carboxymethyl tweezer 150. These results indicate that only the electrostatic interactions do not 
decide the affinity of a tweezer for any guest. 
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Analyzing the hydrogen bonding features, the phosphate tweezer 133 again benefits more with 
the guest binding due to the hydrogen bond acceptor and donor nature of its partially protonated 
phosphate groups. On the other hand, the other tweezers can be expected completely 
deprotonated at the used pH values and therefore, they can benefit the guest binding only by 
accepting the hydrogen bonds from the guest molecules. Further, hydrogen bonding can be more 
prominent in bigger peptide guests that can form multiple hydrogen bonds with the tweezer’s 
anions. A decrease in the affinity of a tweezer for the bigger guest molecules can be expected due 
to the steric hindrance around the lysine or arginine residues, unless more additional interactions, 
i.e. the hydrogen bonding occurs between a tweezer and a guest. This effect can be observed as 
the binding of the phosphate tweezer 133 to AcLysOMe and IAPP1-7 are similar, while the 
binding of the sulfate tweezer 161 for IAPP1-7 is decreased about 5-fold compared to AcLysOMe. 
Noticeably, hydrogen bonding play substantial role in the tweezer binding to a guest, but as the 
tweezer 161, 734 and 150 can have similar tendency to form hydrogen bonds, this factor alone 
does not explain the big difference in the tweezers bindings. 
 
Speaking about the hydrophobic interactions, since all the tweezers have same size and structures 
of their cavity therefore all of them must provide almost similar hydrophobic environment to a 
particular guest. Though, due to the different basicity of the four anionic groups, the electrostatic 
potential of the tweezer’s cavity could be changed, and more basic anion can induce more 
electronegative potential on the tweezer’s cavity. The decreasing order of basicity of tweezer’s 
anions and thereby, the electrostatic potential of the respective tweezers can be listed as-  
{-OPO32- > -OCH2CO2- > -OP(OMe)O2- > -OP(OH)O2- > -OSO3- } 
 
Clearly, this factor does not correlate with the obtained experimental data indicating no 
substantial role of these anions on the hydrophobic cavity. Therefore, similar hydrophobic 
dispersive interactions can be expected from different tweezers towards a particular guest.  
 
The π-π interactions are also found in chemical and biological recognitions. If an arginine guest 
form complex with a tweezer by the inclusion of its side-chain into the tweezer’s cavity, the 
planer guanidinium group of arginine can make π-π interactions with the aromatic rings of the 
tweezer. When this force comes into existence then this will contribute to the negative enthalpy 
of the complex and therefore, strong affinity for arginine can be expected compared to lysine. 
But, all the tweezers are atleast 2-fold weaker to arginine compared to lysine. These data either 
eliminate the possibility of π-π interactions or indicate the overcompensation by the other factors. 
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Interestingly, the enthalpy determined by the ITC experiments for complex 133@AcArgOMe 
(ΔH = -6.8 kcal/mol) is higher than that of complex 133@AcLysOMe (ΔH = -5.5 kcal/mol). This 
indicates that arginine is bound enthaplically much tighter than lysine inside the tweezer 133, and 
most probably due to the additional π-π interactions. But due to the unfavorable entropy (-TΔS = 
0.67 kcal/mole) of the complex 133@AcArgOMe, it is less stable compared to the complex 
133@AcLysOMe, for which the entropy (-TΔS = -1.05 kcal/mole) is favorable. These results 
indicates that though π-π interactions are apparent in the tweezer 133 binding to arginine, but 
there are also other factors that affects the overall stability of the complexes. 
 
The interactions of ions or molecules with the solvent molecules also play crucial roles in the 
stability of molecular complexes. The ionic groups are highly solvated in water and their 
desolvation is always enthalpically unfavorable. Therefore, in complex formation, gain in 
enthalpy by the ion pair formation should be greater than the desolvation penalty of the ions. 
Several reports are published in the literature about the ions in water, dealing with the ions 
solvation and their interactions with water and other ions.[131,132] With the help of neutron 
diffraction, gas phase infrared vibrational spectroscopy, X-ray absorption spectroscopy, and ab 
initio molecular orbital studies, it has been shown that water interacts with the ions via a 
chemical bond that is affected over only a short distance (< 5 Å). This chemical interaction 
involves substantial charge transfer from strongly solvated ions to the solvent to delocalize the 
charge. Further, ions with more surface charge density are strongly solvated and can form strong 
ion pair with other counter charged ions that are also strongly solvated. The phosphate, sulfate 
and carboxylate anions are strongly solvated in water, while the ammonium or guanidinium 
cations of amino acids are weakly solvated. Therefore, on highly water exposure weak ion pair 
interactions could be expected among them however, given the less exposure to water these ions 
can make strong ion pair interactions. Considering the partial charge calculated from Nilsson, the 
desolvation penalty of the three anions will be in the order: -OPO32- > -OP(OMe)O2- > -OSO3-. It 
is not certain if the desolvation of the phosphonate tweezer 734 would be higher or lower than the 
carboxymethyl tweezer 150 because of the similar partial charge of their anions. The entropy 
determined for the complex 133@AcLysOMe is favorable, while for 133@AcArgOMe is 
unfavorable. Obviously, in the later complex, the loss in entropy by the desolvation of 
guanidinium group is more than the gain in entropy by the release of bound water molecules in 
the bulk solution. Due to the lower charge density, the sulfate group will be less strongly solvated 
than the phosphate group. As discussed before, negative entropies are determined in case of the 
complexes of the tweezer 161 with AcLysOMe and AcArgOMe. The lower enthalpy for the 
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complex 161@AcArgOMe compared to complex 161@AcLysOMe indicates that the tweezer 
161 binds lysine more tightly than arginine. It is apparent that the tweezers, due to even small 
differences in their anions, behave very distinctly in the guest binding.  
 
Another factor affecting the complex stability is the modulation of degree of freedom of host 
and/or guest. In a complex formation, atomic motions and conformational flexibility of atleast 
one species become restricted that result in the unfavorable entropy of the system. This factor 
should obviously play a significant role in the complexes with guests that are included in the 
tweezer’s cavity and locked by the ion pairs and hydrogen bonding. But, his factor can not be 
easily distinguished among the four tweezers; we can only say that when the entropy loss is over 
compensated by the enthalpy gain, complex is formed, and the net gain in enthalpy after 
compensating the entropy decide the strength of the complex.  
 
All together, we found that there is no direct relationship between the anionic group 
characteristics and the binding affinities of their respective tweezers towards any guest. Further, it 
is also evident that no single force decides the overall stability of the complex, and only 
collective effects of all kind of favorable and unfavorable interactions govern the final stability of 
the complex. However, some points about the relative binding affinities of the tweezers can be 
made. For example, in the tweezer 734, partial inclusion of the methyl group on the phosphonate 
group inside the tweezer’s cavity, lower partial charge and only the hydrogen bond acceptor 
nature of the phosphonate anion may be the main factor for the decline in affinity of the 
phosphonate tweezer 734 compared to the phosphate tweezer 133. In case of the carboxymethyl 
tweezer 150, the partial inclusion of an amino acid guest inside the cavity and low binding 
affinities are far beyond than our expectation. The factors, like more solvation penalty and high 
flexibility of the carboxymethyl groups may diminish the ion pair interactions between the 
carboxylate anion of the tweezer and ammonium or guanidinium cations of the guests. Other 
factors could also be that the ion pairs of the receptor-guest cannot reach in close contacts and in 
a favorable arrangement. The 1H-NMR of the pure receptor and molecular modeling structure 
suggest that the methylcarboxylate group stay away from the cavity and parallel to the central 
benzene ring that guarantee an open cavity of the tweezer 150. Therefore, any guest must not 
have steric hindrance for the cavity inclusion. The calculated structures of the tweezer 150 with 
lysine and arginine suggest the presence of hydrogen bonds between the tweezer and the guests, 
but the conformation of the carboxymethyl moiety is twisted. Since moderate to strong 
electrostatic and hydrogen bonding interactions are known between carboxylate group and 
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ammonium or guanidinium groups in water, and tweezer’s cavity is not sterically shielded, 
therefore, the poor affinities of the carboxymethyl tweezer 150 towards any guest reflect the 
absence of the proper electrostatic and hydrogen bonding interactions. 
 
Comparisons between the phosphate tweezer 133 and the sulfate tweezer 161 have been more 
interesting because of the similar size and geometry of the two anions. Three differences can 
provide good arguments for the different behavior of these two tweezers. First, partially and fully 
deprotonated phosphate groups have more partial charge on its oxygen atoms than the sulfate 
groups and this factor can be one possible reason for the higher affinities of the tweezer 133 
compared to the tweezer 161. Second, partially protonated phosphate can accept and donate 
hydrogen bonds, while completely deprotonated sulfate only can accept hydrogen bonds. This 
difference leads the tweezer 133 to interact effectively with hydrogen bond acceptor and donor 
guest, while the tweezer 161 can be effective in complexing the guest with only hydrogen bond 
donor nature. As already discussed, that there are good tendency for ion pair interactions and 
hydrogen bonding between the sulfate and ammonium cation, but the anionic sulfate make strong 
repulsion with the anionic carboxylate of the unprotected amino acids backbone. This repulsive 
interaction can be the most probable reason for the drastic loss (about 10-fold) in affinities of 
tweezer 161 for HLysOH, HArgOH and KAA compared to the respective N/C protected amino 
acids (for modeling structures see Figure 3.11). All the data and above discussion about the 
phosphate and the sulfate tweezers highlight the importance of hydrogen bonding in their 
complex stability. As shown before, the NMR chemical shift changes of the protected lysine and 
arginine guests in complex with the tweezers 133 and 161 are almost similar, therefore, the 
difference in the tweezer’s binding affinities must arise by the differences in the electrostatic and 
hydrogen bonding capabilities of the tweezer’s anions that can lock the guest inside the tweezer’s 
cavity in conjunction with the hydrophobic interactions.  
 
A good example to support our results and assumptions is the selective uptake and transportation 
of inorganic phosphate by the phosphate binding protein (PBP) and inorganic sulfate by the 
sulfate binding protein (SBP) into the cells. In the PBP-phosphate complex structure, the 
phosphate ion is completely desolvated and forms extensive hydrogen bonds with 11 donor group 
and 1 acceptor group. On the other hand, in SBP-sulfate complex structure, the sulfate ion 
receives 7 hydrogen bonds from polar groups. Studies revealed that in T141D mutation which 
provides additional negative charge at the binding site; the affinity was not affected at pH below 
the second pK2 of phosphate (where H2PO4- exists exclusively), but it diminished the affinity at 
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pH well above the pK2 where HPO42- species dominates. The loss in affinity is attributed to 
charge-charge repulsion between Asp-HPO42-. This is the same mechanism that fully ionized 
sulfate does not bind to the PBP. The importance of complete hydrogen bonding is again reflected 
by no affinity of SBP towards phosphate. This is because SBP do not contain any hydrogen bond 
acceptor in its binding site. Therefore, we can say that hydrogen bonding can be crucial and 
highly specific. These examples provide strong support for the varied affinities of the phosphate 
tweezer 133 and the sulfate tweezer 161 towards the different guests.  
 
So, all together in this chapter we have investigated distinct supramolecular properties of the 
closely related four anionic tweezers and their recognition abilities of basic amino acids and 
biologically relevant peptides taken from such as amyloid-β, IAPP etc. The phosphate tweezer 
133 and the sulfate tweezer 161 are quite similar but exhibit the remarkable differences in their 
bindings. These tweezers, up to some extent, correlate or imitate the binding of phosphate and 
sulfate ions through the natural proteins PBP and SBP respectively. We are surprised that the 
carboxymethyl tweezer 150 does not bind any guest with a reasonable affinity. Our findings also 
suggest that replacement of one anionic group by other similar anionic groups in an artificial 
receptor molecule have a great impact on the molecular recognition properties. The phosphate 
and the sulfate tweezers can be used up to some extent as specific receptors. The tweezer 133 can 
be expected a strong receptor for a protein target if it has hydrogen bond acceptor and donor 
groups near the binding site (lysine or arginine residue). On the other hand, the tweezer 161 can 
only bind strongly to a protein that can furnish hydrogen bond donor groups near the binding 
sites (lysine or arginine residue). 
 
3.2.3 Biological evaluation of the anionic tweezers against aggregation and 
toxicity of Aβ42 and IAPP  
The biological evaluations of all these anionic tweezers were carried out in collaboration with 
Prof. Gal Bitan at neurology department, UCLA. I contributed the sulfate tweezer 161 and 
Constanze Wilch contributed the carboxymethyl tweezer 150 for the biological studies. In the 
figures, different names were given to the tweezers as listed in the brackets: the phosphate 
tweezer 133 (CLR01), the phosphonate tweezer 734 (CLR02), the sulfate tweezer 161 (CLR04) 
and the carboxymethyl tweezer 150 (CLR05).  Biophysical and cell culture assays suggest that 
the phosphate tweezer 133 is the best inhibitor of aggregation and toxicity of amyloid proteins. 
The other three tweezers are little less effective against the aggregation and also proved to be 
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slightly toxic at the higher concentrations. Results on the phosphate tweezer 133 are published 
elsewhere[88] and the results obtained for the tweezers 161 and 150 are summarized here. The 
data for the phosphonate tweezer 734 are not presented here. 
 
Inhibition of protein aggregation was performed by using the Thioflavin T (ThT) assays. For this, 
Aβ42 and IAPP were incubated with ThT in the absence and presence of molecular tweezers. The 
β-sheet formation was measured by monitoring the fluorescence change of ThT. Both the 
tweezers partially inhibit the aggregation processes at 1:1 Aβ42:tweezer ratio. Not completely, 
but substantial inhibition is achieved at the 10-fold excess of the tweezers. CLR04 is slightly 
superior to CLR05 (Figure 3.14). Inhibition effects of CLR04 are even stronger against IAPP 
aggregation and at 1:1 ratio almost complete inhibition of aggregation is observed. CLR05 shows 
complete inhibition of IAPP fibrils at the 10-fold excess. 
 
     
  
Figure 3.14 Inhibition of β-sheet formation by the molecular tweezers CLR04 and CLR05 as measured by ThT 
assay. 
 
When the samples incubated in the absence of the tweezers were measured by electron 
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microscope, abundant thread like fibrils were observed (Figure 3.15). Aβ42 samples at the 
equimolar ratio of the tweezers, showed less fibrils together with other amorphous structures. At 
the 10-fold excess of CLR04 almost amorphous structures were dominant, while at the 10-fold 
excess of CLR05 substantial amount of fibrils were still observed. At 1:1 ratio of IAPP:CLR04, 
only amorphous structures were observed, as also observed by ThT assays. On the other hand, 
CLR05 also reduce the burden of IAPP fibrils at 1:1 and more at 1:10 ratio, but complete 
inhibition is not observed. All these data correlate with the ThT results and are in good 
agreements with the observed affinities of these tweezers towards the basic amino acids. 
 
To examine whether these tweezers can also protect the cultured cells against the toxicity of 
amyloid and IAPP proteins, MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide) reduction assays were performed. Both the tweezers 161 and 150 did not rescue the 
cells from Aβ42 and IAPP toxicity upto 30 µM (3-fold access) concentrations. Moreover, both 
the tweezers are found slightly toxic to the cells at 100 µM concentrations. 
 
AB42 control         AB42:CLR04 1:1      AB42:CLR04 1:10     AB42:CLR05 1:1    AB42:CLR05 1:10 
       
 
      IAPP control             IAPP:CLR04 1:1       IAPP:CLR04 1:10          IAPP:CLR05 1:1      IAPP:CLR05 1:10 
     
 
Figure 3.15 Electron microscope images of the aggregation reaction of Aβ42 (first row) and IAPP (second row) in 
the absence or presence of CLR04 and CLR05. 
 
The biophysical assays have shown that the new sulfate tweezer 161 and carboxymethyl tweezer 
150 can effectively interfere in the abnormal aggregation process of amyloid-β and IAPP. The 
sulfate tweezer 161 appears to be effective almost similar to the tweezer 133. Less aggregation 
inhibition by the tweezer 150 compared to the phosphate tweezer 133 can be expected due to the 
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lower affinity of the tweezer 150 for lysine and arginine derivatives. The tweezers 161, 150 and 
734 are slightly toxic in cell culture assays at relatively high concentrations. Only the phosphate 
tweezer 133 prove to be the precious tweezer candidate in inhibiting the aggregation process as 
well as recovering the cell viability without showing any significant toxicity until 200 μM 
concentration. 
 
3.2.4 Studies of the 1st generation unsymmetrical linker tweezers 
 
In the second part of the work, unsymmetrical molecular tweezers that carry a phosphate group 
on one side and a linker or additional recognition unit on the other side of the tweezer’s central 
benzene ring were synthesized and studied. The structures of these unsymmetrical linker tweezers 
are shown in Figure 3.16. 
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Figure 3.16 Structures of the 1st generation unsymmetrical phosphate tweezers. 
 
3.2.4.1 Characteristics of the unsymmetrical linker tweezers 
 
Inspection of 1H-NMR spectra of the pure tweezers in methanol and mixture of methanol and 
buffer revealed that the short acetyl tether in tweezer 193 does not undergo self-inclusion in the 
tweezer’s cavity. However, the highly flexible ether moieties in tweezer 196 (∆δ ~ 2.0 ppm in 
methanol/buffer 2:1) as well as in tweezer 198 (∆δ ~ 1.0 ppm in methanol/buffer 2:1) displayed 
significant upfield-shifts compared with their isolated counterparts. These chemical shifts 
indicate that especially the terminal methyl groups of the linkers point inside the open cavity. The 
size of this effect depends on the polarity of the solvent and increases from methanol to water – 
obviously a hydrophobic interaction. Interestingly, the octyl derivative does not include its alkyl 
chain inside the cavity – a counterintuitive observation. The aromatic tweezer signals do not 
show any concentration-dependent upfield-shifts and thus confirm the absence of entangled 
dimers; in addition, no experimental evidence was found for intermolecular self-association. 
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For the tweezer 195 in the free phosphate form and for its protected dimethyl phosphate 
precursor, crystals could be grown whose X-ray diffraction gave rise to 3D structures with 
intriguing properties. Due to severe disorders, the crystals of the free phosphate tweezer 190 
diffracted rather poorly and for this reason the resolution of the electron density is too low to 
obtain a well refined structure model. Nonetheless, the connectivity and the general morphology 
of the molecule can be taken for granting bond length and angles however are not reliable. In 
accordance with the NMR evidence, no intramolecular alkyl inclusion takes place, but the n-octyl 
chain is instead engaged in numerous van-der-Waals contacts to aromatic CH-groups as well as 
CH-л interactions with its own and other aromatic tweezer moieties. Only the crystal packing 
(Figure 3.17) brings forward some intermolecular inclusion effects for dimethyl phosphate 
precursor 182. In this case, methyl group of phosphate pointed inside the cavity of the next 
molecule while dispersed the octyl chain over the top surface of another molecule.  
 
 
Figure 3.17 (A) crystal structures of the octyl dimethylphosphate tweezer 182 and the octyl phosphate tweezer 190 
obtained in methanol-pentane mixture. (B) Crystal packing of the tweezer 182; (C) crystal packing of the tweezer 
190. A molecule of methanol is inserted inside the cavity and makes a hydrogen bond with the phosphate group. Non 
polar hydrogen atoms are omitted for clarity.  
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The packing of free phosphate tweezer 190 showed assembly of four molecules where the 
phosphate groups head in the interior and the rest of the hydrophobic tweezer and octyl chain 
make the exterior surface that is exposed to the less polar solvent (Figure 3.17C) Interestingly, a 
molecule of methanol was found in the cavity and locked by hydrophobic and hydrogen bonding 
interactions. 
 
Molecular mechanics calculations followed by extensive Monte-Carlo simulations were carried 
out for all the tweezer derivatives 193-198, and the best final structures (Figure 3.22,first row) 
which were confined to a narrow energy window of 10 kJ/mol were analyzed with respect to their 
conformational preference (Maestro 9.2, OPLS_2005, water, 5000 steps). The results beautifully 
confirmed the NMR-spectroscopic evidence: Open conformations prevail for monoacetoxy 
tweezer 193, with its carbonyl group always pointing away from the cavity. By contrast, the octyl 
chain in tweezer 195 remains in close van-der-Waals contact with the CH groups flanking the 
cavity opening, precisely as depicted in the crystal structure. The flexible ester and ether tethers 
in tweezers 195 and 196, finally both insert their terminal ethyl group into the tweezer cavity, in 
perfect agreement with the observed upfield-shifts in the 1H NMR spectrum. It may be hence 
expected, that tweezer 193 with its open cavity is superior in binding of amino acid and peptide 
guests, whereas the octyl group in tweezer 195 blocks the cavity entrance and in tweezers 
196/198, the cavity is already occupied, leading to lowered guest affinities. 
 
3.2.4.2 Guest binding of unsymmetrical tweezers with amino acids and peptides 
 
For a reliable determination of affinities of new unsymmetrical tweezers towards the N/C-
protected amino acids and peptides fluorescence titrations were carried out in aqueous phosphate 
buffer. The high fluorescence emission intensity of the tweezer skeleton is efficiently quenched 
by guest binding, if the guest is included inside the cavity (vide infra). Dissociation constants 
(Kd) cover a relatively broad range from the low millimolar to the low µM regime. 
 
Affinities of linkers with ester moieties (193 and 196) are substantially higher than those for 
tethers with ethers and alcohols (195 and 198). Thus, the octyl and the self-included glycerol side 
chain represent the most critical obstacle for guest inclusion. 
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Table 3.9 Dissociation constants Kd [µM] of the unsymmetrical tweezers with lysine- and arginine-containing guests 
measured in phosphate buffer (10 mM, pH 7.6) by the fluorescence titration experiments. 
 
Substrate  
193 
Kd [µM] 
196 
 
198 
AcLysOMe 34 ± 10 % 44 ± 4 % 362 ± 23 % 
KAA 100 ± 7 % - - 
KLVFF 44 ± 8 % 114 ± 14 % - 
IAPP (1-7) 41 ± 12 % 118 ± 6 % - 
AcArgOMe 44 ± 13 % 92 ± 7 % 617 ± 42 % 
IAPP (2-14) 82 ± 17 % 96 ± 36 % - 
 
As usually observed, affinities for lysine are 2-3 times higher than those for arginine, with one 
interesting exception: The short acetyl derivative 193 binds arginine as well as lysine with 
comparable affinities (Kd < 50 µM). Its Kd value is the second lowest among the reported 
tweezers to date for an arginine derivative in aqueous buffer and holds promise for specific 
interference with biological processes which critically depend on strategic arginine residues. 
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Figure 3.18 Left: Schematic representation of the preferred complexation mode for Ac-Lys-OMe by the tweezer 
196; center: fluorescence titration binding isotherm; right: Monte-Carlo simulation. 
 
Comparisons with reference monophosphate tweezer 130 reveal that the simple linkers in 193 
and 196 render these superior to the unsubstituted monophosphate tweezer 130 and comparable 
in affinity to an elaborate specialized tweezer. Hence, the acetyl group in 193 as well as the 
ethoxycarboxylmethyl group in 196 must take part in molecular recognition of their amino acid 
guests in a positively cooperative manner.  A schematic representation of interactions between the 
tweezer 196 and lysine guest AcLysOMe, the binding isotherm obtained by the nonlinear 
regression fitting and a molecular modeling structure are shown in Figure 3.18. 
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NMR experiments offer more structural information than fluorescence titrations, if chemical shift 
changes of sensor protons occur during the addition of the host to its amino acid guest. All new 
tweezer derivatives were therefore first measured alone and then their complexes with 
AcLysOMe and AcArgOMe in methanol:buffer (2:1). In all cases, lysine methylene signals 
become broadened and shifted upfields, indicating specific inclusion of its ammonium butyl side 
chain. These chemical shift changes are accompanied by sizeable downfield shifts of the self-
included receptor tethers of 196 and 198. With increasing excess of the lysine guest, the receptor 
molecule releases its unpolar arm from its own cavity to accommodate the amino acid side chain 
– a beautiful illustration of two competing inclusion processes, one of which benefits not only 
from hydrophobic, but also from electrostatic interactions.  
 
Table 3.10 NMR chemical shifts of the side-chain protons of AcLysOMe in the different ratio with the different 
tweezers in the methanol/buffer (2:1). 
 
Tweezer ratio (TW/AAs) 6-H 5-H 4-H 3-H 2-H 
193 
2:1 
1:1 
1:2 
1:4 
a 
a 
a 
0.45 
a 
0.28 
0.16 
0.08 
a 
0.66 
0.46 
0.28 
a 
0.33 
0.22 
0.14 
0.09 
0.07 
0.05 
0.03 
198 
3:1 
1:2 
1:4 
a 
>0.40 
0.26 
a 
0.08 
0.02 
a 
0.24 
0.10 
a 
0.13 
0.08 
0.06 
0.03 
0.02 
196/203 
2:1 
1:2 
1:4 
a 
>0.50 
0.30 
0.13 
0.09 
 
0.40 
0.29 
0.21 
0.15 
0.06 
0.04 
195 2:1 1:2 
a 
0.20 
0.11 
0.00 
a 
0.00 
0.17 
0.06 
0.05 
0.02 
a: signal was not detected or identified. 
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Figure 3.19 NMR spectra of the tweezer 193, AcLysOMe and 193:AcLysOMe (2:1, 1:1, 1:2 and 1:4) in 
CD3OD/D2O buffer (2:1). All the side-chain protons and particularly, 6-H protons of Lys at 2.9 ppm become very 
broad and shifted upfield.  
 
 
 
Figure 3.20 NMR spectra of the tweezer 203(196), AcLysOMe and 203(196):AcLysOMe (2:1, 1:2 and 1:4) in 
CD3OD/D2O buffer (2:1). 
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Figure 3.21 NMR spectra of the tweezer 198, AcLysOMe and 198/AcLysOMe (3:1, 1:2 and 1:4) in CD3OD/D2O 
buffer (2:1). 
 
The structural informations available from NMR and fluorescence experiments were feed into 
starting geometries for molecular mechanics calculations of all lysine and arginine complexes 
with the unsymmetrical phosphate tweezers. Minimizations were followed by Monte-Carlo and 
subsequent Molecular Dynamics simulations. In all lysine complexes the C-4 side-chain is easily 
threaded through the tweezer cavity and locks its ammonium cation into a strong ion pair with the 
phosphate anion, without the need to pay the penalty for phosphate desolvation.  
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Figure 3.22 Side views of molecular modeling structures of the unsymmetrical linker tweezers (193-198) and their 
complexes with amino acid AcLysOMe and AcArgOMe. 
 
Arginine derivatives can in principle also be drawn into the tweezer’s cavity. Now cation-л 
interactions must replace the polar interaction with the solvent shell, but these are much weaker: 
according to seminal work by the Dougherty (and Schneider) group, cation- л attraction for a 
guanidinium cation and one benzene ring amounts to 1 kcal/mol. But this case does not seems to 
be dominant in unsymmetrical tweezers, as in the calculated minimum energy structures, the side 
chain of arginine penetrates more deeper into the cavity and guanidinium group stay out where it 
can be solvated in solution and make ion pair with the phosphate group. 
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Additional attractive interactions occur between oxygen atoms of the tethers and -NH proton of 
guest amide. These backbone hydrogen bonds are especially effective in complexes with 
tweezers 193 and 196 as reflected by their greater affinities compared to the hydroxyl 
monophosphate tweezer 130 which lack the additional interactions of linker with amino acid 
backbone –NH protons. 
 
Interestingly, molecular dynamics calculations of the two best complexes 193@AcArgOMe and 
196@AcLysOMe show intact complexes even after more than 50 ns of simulation time. A small 
difference occurs in the complex 196@AcLysOMe, where linker flips vertically at 180o and 
exchanged the hydrogen bond between its two ester oxygen to the same guest amide NH group.  
 
 
Figure 3.23 Molecular dynamic simulation structures of the complex 193@AcArgOMe after 100 ns and the 
complex 196@AcLysOMe after 70 ns (Maestro 9.2, OPLS_2005, H2O). Starting structures are minimum energy 
conformations from Monte-Carlo simulations. 
 
In summary, new unsymmetrical monophosphate tweezers have been synthesized, which carry 
ester or ether linkers on the opposite side. From fluorescence and NMR binding studies with 
N/C-protected basic amino acids the following lessons can be learnt: 1) Long alkoxyalkyl tethers 
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lower tweezer affinities for basic amino acids by competing self-inclusion (196, 198); 2) long 
alkyl chains form multiple van-der-Waals contacts with the tweezers’ aromatic side walls 
(dispersive and CH-л interactions) and thus sterically block the entrance to the cavity; 3) short 
esters seem to keep the cavity open; 4) for a potential unsymmetrical tweezer, its linker must be 
able to interact a guest and involve cooperatively in molecular recognition. The acetyl tweezer 
193 binds with similar affinities to lysine and arginine which now opens the door for specific 
interaction with biological processes which rely on critical arginine residues. 
 
From the above-discussed, ester links seem to guarantee an open tweezer cavity for both lysine 
and arginine derivatives. However, for their use, hydrolysis at lower or higher pH or by enzymes 
must be prevented by all means. For this reason, slim ester types with pronounced stability 
towards pH changes must be found; alternatively, the OH group of the hydroxymonophosphate 
tweezer 130 could be replaced by a primary amine via Smiles rearrangement.[133,134] Its 
connection to secondary binding sites could then be smoothly effected with carboxylic acid 
derivatives. 
 
3.2.5 Solvent polarity effects on complexation 
 
In the above section we have seen that the stoichiometric ratios were varied from host excess 
over 1:1 ratio to guest excess in methanol/buffer (2:1), but only small chemical shifts were 
observed in guest protons. The observed small chemical shifts do not correlate with the 
fluorescence results obtained in buffer solution. We assumed that complex formation may not be 
very strong in the presence of methanol. This can be due to less solvent polarity and risk of 
methanol to accommodate into the tweezer’s cavity as seen in the crystal structure. So, we 
investigated the polarity effects on complex formation of selected host/guest by varying the ratio 
of methanol/buffer from pure methanol to 1:9 methanol:buffer. Chemical shift changes of the 
most shifted protons of the guests in the 1:1 ratio of host/guest are listed in the Table 3.11. The 
data indicate that the difference in chemical shifts increases with the increased solvent polarity. 
The data also reflect that even the small amount of methanol (10%) influence the guest inclusion 
into the tweezer’s cavity. For example, chemical shift change for the complex 133@AcArgOMe 
in 10% methanol (∆δobs = 2.16 ppm for 5-H) decreased more than 1 ppm compared to complex in 
pure buffer solution (∆δobs = 3.30 ppm for 5-H). Due to the low solubility it was not possible to 
use pure buffer solution in case of the unsymmetrical tweezer 193. Two observations in pure 
methanol were surprising: first, complex 133@AcLysOMe showed two sets of lysine signals, 
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though not significantly upfield shifted; second, the chemical shifts of complex 161@AcLysOMe 
were similar to those in pure buffer, but the chemical shift difference decreased substantially (~ 2 
ppm) for 161@AcArgOMe. The ITC data together with the negligible NMR chemical shifts of 
lysine protons for the complex 133@AcLysOMe in methanol indicate that the binding of lysine 
does not occur inside the tweezer’s cavity but occurs outside. Therefore, the observed binding 
affinity (172 μM) is purely based on the electrostatic and hydrogen bonding interactions between 
the phosphate anions of the tweezer and the lysine. 
 
Next, the important question arises whether under the same conditions the change in chemical 
shifts can be correlated with the fluorescence changes and the dissociation constants obtained by 
the fluorescence spectroscopy. To find out some correlations among these parameters, 
fluorescence titrations were carried out in the different polarity medium of methanol-buffer 
mixture (Table 3.12). In methanol, lysine form similar complex with the sulfate tweezer 161, 
while 6 times weaker complex with the phosphate tweezer 133 compared to the respective 
complexes in buffer solution. These data suggest that the phosphate and the sulfate groups behave 
significantly different in the two solvents. Therefore, different solvation or different interactions 
of these anions with the solvent molecules are responsible for the difference in their guest 
binding. As observed in most of the cases, changes in the fluorescence and the binding affinities 
(Table 3.12) depend on solvent polarity and increase with the more buffer content and correlate 
with the changes in chemical shifts (Table 3.11). From the data obtained, we can draw a 
conclusion as: 
More polar solvent ~ large chemical shift difference ~ large fluorescence change ~ strong 
complex formation. 
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Table 3.11 Observed chemical shift changes [in ppm] of guest protons in 1:1 ratio with the tweezers 133, 161, 193 in 
increasing polarity solvents. In mixtures of solvents, the chemical shifts in pure methanol were used as reference and 
changes in the chemical shifts of the lysine/arginine protons were measured relative to reference shifts. 
 
Receptor Substrate (concentration) solvent Δδobs(6-H) Δδobs (5-H) Δδobs (4-H) 
Phosphate 
tweezer 133 
AcLysOMe 
(1.0 mM) 
CD3OD 
CD3OD:PB (1:2) 
PB 
0.09, 0.24b 
2.80 
3.60 
0.0, 0.28 
2.30 
3.40 
-0.04, 0.26 
0.74 
1.60 
AcArgOMe 
(1.0 mM) 
CD3OD 
CD3OD:PB (2:1) 
CD3OD:PB (1:2) 
CD3OD:PB (1:9)a 
PB 
 
0.76 
0.72 
1.45 
2.16 
3.30 
0.44 
0.46 
0.96 
1.47 
2.19 
Sulfate 
tweezer 161 
AcLysOMe 
(1.0 mM) 
CD3OD 
PB 
2.96 
3.40 
3.25 
3.30 
1.75 
1.30 
AcArgOMe 
(1.0 mM) 
CD3OD 
PB 
 0.67 
2.67 
0.30 
1.70 
Acetoxy 
tweezer 193 
AcArgOMe 
(0.4 mM) 
CD3OD 
CD3OD:PB(2:1) 
CD3OD:PB(1:4) 
CD3OD:PB(1:9) 
 
0.0 
0.09 
0.27 
0.60 
0.0 
0.06 
0.18 
0.38 
a: Concentrations for this measurement were 0.5 mM for both host/guest. b: the signal for these protons were split 
into two different signals. PB: phosphate buffer (10 mM, pH 7.2). 
 
 
Figure 3.24 1H-NMR spectra of 1:1 complexes of 193@AcArgOMe in methanol-buffer (10 mM, pH 7.6) mixtures. 
With the increasing water content, the spectra shows gradual upfield shifts of arginine protons assigned by numbers. 
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Table 3.12 Dissociation constant Kd [µM] and (ΔImax [%] = 100 • (I0-Imax) / I0) fluorescence change of tweezer 133, 
161, 193 and 196 with lysine and arginine in the varying polarity solvent (methanol - buffer, 10 mM, pH 7.6) 
measured by fluorescence titrations. 
 
Receptor Guest Medium Kd [µM] ΔImax [%] 
Phosphate 
tweezer 133 
AcLysOMe 
 
 
AcArgOMe 
MeOH 
PB 
 
MeOH 
MeOH:PB (2:1) 
MeOH:PB (1:9) 
PB 
66 ± 11 % 
9 ±  6 % 
 
- 
- 
± 8 % 
20 ± 5 % 
   -6 
   40 
 
- 
- 
27 
47 
Sulfate 
tweezer 161  
AcLysOMe 
 
 
AcArgOMe 
MeOH 
PB 
  
MeOH 
PB 
20 ± 6 % 
19 ± 3 % 
 
276 ± 7 % 
77 ± 5 % 
-44 
 44 
 
-22 
 30 
Acetoxy phosphate 
tweezer 193 
AcLysOMe 
 
 
 
 
AcArgOMe 
MeOH 
MeOH:PB (1:4) 
MeOH:PB (1:9) 
PB 
 
MeOH 
MeOH:PB (1:4) 
MeOH:PB (1:9) 
PB 
641 ± 11 % 
192 ± 35% 
- 
34 ± 10 % 
 
- 
n.d. 
167 ± 41% 
44 ± 13 % 
-50 
-10 
 - 
 34 
 
- 
3 
6 
31 
Ethoxycarboxylmethyl 
phosphate tweezer 196 
AcLysOMe 
 
 
 
AcArgOMe 
MeOH 
MeOH:PB (2:1) 
MeOH:PB (1:9) 
PB 
 
MeOH 
MeOH:PB (2:1) 
MeOH:PB (1:9) 
PB 
- 
- 
n.d. 
44 ± 4% 
 
- 
- 
n.d. 
92 ± 7% 
- 
- 
 2 
46 
 
- 
- 
 4 
40 
PB: phosphate buffer (10 mM, pH 7.6); F. L.: Fluorescence; n.d.: not determined  
 
In conclusion, the above data indicate that the complex formation is very sensitive to the solvent 
and solvent polarity. Most of the tweezers either do not bind to any guest in methanol or bind 
very weakly. Inclusion of methanol into the tweezer’s cavity lowers the affinity of any guest. 
Also, the large hydrophobic tweezers and side-chain of lysine or arginine guests can separately be 
more solvated in methanol compared to aqueous solution, and therefore, host and guest do not 
interact in methanol as strongly as in buffer solution. Complex 161@AcLysOMe is an exception 
case which has similar affinities in both the methanol and buffer. The molecular tweezers operate 
best in aqueous solutions that make them best suitable to use under the physiological conditions 
in biological systems. High affinity complexes in aqueous solution are formed due to the 
hydrophobic association of a tweezer and alkyl side-chain of a guest which are otherwise poorly 
solvated in aqueous solution. Remarkably, a correlation could be established in the chemical shift 
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changes, fluorescence change and binding affinity as: more polar solvent ~ large chemical shift 
difference ~ large fluorescence change ~ strong complex formation. 
 
3.2.6 Study of the phosphate tweezer 133 binding to IAPP 
 
All the biophysical and cell culture experiments (ThT assays, EM, CD and MTT assays) were 
performed in collaboration with Prof. Gal Bitan at neurology department, university of 
California, LA, USA. The molecular dynamics (MD) simulations of the tweezer 133 and IAPP 
were performed in collaboration with Prof. Elsa Sanchez at MPI Mulheim, Germany. I 
contributed the tweezer 133(CLR01) for the above studies and investigated the binding sites of 
the tweezer 133 on IAPP fragments by using the 1H-NMR and fluorescence titration experiments. 
 
Type 2 diabetes mellitus (T2DM) is the most common amyloid-related disease affecting hundreds 
of millions of people worldwide[135]. It is closely associated with obesity and elevated blood 
glucose levels. T2DM abnormality include ocular, renal, cardiovascular, and neurologic 
complications[136], increasing morbidity and mortality[137] and causing substantial economic and 
public health burden[138]. 
 
In T2DM, Islet amyloid polypeptide (IAPP) self-assembles into toxic oligomers that cause β-cell-
membrane damage and apoptosis, and later precipitates as extracellular pancreatic amyloid. 
Therefore, preventing IAPP self-assembly is a promising strategy for developing disease-
modifying therapy for T2DM. IAPP is a 37-residue polypeptide pancreatic hormone synthesized 
and secreted with insulin.[139] Since IAPP has one Lys residue at position 1, therefore, inhibition 
of aggregation and toxicity of IAPP by the molecular tweezer 133 can be expected. The 
mechanism of the tweezer 133 inhibition of IAPP assembly and toxicity is investigated using a 
combination of cell viability assays, biophysical methods, spectroscopic and computer modeling.  
Since there is only one Lys and that too at position 1, the tweezer 133 was not expected to inhibit 
aggregation and toxicity of IAPP very effectively. However, using ThT fluorescence and electron 
microscopy (EM), Bitan group showed that the tweezer 133 inhibits IAPP to β-sheet and fibril 
formation at 1:1 ratio. Even more surprisingly, the tweezer 133 inhibits IAPP aggregation at low 
sub-stoichiometric concentrations, whereas inhibition of toxicity required excess of the tweezer 
133. Circular dichroism (CD) studies showed different conformations adopted by IAPP alone (α-
helix) and IAPP in the presence of the tweezer 133 (α-helix and β-sheet), which are in good 
agreements with ThT and EM. IAPP is known to cause β-cell death predominantly by inducing 
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apoptosis.[140] At 10-fold excess, the tweezer 133 inhibits IAPP-induced apoptosis in RIN5fm 
cells completely.  
 
To find out whether binding to only Lys1 mediated the tweezer 133 inhibition of IAPP 
aggregation and/or toxicity or is there other binding sites of the tweezer 133 in IAPP, Bitan group 
investigated the effect of the tweezer 133 on the truncated IAPP2–37. Surprisingly, in the presence 
of equimolar ratio of the tweezer 133, no increase in ThT fluorescence was observed and only 
amorphous structures were detected. These results suggest that the tweezer 133 completely 
inhibit the β-sheet and fibril formation of IAPP2–37. The cell viability measured by MTT assay in 
ArgIN5fm β-cells and IAPP2–37 showed that the tweezer 133 protected the cells against IAPP2–37 
induced toxicity even in the absence of the Lys1 binding site. Taken together, the data obtained 
with IAPP2–37 strongly supported the existence of an additional binding-site on IAPP for the 
tweezer 133. 
 
Using the solution-state 1H-NMR experiments, we investigated the binding of the tweezer 133 to 
unlabeled N-terminal fragments of IAPP. To explore the tweezer 133 binding to Lys1, 1H-NMR 
of IAPP1-7 at different ratios with the tweezer 133 were measured. Already at 1:1 concentration 
ratio of the peptide and the tweezer 133, all the Lys side chain methylene signals shift drastically 
upfield into the negative-ppm range (Figure 3.25), indicating inclusion of the Lys1 side chain 
inside the tweezer’s cavity. No further change occurred at 3-fold excess of the tweezer 133. The 
Lys1 side-chain protons are assigned by 1H-1H COSY spectrum (Figure 3.26) which led to 
determine the ∆δobs values (4.4 and 4.5 ppm for the δ and ε protons, respectively). To identify 
whether the tweezer 133 binds to the disulfide bridge present between the residues Cys2 and 
Cys7, we measured the NMR of IAPP2–7 and the tweezer 133. In contrast to IAPP1–7, no change 
was observed in the spectrum of IAPP2–7 even in the presence of 3-fold excess of the tweezer 133 
(Figure 3.27) indicating that the presence of Lys1 was essential for the tweezer 133 binding to 
IAPP1–7. 
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Figure 3.25 IAPP1-7, tweezer 133, and their 1:1 or 1:3 complexes in 10 mM phosphate-buffered D2O, pH 7.2. The 
Lys1 side-chain methylene signals are assigned as α, β, γ, δ and ε from COSY. All the methylene resonances, most 
notably the δ- and ε-protons, are shifted upfield by 4.4 and 4.5 ppm, respectively, indicating strong binding of 
tweezer 133 to Lys1. 
 
 
 
Figure 3.26 gs-H,H-COSY NMR of 3:1 molar ratio of tweezer 133:IAPP1-7, respectively, in D2O phosphate buffer. 
Lys1 side chain protons in the complex are assigned as α, β, γ, δ and ε. 
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Figure 3.27 1H-NMR spectra of 1.0 mM IAPP2–7, 3.0 mM tweezer 133, and a 1:3 mixture of the two in 10 mM 
sodium phosphate, pH 7.2. No interaction is seen between tweezer 133 and peptide fragment. 
 
We have already shown that the tweezer 133 binds to N/C-protected arginine (Kd = 20 μM) about 
2 times weaker than to N/C-protected lysine. Therefore, to test whether the tweezer 133 also bind 
to Arg11, similar experiments are performed with IAPP1–14. In the presence of 3-fold excess of 
the tweezer 133, the side-chain protons of both Lys1 and Arg11 show an upfield shift (Figure 
3.28), indicating binding at both sites. The shift of Arg11 protons resonances appeared weaker 
than that of Lys1 protons in the spectrum of IAPP1–14. The peak overlap made analysis of the 
spectrum difficult. Therefore, we examined the tweezer 133’s affinity for Arg11 in IAPP2–14, 
where unambiguous binding of the tweezer 133 to Arg11 was confirmed (Figure 3.29). The 
chemical shifts of the complexed side-chain protons of Arg11 were confirmed by 1H-1H COSY 
(Figure 3.30).  
 
 
 
Figure 3.28 1H-NMR spectra of 1.0 mM IAPP1–14, 3.0 mM tweezer 133, and a 1:3 mixture of the two in 
phosphate buffer(10 mM, pH 7.2). The tweezer 133 is involved in complex formation with both, Lys1 and 
Arg11 (Lys1 signals marked in black, Arg11 signals in red). Complexed Lys1 signals show almost the same 
upfield shift as in the complex with IAPP1-7. By contrast, Arg11 signals are broadened and significantly less 
upfield-shifted.  
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Figure 3.29 1H-NMR of IAPP2-14, tweezer 133, and their 1:3 complex in 10 mM phosphate-buffered D2O, pH 7.2. 
The Arg11 side-chain methylene signals are assigned as α, β, γ, and δ (COSY). The δ-protons are shifted upfield by 
~ 4 ppm indicating strong binding of tweezer 133 to Arg11. 
 
 
Figure 3.30 gs-H,H-COSY NMR of 3:1 molar ratio of tweezer 133:IAPP2–14, respectively, in D2O phosphate buffer. 
Arg11 protons in the complex are assigned α, β, γ and δ. 
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In earlier discussions, we have shown that dissociation constants obtained by 1H-NMR titration 
and fluorescence titration experiments are in good agreements. So, fluorescence titration 
experiments were performed to determine the binding affinities of the tweezer 133 to the lysine- 
and arginine- containing IAPP peptide fragments. Tight binding of the tweezer 133 to Lys1 of 
IAPP1-7 is confirmed with the Kd = 9 μM (Figure 3.31) which is similar to value obtained for 
AcLysOMe (Kd = 9 μM) under the same conditions. Fluorescence titration experiments also 
reveals that the tweezer 133 bind to Arg11 with Kd = 104 μM, an order of magnitude weaker than 
at Lys1 and 5-fold weaker than the arginine derivative AcArgOMe. The decline in tweezer’s 
affinity for Arg 11 in IAPP2-14 can be attributed to steric hindrance around the arginine residue. 
Taken together, the NMR and fluorescence data strongly support that the tweezer 133 
predominantly binds to Lys1 and weakly to a second binding site at Arg11. The latter observation 
provided a plausible explanation for the inhibition of IAPP2–37 aggregation and toxicity by the 
tweezer 133. However, these results do not reveal how the tweezer 133 affected IAPP assembly 
at fM concentrations.  
 
 
 
Figure 3.31 left: fluorescence emission spectra of the tweezer 133 on titration with IAPP1–7 in 10 mM sodium 
phosphate buffer, pH 7.6 and, right: binding isotherm obtained by non linear curve fitting using SigmaPlot. 
 
MD simulations performed in the Sanchez group showed that the tweezer 133 preferentially 
binds at Lys1 in IAPP1–37. When MD simulations were performed by docking the tweezer 133 on 
Arg11 of IAPP, it was found that the Lys1 side chain competed effectively for the tweezer 133. 
Lys1 pulled the tweezer off of the Arg11 side chain and slipped itself into the tweezer’s cavity. 
The binding of the tweezer 133 to Lys1 resulted in a thermodynamically favourable complex in 
which the C- and N-termini of IAPP come into close proximity leading to a “wrapped” 
conformation that is stabilized by several intramolecular hydrogen bonds and ion pair 
interactions. It was speculated that most probably this structure serves as a template that can 
recruit other IAPP monomers into non-fibrillar assemblies. These results provided a possible 
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explanation for the catalytic effect of fM concentrations of the tweezer 133 on IAPP aggregation. 
Interestingly, when the tweezer 133 was removed from this complex, it was found that the 
prolonged MD simulations of IAPP have maintained this compact conformation.  
 
In summary, in conjunction to the biophysical and MD simulations experiments we have shown 
that the tweezer 133 preferred complexation with Lys1 in IAPP. The strong complex formation 
between the tweezer 133 and IAPP was confirmed by NMR and fluorescence titrations of IAPP 
fragments with the tweezer 133. The resulting dissociation constant (Kd) value by the 
fluorescence experiments corresponded well with that of isolated lysine derivatives. Further, the 
drastic upfield shifts of Lys1 side-chain signals provided the evidence that the tweezer´s binding 
occurs by the insertion of the Lys1 side-chain inside the tweezer’s cavity.  
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4 Summary and outlook 
4.1 Summary  
4.1.1 Symmetrical anionic tweezers 
 
The molecular tweezer 161 substituted with sulfate anion at the central benzene ring was 
synthesized starting from the dihydroxy tweezer 121. The sulfate tweezer 161 is soluble in 
methanol and water. Chemical shifts observed by the 1H-NMR dilution experiment in aqueous 
solution and calculated structures suggest that the tweezer 161 weakly self-assemble into the 
dimer (Kdm = 370 M-1). In contrast, such dimer formation is absent in methanol, indicating that a 
hydrophobic effect operate in water. Among all the anionic tweezers, the tweezer 161 aggregates 
more efficiently than the tweezer 133, whereas, the tweezers 734 and 150 do not self-assembled 
at all. The structures of all the four anionic tweezers are shown in figure 4.1. 
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Figure 4.1 Structures of the four anionic tweezers substituted with phosphonate, phosphate, sulfate and carboxylate 
anions.   
 
Binding affinities of the tweezer 161 were evaluated with lysine and arginine derivatives, and 
peptide guests. The tweezer 161 binds to protected lysine about 13-fold stronger compared to free 
lysine. Also, it shows about fourfold decreased affinity to the N/C free arginine compared to N/C 
protected arginine. The lower affinities to the free amino acids are expected due to the 
electrostatic repulsion between the sulfate anion of the tweezer and the carboxylate anion of the 
guest amino acids. The KLVFF case was interesting as some additional interactions between the 
guest’s aromatic residues and tweezer’s aromatic rings likely occur that alter the fluorescence 
emission band of the complex. 
 
Comparative studies among the tweezers 161, 133, 734 and 150 were carried out based on NMR, 
fluorescence and ITC titration experiments, and molecular modeling to investigate roles of the 
88 
anionic groups on the different tweezers in binding to the lysine and arginine amino acid 
derivatives and peptide guests. All the studies suggest that the tweezer 133 is the most potential 
receptor. The tweezer 161 proved to be the second best anionic tweezer followed by the tweezer 
734 and the tweezer 150 respectively. Usually, all the anionic tweezers bind to lysine about 2-3 
times stronger than arginine. The tweezer 133 binds to all the guests almost in the low 
micromolar affinities (< 30 μM). The tweezer 161 is quite selective to N/C protected lysine 
among all the amino acid derivatives. Remarkably, the tweezer 133 binds to the free and 
protected lysine with similar affinities, while, the tweezers 161, 734 and 150 bind to the free 
lysine about one order of magnitude weaker than to the protected lysine. The strong upfield 
chemical shifts of 3-5 ppm for the guest protons obtained by the 1H-NMR titration experiments 
strongly support the guest binding by the inclusion of lysine or arginine side-chain into the 
tweezer’s cavity. The chemical shifts of < 1 ppm of guest protons of the complexes of the tweezer 
150 with lysine or arginine derivatives indicate very week stability of the complex formed by the 
inclusion of any guest inside the tweezer’s cavity.  
 
The ITC studies of the complexes of the tweezers 133 and 161 bring forward the individual 
enthalpy and entropy of the complex formation. The tweezer 133 binds to AcArgOMe 
enthalpically more tightly than AcLysOMe but due the favorable entropy of the complex 
133@AcLysOMe, it is 2-fold stronger than the complex 133@AcArgOMe. The enthalpy and 
entropy contributions of the complexes of the tweezer 161 are somewhat contrary to those of the 
complexes of the tweezer 133. Surprisingly, the complex 133@AcLysOMe is entropy driven in 
methanol. The ITC data together with the negligible NMR chemical shifts of lysine protons of the 
complex 133@AcLysOMe in methanol indicate that the binding of lysine does not occur inside 
the tweezer’s cavity but outside. These results imply that the observed binding affinity in 
methanol is purely based on the electrostatic and hydrogen bonding interactions between the 
phosphate anions of the tweezer 133 and the lysine. Surprisingly, in methanol and aqueous buffer 
solution the tweezer 161 binds to lysine with the similar affinity and by the lysine side-chain 
inclusion into the tweezer’s cavity. This is contrary to the external binding of the tweezer 133 to 
lysine in methanol. These results point towards very different characteristics of the phosphate and 
the sulfate groups in methanol and water. 
 
In neutral aqueous buffer, partial protonated form and the highest negative partial charge on the 
oxygen atoms of the phosphate group in the tweezer 133 are expected to be responsible for the 
higher affinities of this tweezer compared to the other tweezers. The tweezers 161, 734 and 150 
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due to their fully deprotonated anions can only act as hydrogen bond acceptor. Therefore, these 
tweezers lack hydrogen bond donor sites and experience strong electrostatic repulsive 
interactions from the carboxylate anion of the free amino acids or peptides backbone. The lower 
affinities of the tweezer 734 compared to the tweezer 161 are attributed to the partial steric 
hindrance of the tweezer 734’s cavity by the methyl group on its phosphate group. On the other 
hand, the much lower affinities of the tweezer 150 are believed due to the absence of proper 
hydrogen bonding and electrostatic interactions between the carboxylate anion of the tweezer and 
the ammonium or guanidinium groups of the guests. Longer length and high flexibility of the 
carboxymethyl groups of the tweezer 150 are supposed to reduce the suitable hydrogen bonding 
and ion pair interactions between the tweezer and the guests. Our studies suggest that no single 
force (i.e. hydrophobic or electrostatic) decides the overall stability of the complex, and only 
collective effects of all kind of favorable and unfavorable interactions govern the final stability of 
the complex. 
 
Biological studies performed in the collaboration with Prof. Bitan suggest that all these anionic 
tweezers interfere in the aggregation process of several pathological amyloid proteins like Aβ and 
IAPP etc. The inhibition effects are usually in the order of the tweezers affinities to the isolated 
amino acid derivatives. Surprisingly, the tweezer 161, 734 and 150 are found slightly toxic to the 
cells and only the tweezer 133 is the most prominent tweezer candidate. 
 
4.1.2 Unsymmetrical phosphate tweezers 
 
In the second part of the work, effects of replacing one phosphate group of the tweezer 133 by 
other substitutions were investigated. For this purpose, the unsymmetrical molecular tweezers 
that carry a phosphate group on one side and a linker or additional recognition unit on the other 
side of the tweezer’s central benzene ring were synthesized and studied. The structures of these 
unsymmetrical linker tweezers are shown in Figure 4.2. The unsymmetrical tweezers are soluble 
in aqueous buffer (1-50 μM).  
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Figure 4.2 Structures of the four unsymmetrical phosphate tweezers synthesized and studied. 
 
1H-NMR and molecular modeling structures suggest that the tweezer 193 keeps the cavity open 
and accessible for the guest molecules. From the crystal structures, 1H-NMR and molecular 
modeling structures, the tweezer 195 is found to completely block the cavity entrance by 
engaging its n-octyl chain in numerous van-der-Waals contacts to aromatic CH-groups as well as 
CH-л interactions with its own and other aromatic tweezer moieties. Unexpectedly, the tweezer 
196 and 198 insert the ethyl group of their linkers into the tweezer’s cavity that suggest an 
intramolecular hydrophobic effect. 
 
The dissociation constants of these tweezers cover relatively broad range of affinities ranging 
from 30 µM to 600 µM in aqueous phosphate buffer. The tweezers with ester groups (tweezers 
193 and 196) are better tweezer candidate for complexing the guests compared to the tweezers 
with ether tethers (tweezers 195 and 198). Additionally, the tweezers 193 and 196 binds N/C-
protected lysine or arginine more strongly compared to the unsubstituted hydroxy 
monophosphate tweezer 130 which indicate that the acetyl group and the ethoxycarboxymethyl 
group take part in molecular recognition of their guests in a positive cooperative manner. 
Interestingly, the guest molecules compete with self-included linker units in the tweezers 196 and 
198. The tweezer 193 binds to lysine and arginine derivatives with almost similar affinities. This 
tweezer also binds to IAPP2-14 slightly stronger compared to the tweezer 133. 
 
The effects of solvent polarity were also evaluated on the guest binding of all the tweezers by 
using the methanol-buffer mixtures. A correlation is found among the solvent polarity, chemical 
shifts of the guest protons, fluorescence change of the tweezer and binding affinity as: more polar 
solvent ~ large chemical shift difference ~ large fluorescence change ~ strong complex formation. 
 
The results that the carbonyl group takes part in the guest binding of the tweezers 193 and 196, 
and that the affinities of these tweezers are still lower than the tweezer 133, render both the 
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phosphate groups essential for the optimum affinity of a tweezer. For this reason it is realized that 
both the phosphate groups must be installed in the new unsymmetrical bisphosphate tweezers and 
the additional recognition site should be attached to one or both the phosphates. Therefore, to 
synthesize more elaborative unsymmetrical molecular tweezers, we have synthesized 2nd 
generation linker tweezers that contain an alkyne or ester linker on one phosphate group (Figure 
4.3).  
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Figure 4.3 Structures of the synthesized 2nd generation alkyne and ester containing linker tweezers 248 and 247. 
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4.2 Outlook 
 
All the anionic tweezers can be used in solutions which have the pH values well above the pKa 
values of the tweezer’s anionic groups. Therefore, the tweezers 133, 734 and 150 can not be used 
at acidic pH (< 4) due to the protonation of their anionic groups.[141] On the other hand, the 
sulfate group can be readily deprotonated in acidic medium (pKa < 0), therefore, the tweezer 161 
holds the promise of a potential receptor for the proteins that are used at acidic pH. For that 
reason, the tweezer 161 will be tested to modulate the structure and function of lysozyme in 
acidic medium (pH < 2) in collaboration with Prof. Bitan. 
 
In order to achieve protein selectivity, several protein specific recognition units could be designed 
and synthesized for various protein targets and then can be coupled with the alkyne or ester 
containing tweezers 248 or 247 to synthesize 2nd generation unsymmetrical bisphosphate 
tweezers. The new unsymmetrical tweezers thus obtained shall be evaluated for their binding to 
the required guests. Finally, biological studies of the new tweezers shall be performed in 
collaboration with Prof. Bitan.  
 
4.2.1 2nd generation unsymmetrical tweezers 
 
The tweezer 248 can be coupled with an azide containing recognition unit through cupper 
catalyzed click reaction and then the protecting groups can be cleaved to obtain the final tweezer 
(Scheme 4.1). If a recognition site does not have protecting groups then the methyl groups of the 
tweezer 248 can be cleaved prior to couple the tweezer with protecting group free azide 
containing recognition sites.   
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Scheme 4.1 General synthetic route for the unsymmetrical tweezer I starting from tweezer 248. 
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Scheme 4.2 Synthesis plan of the simple unsymmetrical tweezer II starting from the tweezer 248. 
 
 
The tweezer 247 is the another potential linker tweezer that provides the opportunity to couple 
the ester group with an amine containing recognition unit as shown in Scheme 4.3. 
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Scheme 4.3 General synthetic route for the unsymmetrical tweezer III starting from the tweezer 247. 
 
 
4.2.2 Structure based design of the molecular tweezers for Aβ peptide 
 
The tweezer IV is designed to bind specifically at Lys16 in Aβ (10-42). The calculated structures 
obtained by means of Conformational Search (Maestro 9.2, OPLS_2005, water, 5000 steps) 
suggest that this tweezer might complex to Aβ with nanomolar affinity compared to the 
micromolar affinity of the phosphate tweezer 133. The tweezer IV can be synthesized according 
to the synthesis plan shown in Scheme 4.4. 
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Scheme 4.4 A possible synthesis scheme for the unsymmetrical tweezer IV. 
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Figure 4.4 Calculated structure of the tweezer IV (shown in pink) docked on Lys16 in Aβ (10-42) (Maestro 9.2, 
conformational search, OPLS_2005, water, 5000 steps). The peptide residues involved in the interactions with the 
tweezer are shown in red color and the rest peptide in gray. All the hydrogen bonds are shown by doted lines. 
 
The following tweezers V and VI substituted with serine or serine derivatives could also be 
synthesized and tested.  
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Figure 4.5 Calculated structure of the tweezer VI docked on Lys16 of Aβ (10-42) (Maestro 9.2, Conformational 
Search, OPLS_2005, water, 5000 steps). The peptide residues involved in the interactions with the tweezer are 
shown in red color and the rest peptide in gray. All the hydrogen bonds are shown by doted lines. 
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5 Experimental part 
5.1 Material and method 
  
Chemicals 
All the chemicals required for this work were purchased from Sigma-Aldrich, Fluka, Acros 
Organics, Bachem and Merck in high commercial grade. The technical grade solvents were 
distilled/dried prior to use by standard literature methodology.[142] 
 
Chromatography 
Thin Layer Chromatography (TLC) plates from Merck with silica gel-60 were used to monitor 
the reactions. Silica gel-60 (200-400 mesh) from Merck was used for the column chromatography 
purification of compounds.[143] 
 
UV-Vis spectroscopy 
UV/Vis- Spectrum were measured on a Jasco V-550 Spectrometer. Quartz cuvette of 10 mm was 
used for solution. 
 
Mass spectroscopy 
High-resolution electron spray ionization (ESI) mass spectra were measured on a Bruker 
BioTOF III spectrometer by Mr. Werner Karow. 
 
Crystallography 
Single crystal analyses were carried out on an X-ray diffractometer by Dr. Christoph Wölper in 
the research group of Prof. Schulz at University of Duisburg-Essen. 
 
Buffer preparation for fluorescence titration and ITC measurements 
 PB, 10 mM, pH 7.2: 109 mg (0.7 mmol) of NaH2PO4•2H2O and 170 mg (1.2 mmol) Na2HPO4 
were dissolved in 200 ml bidist water and the pH was adjusted to 7.2 by dropwise adding an 
aqueous solution of 0.1M NaOH or 0.1 M solution of phosphoric acid.  
Following buffers were also prepared using the same procedure. 
PB, 10 mM, pH 6.2 
PB, 10 mM, pH 7.6  
PB, 10 mM, pH 8.5  
PB, 200 mM, pH 7.6 
98 
PBS: 10 mM phosphate buffer + 150 mM NaCl, pH 7.6. 
 
Buffer preparation for NMR titration 
(PB, 10 mM, pH 7.2): 28 mg (0.10 mmol) KH2PO4 were dissolved in 20 ml D2O and pH was 
adjusted to 7.2 with 0.1 M NaOH solution in D2O. Phosphate buffer for IAPP measurements was 
also prepared in D2O:H2O (1:9) in the same way. 
 
Fluorescence spectroscopy 
Fluorescence measurements were performed at 25 oC on a Jasco FP-6500 spectrofluorometer. 
Solutions were measured in a round quartz cuvette of 1 cm diameter. 
 
Isothermal titration calorimetry (ITC) 
ITC measurements were performed on a VP-ITC instrument from MicroCal Inc. All the 
measurements were carried out with the help of Mr. Kowski. 
 
NMR spectroscopy 
 NMR spectra were recorded on Bruker AMX 300 or Bruker DRX 500. Chemical shifts were 
reported in ppm relative to tetramethylsilane (δ = 0 ppm). NMR signals of commonly used 
solvents were taken from literature.[144] Multiplicities were indicated by s (singlet), d (doublet), t 
(triplet), m (multiplet) and br (broad). 13C spectra were broadband decoupled and calibrated on 
the particular solvent signal. All the spectra at 500 MHz were measured by Mr. Bandmann or Dr. 
Schaller, whereas, NMR titrations were performed by myself.  
 
NMR experiments examining the interactions between CLR01 and unlabeled IAPP fragments 
were carried out at 25 °C using a Bruker DRX-500 MHz spectrometer equipped with a 5 mm 
QNP-Probe (1H) or a 5 mm TBI-Probe (1H, X, 13C) with Z-Gradient (gs-COSY90 and gs-
NOESY). 1H-NMR of CLR01 alone was measured by dissolving CLR01 at 1.0 mM in 10 mM 
phosphate-buffered D2O, pH 7.2. Solutions of IAPP fragments in the absence or presence of 3 
equivalents of CLR01 were prepared in 10 mM sodium phosphate in 9:1 – H2O:D2O, pH 7.2, at 
peptide concentration of 1.0 mM in all cases. 1H-NMR was measured with water suppression 
using presaturation and composite pulses (zgcppr). For COSY experiments, samples of IAPP1–7 
or IAPP2–14 were prepared in phosphate-buffered D2O, pH 7.2, in the absence or presence of 3 
equivalents of CLR01 and gs-COSY90 (cosygpqf) spectra were measured. For NOESY 
experiments, a 1:1 mixture of IAPP2–14:CLR01 was prepared in sodium phosphate in 9:1 – 
99 
H2O:D2O, pH 7.2, degassed and sealed under argon. A gs-NOESY (noesyesgpph) spectrum was 
measured with water suppression using excitation sculpting with gradient. 
 
Molecular modeling 
Molecular modeling was performed on Maestro 9.2 using OPLS_2005 force field. Minimized 
structures were calculated by Monte-Carlo Simulations for 5000 steps with 5000 iterations using 
Mixed Torsional/Low-Mode Sampling method. Minimum energy structures obtained from 
Monte-Carlo Simulations were used for Molecular Dynamics Simulations.  
 
Measuring the association constant Ka by 1H-NMR titration spectroscopy 
All the NMR titration experiments were performed by the standard 1H-NMR titration method or 
the dilution titration method. In a standard titration method, guest is kept at constant 
concentration while the receptor concentration varies. In a typical experiment, a tweezer is 
dissolved in a guest solution at about 3:1 ratio of tweezer:guest in an NMR tube. Guest solution is 
added in several aliquots of 50-100 µl and the 1H-NMR is recorded after each addition. Guest is 
added until the guest stoichiometry reached above the tweezer stoichiometry.  In the dilution 
titration method, a tweezer and a guest are dissolved in 1:1 ratio and at different overall 
concentrations. Usually, six samples which differ in concentration by a factor of ~ 2 are required 
and the observed chemical shifts of guest protons at each concentration are recorded. Association 
constants of complex are determined by standard non linear regression analysis of the data using 
program Table Curve.[145] 
  
Measuring the association constant Ka by fluorescence titration spectroscopy 
A tweezer was dissolved in a solvent of choice (buffer or methanol or mixture of two solvent) 
and at a given concentration (10-50 μM). A guest was dissolved (0.2-3.0 mM) in the tweezer 
solution to keep the tweezer concentration constant over the entire titration. Seven-hundred µl of 
tweezer solution were placed in a quartz cuvette of 1-cm path length and fluorescence spectra 
were measured on a FP-6500 spectrophotometer (JASCO). Aliquots of guest solution were added 
to the tube and fluorescence spectra were recorded following each addition. Binding isotherms 
for a 1:1 complex were obtained from fluorescence of maximum emission intensities and 
converted into binding constants by standard, non-linear regression fitting[146] using SigmaPlot 
10.0 (Systat, San Jose, CA) [147]. 
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Measuring the association constant Ka by isothermal titration calorimetry (ITC) 
 
ITC measurements were performed on an isothermal titration calorimeter from MicroCal.[121] In a 
typical experiment, 0.1 mM tweezer solution is placed in the calorimetry cell.  1.0 mM solution 
of a guest is mixed to the tweezer solution by a syringe in 5 µl aliquots at an interval of 300 s. A 
total 120 µl guest solution is added to the tweezer solution in 120 min. The solution was 
continuously stirred and maintained at a fix temperature of 25 oC throughout the experiment. 
Association constants and enthalpy (ΔH) of complex formation are calculated from the non linear 
least square regression method using the Origin software. Entropy (ΔS) of complex formation is 
determined by the formula ΔG = ΔH-TΔS. 
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5.2 Synthesis 
5.2.1 Synthesis of the sulfate tweezer 161 
 
S
O
O
O
O
O
2Na
SO O
O
 161
C42H28Na2O8S2
 770,78 g/mol
HO
OH
 121 
C42H30O2
 566,69 g/mol
1. SO3.Py
Pyridine, 90 o C, 2d
65%
2. NaHCO3
 
 
75 mg (0.1325 mmol) of the hydroxy tweezer 121 and 85 mg (0.53 mmol) sulfur trioxide 
pyridinium complex were dissolved in 7 ml dry pyridine and refluxed at 90 o C for 24 h. After 
that additional 63 mg (0.397 mmol) of SO3.Py complex were added to this solution and stirred the 
mixture for another 36 h. The mixture was cooled to RT and quenched with sat. NaHCO3 
solution. The excess of inorganic salts was filtered off by a glass filter (D4) and the filtrate 
aqueous solution was extracted with diethyl ether (3×50 ml). The aqueous phase was dried on 
rotary evaporator and solid residue suspended in ethanol and filtered. Solvent removed on vacuo 
and 70 mg of white solid product were collected.  
Yield: 70 mg. 68% 
Melting Point: > 229 oC, brown coloration, decomposition. 
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1H-NMR in CD3OD 
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1H-NMR in D2O 
1H-NMR (500 MHz, CD3OD): δ [ppm] = 2.26 (td, 2H, H-24a, H-25a), 2.33 (s, 4H, H-23, H-
26), 2.51 (td, 2H, H-24i, H-25i), 4.00 (4H, H-5, H-11, H-16, H-22), 4.48 (s, 4H, H-7, H-9, 
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H-18, H-20), 6.78 (m, 4H, 4H, H-2, H-3, H-13, H-14), 7.02 (m, 4H, H-4, H-12, H-1, H-
15), 7.10 (s, 4H, H-6, H-10, H-17, H-21). 
 
1H-NMR (500 MHz, D2O): δ [ppm] = 2.34 (d, 2H, H-24a, H-25a), 2.39 (m, 4H, H-23, H-26), 
2.48 (d, 2H, H-24i, H-25i), 4.20 (4H, H-5, H-11, H-16, H-22), 4.45 (s, 4H, H-7, H-9, H-18, 
H-20), 6.06 (br, s, 4H, 4H, H-2, H-3, H-13, H-14), 7.03 (m, 4H, H-4, H-12, H-1, H-15), 
7.18 (s, 4H, H-6, H-10, H-17, H-21). 
 
13C-NMR (125,7 MHz, CD3OD): δ [ppm] = 50.0 (C-7, C-9, C-18, C-20), 52.4 (C-5, C-11, C-16, 
C-22), 69.0, 69.4 (C-23, C-24, C-25, C-26), 117.3 (C-6, C-10, C-17, C-21), 122.1 (C-4, C-12, C-
1, C-15), 125.8 (C-2, C-3, C13, C-14), 139.3 (C-8, C-19) 144.8 (C-7a, C-8a, C-18a, C-19a ), 
148.6 (C-6a, C-9a, C-17a, C-20a), 149.2 (C-5a, C-10a, C-16a, C-21a), 151.9 (C-4a, C-11a, C-
15a, C-22a). 
 
HR-MS (ESI, pos., neg., MeOH): 
m/z [M+Na]+ : cal. : 793.0913 
             obs.: 793.0944 
m/z [M-Na]⎯ : cal. : 747.1129 
             obs.: 747.1131 
m/z [M-2Na]2- : cal.: 362.0618 
              obs.: 362.0635 
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5.2.2 Synthesis of the unsymmetrical linker tweezers 
5.2.2.1 Synthesis of the acetoxy tweezer 193 
 
 
HO
OAc
120
C44H32O3
608,72 g/mol
1. POCl3, Et3N
THF, 0oC to RT, 8 h
76%
P
OMe
MeO
O
O
OH
189
C44H35O5P
674,72 g/mol
2. MeOH, RT, 2d
 
 
Under argon atmosphere, 300 mg (0.493 mmol) tweezer 120 was dissolved in 40 ml anhydrous 
THF and cooled the solution to 0 oC. To this cooled solution 90 μl (0.987 mmol) POCl3 and after 
10 min. 137 μl (0.987 mmol) Et3N were added. The reaction mixture is stirred from 0oC to RT for 
8 h and then 8 ml dry methanol were added and stirred again at RT for 2 days. The solvent was 
removed on rotary evaporator and to the crude 50 ml sat.NH4Cl solution were added and 
extracted with CH2Cl2 (3×100 ml). The organic layer was washed the with brine solution. Solvent 
was removed on rotary evaporator and solid purified by column chromatography using 
EtOAc//cyclohexane (1:3) eluent. 
 
Yield: 250 mg, white solid, 76 %. 
 
Melting Point: > 240 oC brown coloration. 
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1H-NMR 
 
-35-30-25-20-15-10-540 35 30 25 20 15 10 5 0 ppm
-4
.0
80
 
 
31P-NMR 
 
 
1H-NMR (500MHz, CD3OD): δ [ppm] = 2.28 (dt, 2H, H-24a, H-25a), 2.33 (dt, 2H, H-24i, H-
25i), 2.36 (s, 4H, H-23, H-26), 3.99 (s, 2H), 3.22 (d, 3JH-27/P, H-28/P  = 11.00, 6H, H-27, H-28), 4.03 
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(s, 4H, H-5, H-11, H-16, H-22), 4.25 (s, 4 H, H-7, H-9, H-18, H-20), 6.78 (m, 4H, H-2, H-3, H-
13, H-14), 7.01 (m, 2H, H-1, H-15), 7.04 (m, 2H, H-4, H-12), 7.11 (s, 2H, H-17, H-21), 7.15 (s, 
2H, H-6, H-10). 
 
13C-NMR (125.7MHz, CD3OD): δ [ppm] = 48.6-49.3 (C-7, C-9, C-18, C-20), 52.4(d, C-5, C-11, 
C-16, C-22), 55.8(d, C-27, C-28), 68.8, 69.2 (C-23, C-24, C-25, C-26), 117.0 (C-17, C-21), 117.8 
(C-6, C-10), 121.8 (C-1, C-15), 122.3 (C-4, C-12), 126.0 (d, C-2, C-3, C13, C-14), 138.4, 141.7, 
144.0 (C-5a, C-16a, C-21a, C-10a,C-7a, C-8a, C-18a, C-19a), 148.4, 148.9, 149.2 (C-6a, C-9a, 
C-17a, C-20a, C-8, C-9), 152.2 (d, C-4a, C-11a, C-15a, C-22a). 
 
31P-NMR (202MHz, CD3OD): δ [ppm] = -4.08 
 
HR-MS (ESI pos., MeOH): m/z [M+Na]+ : cal. 697.2114, obs. 697.2133. 
 
 
P
OMe
MeO
O
O
OH
189
C44H35O5P
674,72 g/mol
CH3COCl, Et3N
THF, 0oC to RT, 5h
87%
P
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O
192
C46H37O6P
 716,76 g/mol  
 
 
Under argon atmosphere, 30 mg (0.044 mmol) tweezer 189 were dissolved in 5 ml anhydrous 
THF and cooled to 0 oC. Then 9 μl (0.066 mmol) Et3N were added by micro syringe. After 5 min. 
were added 5 μl (0.066 mmol) of acetyl chloride with subsequent formation of white precipitate 
of Et3N.HCl.  The reaction stirred for 5 hour from 0 oC to rt and then added sat. NaHCO3 solution 
and extracted three times with CH2Cl2. The combined organic phase is then washed with dist. 
water and dried over MgSO4. Solvent removed on a rota vap and thus collected 27 mg pure white 
solid. 
 
Yield: 27 mg, 87% 
107 
 
Melting Point: > 200 oC brown coloration. 
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1H-NMR 
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-35-30-25-20-15-10-540 35 30 25 20 15 10 5 0 ppm
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31P-NMR 
 
1H-NMR (500MHz, CDCl3): δ [ppm] = 2.36 (m, 5H, H-24a, H-25a, H-29), 2.43 (s, 4H, H-23, 
H-26), 2.48 (d, 4H, H-23, H-26), 3.25 (d, 3JH-27/P, H-28/P =1.00, 6H, H-27, H-28), 3.97 (s, 2H, 
H-7, H-9), 3.06 (d, 4H, H-5, H-11, H-16, H-22), 4.38 (s, 2H, H-18, H-20), 6.73 (m, 4H, 
H-2, H-3, H-13, H-14), 7.02 (d, 2H, H-4, H-12), 7.07 (d, 2H, H-1, H-15), 7.12 (s, 2H, H-
6, H-10), 7.24 (s, 2H, H-17, H-21). 
 
13C-NMR (125.7MHz, CDCl3): δ [ppm] = 20.9 (C-29), 48.7 (C-7, C-9, C-18, C-20), 51.3(d, C-5, 
C-11, C-16, C-22), 54.9(d, C-27, C-28), 68.5, 69.7 (C-23, C-24, C-25, C-26), 116.6 (C-17, C-21), 
117.2 (C-6, C-10), 121.0 (C-1, C-15), 121.8 (C-4, C-12), 124.8 (d, C-2, C-3, C13, C-14), 136.7, 
141.4, 142.3 (C-5a, C-16a, C-21a, C-10a,C-7a, C-8a, C-18a, C-19a), 146.4, 146.8, 147.8 (C-6a, 
C-9a, C-17a, C-20a, C-8, C-9), 150.6 (d, C-4a, C-11a, C-15a, C-22a), 169.0 (-CH3CO). 
 
31P-NMR (202MHz, CD3OD): δ [ppm] = -3.78 
 
HR-MS (ESI pos., MeOH):  m/z [M+Na]+ :  cal. 739.2220,  obs. 739.2281. 
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General procedure for methyl deprotection of phosphate ester of the tweezers 
 
 
P
OMe
MeO
O
O
O
O
192
C46H37O6P
 716,76 g/mol
1. Me3SiBr, CH2Cl2
0oC to RT, 8 h
2. CH2Cl2/H2O, RT, 1 d
97%
P
OH
HO
O
O
O
O
193
C44H33O6P
 688,7 g/mol  
 
To a 0 oC cooled solution of 24 mg (0.0336 mmol) tweezer 192 in anhydrous CH2Cl2, 44 μl 
(0.336 mmol) trimethylsilyl bromides (TMSBr) were added dropwise and then stirred at RT for 8 
hour. The excess of TMSBr and solvent were removed by condensation and remaining residue 
was dried on oil pump for 2-5 h. The solid residue was then dissolved in CH2Cl2/H2O (1:1) and 
stirred at RT for 24 h. Two phases were separated, and after drying organic phase on rota vap, 22 
mg of white solid were collected. The crude was washed with n-hexane or acetonitrile to remove 
the trace amount of grease from the product. This procedure is used as a general procedure for the 
methyl group deprotection of all the other tweezers. 
Yield: 22 mg, 97 %. 
 
Melting Point: > 221 oC brown coloration. 
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31P-NMR 
 
1H-NMR (500 MHz, CD3OD): δ [ppm] = 2.29 (d, 2H, H-24a, H-25a), 2.35 (m, 7H, H-23, H-
26, H-27), 2.40 (d, 2H, H-24i, H-25i), 3.99 (2H, H-7, H-9), 4.02 (s, 4H, H-5, H-11, H-16, 
111 
H-22), 4.38 (s, 2H, H-18, H-20), 6.81 (m, 4H, 4H, H-2, H-3, H-13, H-14), 7.03 (m, 6H, 
H-6, H-10, H-4, H-12, H-1, H-15), 7.15 (s, 2H, H-17, H-21). 
 
13C-NMR (125.7 MHz, CD3OD): δ [ppm] = 20.6 (C-27), 49.4 (C-7, C-9, C-18, C-20), 52.5(C-5, 
C-11, C-16, C-22), 69.2, 69.4 (C-23, C-24, C-25, C-26), 117.2 (C-6, C-10), 118.3 (C-17, C-21), 
122.3 (d, C-4, C-12, C-1, C-15), 126.1 (d, C-2, C-3, C13, C-14), 137.7, 138.9, 143.4 (C-5a, C-
16a, C-21a, C-10a,C-7a, C-8a, C-18a, C-19a), 148.2, 148.7, 149.2 (C-6a, C-9a, C-17a, C-20a, C-
8, C-9), 150.2 (d, C-4a, C-11a, C-15a, C-22a), 170.9 (-CH3CO). 
 
31P-NMR (202MHz, CD3OD): δ [ppm] = -4.14 
 
HR-MS (ESI pos., neg., MeOH): m/z [M+Na]+ : cal. 711.1907, obs. 711.2030, m/z [M-H]- : cal. 
687.1942, obs. 687.2061. 
 
5.2.2.2 Synthesis of the octyl phosphate tweezer 195 
 
P
OMe
MeO
O
O
O
P
OMe
MeO
O
O
OH
K2CO3, 18-Krown-6
1-bromooctane
Acetone, 60oC, 16 h
60%
189
C44H35O5P
674,72 g/mol
182
C52H51O5P
 786,93 g/mol  
 
In a suspension of 22 mg (0.0326 mmol) tweezer 189 and 5.0 mg (0.0326 mmol) K2CO3 in abs 
acetone, 9 µl (0.0489 mmol) 1-bromooctane were added. A catalytic amount of 18-Krown-6 was 
also added and the reaction mixture was stirred at 60 oC for 24 h. The mixture was then cooled to 
RT and transferred into a separating funnel. After adding sat NaHCO3, the mixture was extracted 
three times with dichloromethane. The combined organic layer was washed once with sat NH4Cl 
and once with brine solution. Organic phase was dried over Na2SO4 and the solvent was removed 
by reduced pressure. Product was purified by column chromatography using 1:3 (EtOAc/ 
Cyclohexane) as eluent. Compound 182 also crystallized in methanol. 
112 
Yield: 15 mg, 60% 
Melting Point: 188 oC 
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1H-NMR 
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31P-NMR 
 
1H-NMR (500MHz, CDCl3): δ [ppm] = 0.92 (t, 3H, H-36), 1.29 (m, 8H, H-32, H-33, H-34, H-
35), 1.40 (m, 2H, H-31), 1.59 (m, 2H, H-30), 2.35 (d, 2H, H-24a, H-25a), 2.39 (d, 2H, H-24i, H-
25i), 2.43 (s, 4H, H-23, H-26), 3.39 (d, 3JH-27/P, H-28/P  = 11.00, 6H, H-27, H-28), 3.85 (t, 2H, H-
29), 4.06 (d, 4H, H-5, H-11, H-16, H-22), 4.25 (s, 2 H, H-18, H-20), 4.35 (s, 2H, H-7, H-9), 6.73 
(m, 4H, H-2, H-3, H-13, H-14), 7.05 (dm, 4H, H-1, H-15, H-4, H-12), 7.09 (s, 2H, H-17, H-21), 
7.23 (s, 2H, H-6, H-10). 
 
13C-NMR (125.7MHz, CDCl3): δ [ppm] = 14.3 (C-36), 22.9 (C-35), 26.2 (C-34), 29.5 (C-32, C-
33), 30.4 (C-31), 31.9 (C-30),  48.6, 51.4 (d, C-7, C-9, C-18, C-20, C-5, C-11, C-16, C-22), 68.8, 
69.7 (C-23, C-26, C-24, C-25), 74.1 (C-29), 116.1, 117.2 (C-17, C-21, C-6, C-10), 121.2, 121.6 
(C-1, C-15, C-4, C-12), 124.7 (d, C-2, C-3, C13, C-14), 134.9, 140.8, 141.2, 145.8 (C-5a, C-16a, 
C-21a, C-10a,C-7a, C-8a, C-18a, C-19a), 147.1, 147.7 (C-6a, C-9a, C-17a, C-20a, C-8, C-9), 
150.6 (d, C-4a, C-11a, C-15a, C-22a). 
 
31P-NMR (202MHz, CDCl3): δ [ppm] = -3.47 
 
HR-MS (ESI pos., MeOH): m/z [M+Na]+ : cal. 809.3366, obs.  809.3442. 
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O
O
1. Me3SiBr, CH2Cl2
0oC to RT, 8 h
2. CH2Cl2/H2O, RT, 1 d
88%
P
OH
HO
O
O
O
190
C50H47O5P
 758,88 g/mol
182
C52H51O5P
 786,93 g/mol  
 
13 mg (0.0165mmol) of 182 were treated with 22 µl (0.165mmol) of TMSBr in 5 ml CH2Cl2 by 
using the general procedure. 
Yield: 11 mg, 88 %. 
 
Melting Point:  > 185 oC brown coloration. 
 
O
O
P
O
OH
HO
1
2
3
456789101112
13
14
15 16 17 18 19 20 21 22
23 24 25 26
27
28
29
30
31
32
33
34
190  
 
115 
7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0.
97
5
1.
18
2
1.
37
1
2.
30
2
2.
35
6
2.
37
2
3.
31
1
3.
78
9
4.
03
6
4.
20
2
4.
33
2
6.
81
2
7.
00
6
7.
05
7
7.
16
6
3.
13
7
13
.1
58
1.
98
0
6.
02
2
1.
91
0
4.
02
7
1.
97
0
1.
99
6
4.
00
0
2.
07
3
3.
94
0
1.
99
8
6.97.07.1 ppm ppm 1.01.21.4 ppm2.4 ppm
 
 
1H-NMR 
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31P-NMR 
 
1H-NMR (500MHz, CD3OD): δ [ppm] = 0.97 (t, 3H, H-34), 1.18-1.37 (m, 12H, H-28, H-29, H-
30, H-31, H-32, H-33), 2.30 (d), 2.35 (d), 2.37(s)  (8H, H-24, H-25, H-23, H-26), 3.79 (t, 2H, H-
27), 4.04 (ds, 4H, H-5, H-11, H-16, H-22), 4.20 (s, 2 H, H-18, H-20), 4.33 (s, 2H, H-7, H-9), 6.81 
(m, 4H, H-2, H-3, H-13, H-14), 7.00 (d, 2H, H-1, H-15), 7.06 (m, 4H, H-4, H-12, H-17, H-21), 
7.17 (s, 2H, H-6, H-10). 
116 
31P-NMR (202MHz, CD3OD): δ [ppm] = -4.44. 
 
 
NaOH
MeOH, RT, 30 min.
quantitative yield
195
C50H46Na2O5P
802,84 g/mol
P
O
O
O
O
O
2NaP
OH
HO
O
O
O
190
C50H47O5P
758,88
 
 
In a solution of 9.0 mg (0.0118 mmol) tweezer 190, 0.316 mg (0.948 mmol) sodium hydroxide 
was added and stirred the solution for 30 min. at RT. The solvent was removed on a rota vap and 
white solid product was obtained in quantitative yield. 
Melting Point: > 220 oC, decomposition. 
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1H-NMR 
 
-35-30-25-20-15-10-535 30 25 20 15 10 5 0 ppm
0.
89
3
 
 
31P-NMR 
 
1H-NMR (500MHz, CD3OD): δ [ppm] = 0.93 (t, 3H, H-34), 1.23-1.38 (m, 10H,  H-29, H-30, H-
31, H-32, H-33), 1.51 (m, 2H, H-28), 2.24 (d, 2H, H-24a, H-25a), 2.35 (s, 4H, H-23, H-26), 2.47 
118 
(d, 2H, H-24i, H-25i), 3.75 (t, 2H, H-27), 4.00 (ds, 4H, H-5, H-11, H-16, H-22), 4.11 (s, 2 H, H-
18, H-20), 4.69 (s, 2H, H-7, H-9), 6.78 (m, 4H, H-2, H-3, H-13, H-14), 7.01 (m, 6H, H-1, H-15, 
H-4, H-12, H-17, H-21), 7.18 (s, 2H, H-6, H-10). 
 
13C-NMR (125.7MHz, CD3OD): δ [ppm] = 14.6 (C-34), 23.8 (C-33), 27.1 (C-32), 30.5 (d, 
C-31, C-30), 31.2 (C-29), 32.9 (C-28), 49.3-49.6 (C-7, C-9, C-18, C-20), 52.4 (C-5, C-11, C-
16, C-22), 69.1 (d, C-23, C-26, C-24, C-25), 74.9 (C-27), 116.3, 117.6 (C-17, C-21, C-6, C-10), 
122.0 (d, C-1, C-15, C-4, C-12), 125.9 (d, C-2, C-3, C13, C-14), 141.3, 143.2, 144.6 (C-5a, C-
16a, C-21a, C-10a,C-7a, C-8a, C-18a, C-19a), 148.5(d), 149.6, 150.1 (C-6a, C-9a, C-17a, C-20a, 
C-8, C-9), 152.1 (d, C-4a, C-11a, C-15a, C-22a). 
 
31P-NMR (202MHz, CD3OD): δ [ppm] = 0.893 
 
HR-MS (ESI pos., MeOH): m/z [M+H]+ :  cal. 803.2873, obs. 803.2904. 
 
 
5.2.2.3 Synthesis of the ethoxycarboxymethyl phosphate tweezer 196 
 
P
OMe
MeO
O
O
OH
O
Br
O K2CO3, KI
Acetone, RT, 4d
72%
P
OMe
MeO
O
O
O O
O
189
C44H35O5P
674,72 g/mol
191
C48H41O7P
 760,81 g/mol  
 
Under argon atmosphere, in a solution of 30 mg (0.044 mmol) tweezer 189 in 5 ml absolute 
acetone 9.0 mg (0.066 mmol) K2CO3, 7.0 µl (0.066 mmol) ethylbromoacetate and a few granules 
of KI were added and then the reaction mixture is stirred at RT for 4 days. The reaction mixture 
was diluted with CH2Cl2 and washed with sat NH4Cl and finally with dist water. Organic phase 
was dried over Na2SO4. Solvent removed on a rotary evaporator and crude was purified by 
column chromatography using EtOAc/cyclohexane (1:3) eluent.  
 
Yield: 24 mg, 72% 
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Melting Point:  > 170 oC brown coloration. 
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1H-NMR 
 
120 
-30-20-1030 20 10 0 ppm
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31P-NMR 
 
1H-NMR (500MHz, CDCl3): δ [ppm] = -1.51 (t, 3H, H-32), 2.37 (tm, 4H, 24a, H-25a, H-24i, H-
25i), 2.43 (s, 4H, H-23, H-26), 2.85 (m, 2H, H-31), 3.50 (d, 3JH-27/P, H-28/P  = 11.00, 6H, H-27, H-
28), 4.05 (s, 4H, H-5, H-11, H-16, H-22), 4.27 (s, 2 H, H-18, H-20), 4.34 (s, 2H, H-7, H-9), 4.70 
(s, 2H, H-29), 6.76 (m, 4H, H-2, H-3, H-13, H-14), 6.99 (m, 2H, H-1, H-15), 7.07 (m, 4H, H-4, 
H-12, H-17, H-21), 7.19 (s, 2H, H-6, H-10). 
 
13C-NMR (125.7MHz, CDCl3): δ [ppm] = 10.9 (C-32), 48.1, 48.8 (C-7, C-9, C-18, C-20), 
51.2(C-5, C-11, C-16, C-22), 54.9 (d, C-27, C-28), 61.1 (C-31), 68.5 (C-23, C-26, C-24, C-25), 
69.1 (C-29), 116.3, 117.0 (C-17, C-21, C-6, C-10), 120.9, 121.5 (C-1, C-15, C-4, C-12), 124.8 (d, 
C-2, C-3, C13, C-14), 134.7(d), 139.8, 141.1(d), 145.0 (C-5a, C-16a, C-21a, C-10a,C-7a, C-8a, 
C-18a, C-19a), 146.9, 147.2, 147.5, 147.7 (C-6a, C-9a, C-17a, C-20a, C-8, C-9), 150.8, 151.0 (C-
4a, C-11a, C-15a, C-22a), 169.1 (C-30). 
 
31P-NMR (202MHz, CDCl3): δ [ppm] = -3.62 
 
HR-MS (ESI pos., MeOH): m/z [M+Na]+ : cal. 783.2482, obs. 783.2550. 
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191
C48H41O7P
 760,81 g/mol
P
OH
HO
O
O
O O
O
196
C46H37O7P
732,76 g/mol
1. Me3SiBr, CH2Cl2
0oC to RT, 8h
2. CH2Cl2/H2O, RT, 1d
92%
 
 
28 mg (0.0368 mmol) 191 were treated with 48 μl (0.368 mmol) TMSBr using the general 
procedure. 
Yield: 24 mg, 92%. 
Melting Point:  > 282 oC brown coloration. 
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1H-NMR 
 
 
-35-30-25-20-15-10-535 30 25 20 15 10 5 0 ppm
-4
.3
68
 
 
31P-NMR 
 
1H-NMR (500MHz, CD3OD): δ [ppm] = -0.089 (t, 3H, H-30), 2.29 (d, 2H, 24a, H-25a), 2.36 
(m, 6H, H-23, H-26, H-24i, H-25i), 3.43 (m, 2H, H-29), 4.03 (s, 4H, H-5, H-11, H-16, H-22), 
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4.27 (s, 2 H, H-18, H-20), 4.36 (s, 2H, H-7, H-9), 4.53 (2H, H-27), 6.81 (m, 4H, H-2, H-3, H-13, 
H-14), 7.03 (m, 4H, H-1, H-15, H-4, H-12), 7.09 (s, 2H, H-17, H-21), 7.13 (s, 2H, H-6, H-10). 
 
13C-NMR (125.7MHz, CD3OD): δ [ppm] = 13.4 (C-30), 49.4 (m, C-7, C-9, C-18, C-20), 52.5 
(C-5, C-11, C-16, C-22), 62.4 (C-29), 69.1 (C-23, C-26, C-24, C-25), 70.8 (C-27), 117.1, 118.1 
(C-17, C-21, C-6, C-10), 122.3 (d, C-1, C-15, C-4, C-12), 126.1 (d, C-2, C-3, C13, C-14), 141.8, 
143.1 (C-5a, C-16a, C-21a, C-10a,C-7a, C-8a, C-18a, C-19a), 148.7, 148.9, 149.1(d) (C-6a, C-9a, 
C-17a, C-20a, C-8, C-9), 152.3 (C-4a, C-11a, C-15a, C-22a), 171.1 (C-28). 
 
31P-NMR (202MHz, CD3OD): δ [ppm] = -4.37 
 
HR-MS (ESI pos., neg., MeOH): m/z [M+Na]+ : cal. 755.2169, obs. 755.2237. m/z [M-H]- :    
cal. 731.2204, obs. 731.2301. 
 
P
OH
HO
O
O
O O
O
196
C46H37O7P
732,76 g/mol
P
OH
O
O
O
O O
O
203
C46H36O7PNa
754,74 g/mol
NaOH, dioxane, H2O
RT, 1 h
Na
quantitative yield
 
To a solution of 16 mg (0.022 mmol) 196 in 10 ml dioxane, 0.813 mg (0.022 mmol) NaOH in 1.0 
ml water was added and stirred for 1 h at RT. Solvent removed in vacuo and solid was supended 
in 5 ml water and dried on lyophilization apparatus. 
 
Yield: quantitative. 
Melting Point:  > 225 oC brown coloration. 
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1H-NMR in CD3OD 
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1H-NMR in CD3OD/D2O buffer 10 mM, pH 7.2 (2:1) 
 
1H-NMR (300 MHz, CD3OD): δ [ppm] = -0.45 (2H, H-30), 2.24 (d, 2H, 24a, H-25a), 2.35 (s, 
4H, H-23, H-26), 2.39 (d, 2H, H-24i, H-25i), 3.30 (m, 2H, H-29), 4.02 (ds, 4H, H-5, H-11, H-16, 
H-22), 4.21 (s, 2H, H-18, H-20), 4.52 (s, 2H, H-27), 4.53 (s, 2H, H-7, H-9), 6.80 (m, 4H, H-2, H-
3, H-13, H-14), 7.02, 7.04 (m, 6H, H-1, H-15, H-4, H-12, H-17, H-21), 7.16 (s, 2H, H-6, H-10). 
1H-NMR {500MHz, CD3OD/D2O buffer (2:1)}: δ [ppm] = -1.01 (3H, H-30), 2.25 (d, 2H, 
24a, H-25a), 2.34 (s, 4H, H-23, H-26), 2.41 (d, 2H, H-24i, H-25i), 3.00 (m, 2H, H-29), 4.04 (d, 
4H, H-5, H-11, H-16, H-22), 4.20 (s, 2H, H-18, H-20), 4.53 (s, 2H, H-7, H-9), 4.59 (s, 2H, H-27),  
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6.81 (m, 4H, H-2, H-3, H-13, H-14), 7.04 (m, 6H, H-1, H-15, H-4, H-12, H-17, H-21), 7.17 (s, 
2H, H-6, H-10). 
 
31P-NMR (202MHz, CD3OD): δ [ppm] = -2.50 
 
HR-MS (ESI pos., neg., MeOH): m/z [M+H]+ : cal. 755.2169, obs. 755.2289, m/z [M+Na]+ : cal. 
777.1989, obs. 777.2096, m/z [M-Na]- : cal. 731.2204, obs. 731.2329. 
 
5.2.2.4 Synthesis of the glycerol phosphate tweezer 198 
 
 
AcO
OH
AcO
O
(6.0 eq)
DMF,
(1.1 eq)
86%
RT, 12 h
CsFO
S
O2N
O
O
O
120
C44H32O3
608,72 g/mol
164
C47H36O4
664,79 g/mol
O
 
 
Under argon atmosphere, to a solution of 165 mg (0.271 mmol) tweezer 120 in 5 ml anhydrous 
DMF, 124 mg (0.814 mmol) CsF were added. The reaction mixture was stirred at RT for 1 h and 
84 mg (0.325 mmol) glycidyl nosylate were added and stirred the mixture at 40 oC for 24 h. After 
cooling to RT, water was added and extracted three times with EtOAc. Organic phase was dried 
over MgSO4 and solvent was removed by reduced pressure. The residue was purified by column 
chromatography over silica gel (1:5, EtOAc/cyclohexane).  
Yield: 155 mg, 86%. 
 
Melting Point: > 230 oC, brown coloration. 
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1H-NMR (500MHz, CDCl3): δ [ppm] = 2.33-2.48 (m, 13H, H-29a, H-29i, H-31, 24a, H-25a, H-
24i, H-25i, H-23, H-26), 3.11 (m, 1H, H-28), 3.88, 3.94 (m, 2H, H-27a, H-27i), 3.98 (ds, H-7, H-
9), 4.07 (s, 4H, H-5, H-11, H-16, H-22), 4.26, 4.31 (dd, 2 H, H-18, H-20), 6.76 (m, 4H, H-2, H-3, 
H-13, H-14), 7.08 (m, 4H, H-1, H-15, H-4, H-12), 7.10-7.15 (m, 4H, H-17, H-21, H-6, H-10). 
 
 
13C-NMR (125.7MHz, CDCl3): δ [ppm] = 21.0 (C-31), 44.9 (C-29), 48.7 (m, C-7, C-9, C-18, 
C-20), 50.4 (C-28), 51.4(C-5, C-11, C-16, C-22), 69.1, 70.1 (C-23, C-26, C-24, C-25), 74.4 (C-
27), 116.1, 116.8 (m, C-17, C-21, C-6, C-10), 121.6 (m, C-1, C-15, C-4, C-12), 124.8 (m, C-2, C-
128 
3, C13, C-14), 135.7, 141.0 (C-5a, C-16a, C-21a, C-10a,C-7a, C-8a, C-18a, C-19a), 145.7, 146.4, 
146.7, 147.0 (C-6a, C-9a, C-17a, C-20a, C-8, C-9), 150.4 (C-4a, C-11a, C-15a, C-22a), 169.2 (C-
30). 
 
HR-MS (ESI pos., MeOH): m/z [M+Na]+:  cal. 687.2506, obs. 687.2607. 
 
AcO
O
NaH(50 eq), THF
EtOH, 0oC
80oC, overnight
70%
HO
O
O
164
C47H36O4
664,79 g/mol
172
C47H40O4
 668,82 g/mol
HOO
 
 
120 mg (3.0 mmol) NaH (60%) were suspended in 2 ml anhydrous THF and cooled to 0oC. To 
this suspension, 1.0 ml dry ethanol was added dropwise and stirred for 10 min. This solution was 
transferred with the syringe to a solution of 40 mg (0.06 mmol) 164 in 7 ml dry ethanol and 
stirred the reaction mixture at 80 oC for 12 h. After cooling the mixture to RT, 5% aq. HCl were 
added and extracted with EtOAc for three times. The organic phase was washed with sat. NH4Cl 
and brine and the solvent were evaporated. The product was purified by column chromatography 
over silica gel (1:3, EtOAc/cyclohexane). 
 
Yield: 25 mg, 62%. 
 
Melting Point: >160 oC, brown coloration 
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1H-NMR in CDCl3 
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1H-NMR in CD3OD 
 
1H-NMR (500MHz, CDCl3): δ [ppm] = 0.65 (t, 3H, H-31), 2.37, 2.43 (m, 8H, 24, H-25, H-23, 
130 
H-26), 2.54 (d, 1H, OH), 3.15 (m, 2H, H-30), 3.43 (m, 2H, H-29a, H-29i), 3.84, 3.89 (m, 2H, H-
27a, H-27i), 3.97 (m, 1H, H-28), 4.06 (s, 4H, H-5, H-11, H-16, H-22), 4.17 (s, 2 H, H-7, H-9), 
4.25 (s, 2H, H-18, H-20), 4.27 (s, 1H, OH), 6.75 (m, 4H, H-2, H-3, H-13, H-14), 7.07 (m, 4H, H-
1, H-15, H-4, H-12), 7.14 (d, 4H, H-17, H-21, H-6, H-10).  
 
1H-NMR (500MHz, CD3OD): δ [ppm] = 0.78 (t, 3H, H-31), 2.28 (m, 4H, H-24, H-25), 2.36 
(s, 4H, H-23, H-26), 3.28 (m, 2H, H-30), 3.45, 3.54 (m, 2H, H-29a, H-29i), 3.72, 3.78 (m, 2H, H-
27a, H-27i), 3.88 (m, 1H, H-28), 4.02 (s, 4H, H-5, H-11, H-16, H-22), 4.22 (s, 4H, H-7, H-9, H-
18, H-20), 4.57 (s, 1H, OH), 6.79 (m, 4H, H-2, H-3, H-13, H-14), 7.03 (m, 4H, H-1, H-15, H-4, 
H-12), 7.09 (s, 2H, H-6, H-10 ), 7.12 (d, 2H, H-17, H-21). 
 
13C-NMR (125.7MHz, CD3OD): δ [ppm] = 15.3 (C-31), 28.1, 49.4, 52.6, 67.9, 69.1, 69.3, 
70.9, 72.5,  76.2, 117.1 (t), 122.3 (d), 126.1(d), 137.3, 141.5, 142.5, 143.6, 148.9, 149.2, 
149.5, 152.2 (d).  
HR-MS (ESI pos., MeOH): m/z [M+Na]+: cal. 691.2819, obs. 691.2930. 
 
P
OMe
MeO
O
O
O
O
1. POCl3, Et3N
THF, 0oC to RT, 8 h
2. MeOH, RT, 24
62%
194
C49H45O7P
776,85 g/mol
HO
O
O
172
C47H40O4
 668,82 g/mol
HO HO
 
 
 A solution of 21 mg (0.0313 mmol) 172 in 5 ml anhydrous THF was cooled to 0 oC. To the 
stirred solution under inert atmosphere, 26 μl (0.1878 mmol) Et3N were added. After 10 min 57 
μl (0.627 mmol) POCl3 were added and the reaction mixture stirred from 0 oC to RT for 8 h. 
Thereafter, 4 ml dry methanol was added and stirred again for 24 h at RT. Solvent was removed 
on rotary evaporator and after adding 30 ml Dist. H2O, the crude is extracted with CH2Cl2 (3×20 
ml). Organic layer is dried on rotary evaporator and residue is purified by column 
chromatography on silica gel (1:3, EtOAc/cyclohexane).  
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Yield: 15 mg, 62%, white solid. 
 
Melting Point: 195 oC. 
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1H-NMR (500MHz, CDCl3): δ [ppm] = 0.30 (t, 3H, H-31), 2.38 (m, 4H, H-24, H-25), 2.43 (s, 
4H, H-23, H-26), 3.02 (m, 2H, H-30), 3.40 (m, 2H, H-29), 3.42 (d, 6H, 3J H-32/P, H-33/P = 11.3 Hz, 
H-32, H-33), 3.98 (m, 3H, H-27, H-28), 4.07 (s, 4H, H-5, H-11, H-16, H-22), 4.27 (s, 2H, H-18, 
H-20), 4.36 (s, 2H, H-7, H-9), 6.73 (m, 4H, H-2, H-3, H-13, H-14), 7.04 (dd, 4H, H-1, H-15, H-4, 
H-12), 7.13 (d, 2H, H-17, H-21), 7.23 (s, 2H, H-6, H-10). 
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1H-NMR in CD3OD 
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-35-30-25-20-15-10-535 30 25 20 15 10 5 0 ppm
-3
.5
20
 
31P-NMR in CDCl3 
 
1H-NMR (500MHz, CD3OD): δ [ppm] = 0.34 (t, 3H, H-31), 2.32, 2.36 (d, 4H, H-24, H-25), 
2.37 (s, 4H, H-23, H-26), 3.06 (m, 2H, H-30), 3.36 (dd, 6H, 3J H-32/P, H-33/P = 11.3 Hz, H-32, H-33), 
3.41, 3.49 (m, 2H, H-29a, H-29i), 3.89 (m, 2H, H-27a, H-27i), 3.98 (m, 1H, H-28), 4.05 (s, 4H, 
H-5, H-11, H-16, H-22), 4.29(s), 4.32(d) (4H, H-7, H-9, H-18, H-20), 6.78 (m, 4H, H-2, H-3, H-
13, H-14), 7.01, 7.04 (m, 4H, H-1, H-15, H-4, H-12), 7.16 (d, 2H, H-17, H-21), 7.18 (s, 2H, H-6, 
H-10). 
 
13C-NMR (125.7MHz, CDCl3): δ [ppm] = 14.1 (C-31), 48.5-48.8 (m, C-7, C-9, C-18, C-20), 
50.4 (C-28), 51.3 (C-5, C-11, C-16, C-22), 54.9 (d, C-32, C-33), 66.6 (C-30), 68.8, 69.4 (d, C-23, 
C-26, C-24, C-25), 69.7 (C-28), 70.3 (C-29),  74.0 (C-27), 116.2, 117.2 (C-17, C-21, C-6, C-10), 
121.1, 121.7 (C-1, C-15, C-4, C-12), 124.7 (d, C-2, C-3, C13, C-14), 134.9, 140.5, 141.1, 
145.7(s) (d, C-5a, C-16a, C-21a, C-10a,C-7a, C-8a, C-18a, C-19a), 146.8, 147.1, 147.7 (d, C-6a, 
C-9a, C-17a, C-20a, C-8, C-9), 150.6, 150.8 (C-4a, C-11a, C-15a, C-22a). 
 
31P-NMR (202MHz, CDCl3): δ [ppm] = -3.52 ppm. 
 
HR-MS (ESI pos., MeOH): m/z [M+Na]+:  cal. 799.2795, obs. 799.2860. 
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1. Me3SiBr, CH2Cl2
0oC to RT, 8h
2. CH2Cl2/H2O, RT, 1d
95%
3. 1.0 eq NaOH, MeOH
198
C47H40NaO7P
770,78 g/mol
P
OMe
MeO
O
O
O
O
194
C49H45O7P
776,85 g/mol
P
OH
O
O
O
O
O
Na
HO HO
 
 
To a 0oC cooled solution of 13 mg (0.0167 mmol) 194 in anhydrous CH2Cl2, 22 μl (0.167 mmol) 
TMSBr were added dropwise and solution was stirred at RT for 8 hour. The excess of TMSBr and 
solvent were removed by condensation and remaining residue dried on oil pump for 4 h. The 
solid residue was dissolved in 10 ml CH2Cl2/H2O (1:1) and stirred at RT for 24 h. Two phases 
were separated, and from organic phase collected 12 mg (95%) of white solid. For the 
neutralization of phosphate, to a solution of 5.0 mg (0.0067 mmol) of phosphoric acid tweezers in 
5 ml methanol 0.27 mg (0.0067 mmol) NaOH were added and stirred at RT for 30 min., dried the 
solvent and collected white solid in quantitative yield.  
Melting Point: > 215 oC, brown coloration. 
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1H-NMR in CD3OD 
 
 
1H-NMR (500MHz, CD3OD): δ [ppm] = 1.02 (t, 3H, H-31), 2.29-2.36 (m, 8H, H-24, H-25, H-
23, H-26), 3.43 (m, 2H, H-30), 3.48, 3.56 (m, 2H, H-29a, H-29i), 3.77 (m, 2H, H-27), 3.91 (m, 
1H, H-28), 4.03 (s, 4H, H-5, H-11, H-16, H-22), 4.29, 4.35 (s, 4H, H-7, H-9, H-18, H-20), 6.81 
(m, 4H, H-2, H-3, H-13, H-14), 7.03 (m, 4H, H-1, H-15, H-4, H-12), 7.14 (d, 4H, H-17, H-21, H-
6, H-10). 
 
13C-NMR (125.7MHz, CD3OD): δ [ppm] = 15.5 (C-31), 49.0 (m, C-7, C-9, C-18, C-20), 52.4 
(C-5, C-11, C-16, C-22), 67.9 (C-30), 69.0 (d, C-23, C-26, C-24, C-25), 70.7 (C-28), 72.4 (C-29),  
75.9 (C-27), 116.6(d), 118.2 (C-17, C-21, C-6, C-10), 122.0, 122.2 (C-1, C-15, C-4, C-12), 125.9 
(d, C-2, C-3, C13, C-14), 142.4, 142.9, 146.3 (C-5a, C-16a, C-21a, C-10a,C-7a, C-8a, C-18a, C-
19a), 148.8, 149.1 (m, C-6a, C-9a, C-17a, C-20a, C-8, C-9), 152.1 (C-4a, C-11a, C-15a, C-22a). 
 
31P-NMR (202MHz, CDCl3): δ [ppm] = -4.16 ppm. 
 
HR-MS (ESI pos., neg., MeOH): m/z [M+Na]+:  cal. 771.2482, obs. 771.2538, m/z [M-H]-:     
cal. 747.2517, obs. 747.2591. 
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1H-NMR in CD3OD 
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31P-NMR in CD3OD 
 
 
1H-NMR (500MHz, CD3OD): δ [ppm] = 0.88 (t, 3H, H-31), 2.25 (d, 2H, H-24a, H-25a), 2.35 
(s, 4H, H-23, H-26), 2.40 (d, 2H, H-24i, H-25i), 3.35 (m, 2H, H-30), 3.45, 3.55 (m, 2H, H-29a, 
H-29i), 3.76 (m, 2H, H-27), 3.88 (m, 1H, H-28), 4.01 (d, 4H, H-5, H-11, H-16, H-22), 4.22 (s, 
4H, H-18, H-20), 4.54 (s, 2H, H-7, H-9), 6.78 (m, 4H, H-2, H-3, H-13, H-14), 7.02 (m, 4H, H-1, 
H-15, H-4, H-12), 7.09 (s, 2H, H-17, H-21), 7.19 (d, 2H, H-6, H-10). 
 
31P-NMR (202MHz, CD3OD): δ [ppm] = -2.32 ppm. 
 
5.2.3 Synthesis of 2nd generation unsymmetrical bis phosphate tweezers 
5.2.3.1 Synthesis of the phosphoramidite tweezer 246 
 
O
OH
 0o C to RT, 6 h
          90 %
246
O
O
P
O O
O
P N
O
Cl
P N
O
DIPEA, THFP
O O
O
189
 3A MS
 
 
Prior to use, tweezer 189 was dried at 60-80oC on an oil pump. A solution of 165 mg (0.244 
137 
mmol) of 189 in 15 ml dry THF was transferred to well dried argon fluxed flask containing 10 
beads of 3Ǻ molecular sieves. To the 0oC cooled solution, 340 μl (1.956 mmol) of 
diisopropylethylamine (DIPEA) and 190 μl (0.978 mmol) of chloro-N, N-disopropyl methyl 
phosphoramidite were added. After 6 hour, TLC showed the complete conversion. The mixture 
was diluted with 10 ml ethyl acetate and transferred to the separating funnel. After adding 20 ml 
saturated NaHCO3, the organic phase was separated and aqueous layer was washed twice with 
EtOAc. The combined organic layer was washed with 20 ml brine solution and dried over 
Na2SO4. After removing the solvent on rotory evaporator, the resulting yellowish residue was 
purified by column chromatography using EtOAc/cyclohexane (1:4) eluent. Thus 204 mg pure 
white solid of 246 were obtained. 
 
Rf: 0.30 (1:3, EtOAc/cyclohexane) 
Yield: 90%, white solid 
MP: 108 oC 
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1H-NMR spectra of TW 246 in CDCl3 
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31P-NMR spectra of TW 246 in CDCl3 
 
1H-NMR (500MHz, CDCl3): δ [ppm] = 1.34 (m, 12H, H-30, H-32, H-33, H-35), 1.95 (d, 3H, H-
29), 2.37, 2.44 (m, 8H, H-23, H-26, H-24, H-25), 2.96 (m, 6H, H-27, H-28), 3.88 (m, 2H, H-31, 
H-34), 4.06 (m, 4H, H-5, H-11, H-16, H-22), 4.26, 4.32 (m, 4H, H-7, H-9, H-18, H-20), 6.66, 
6.72 (m, 4H, H-2, H-3, H-13, H-14), 6.98, 7.03 (m, 4H, H-1, H-15, H-4, H-12), 7.09, 7.17 (s, 2H, 
H-17, H-21), 7.24 (s, 2H, H-6, H-10). 
139 
 
13C-NMR (125.7MHz, CDCl3): δ [ppm] = 24.9, 43.9, 48.5, 48.8, 49.2, 51.2, 54.7, 67.6, 68.0, 
68.5, 68.7, 116.8, 117.0, 117.2, 120.9, 121.1, 124.6, 134.7, 140.4, 140.9, 141.7, 142.5, 147.4, 151.  
 
31P-NMR (202MHz, CDCl3): δ [ppm] = -3.80 and 152.4. 
 
HR-MS (ESI pos., MeOH): m/z [M+Na]+:  cal. 858.3084, obs. 858.3082.  
 
 
5.2.3.2 Synthesis of the ester linker tweezer 247 
 
246
O
O
P
O O
O
P N
O
O
O
P
O O
O
P
O
CH3CN, RT, 6 h
O
HO
O
OO
O
O
Tetrazole, 3A MS
1.
2. t-BuOOH
0o C to RT, 6 h
          50 %
247  
 
85 mg (0.101 mmol) of intermediate phosphoramidite 246 were dissolved in 6.0 ml dry 
acetonitrile and 5-10 beads of 3Ǻ molecular sieves were added to the solution. To this clear 
solution 46 μl (0.61 mmol) of methyl glycolate and 610 μl (0.305 mmol) of tetrazole solution 
(0.45 M solution in CH3CN) were added and the reaction mixture stirred at RT. After 2 hour, TLC 
indicated conversion of starting material; however, the new spot appears at the same Rf value as 
tweezer 189. Therefore, the formation of product was monitored by oxidizing a small fraction of 
the reaction mixture with tert-butylhydroperoxide (TBHP). After 6 hour the reaction mixture was 
cooled to 0oC and 92 μl (0.508 mmol) of anhydrous TBHP solution (5.5 M in octane) were 
added. The reaction stirred from 0oC to RT for 12 hour and then saturated NaHCO3 solution was 
added and extracted three times with dichloromethane. The resulting organic phase was washed 
with dist water and dried over NaSO4. The solvent removed on rotory evaporator and residue 
purified by column chromatography using EtOAc/cyclohexane (1:1) eluent. Thus 42 mg pure 
white solid of 247 were obtained. 
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Rf: 0.25 (1:1, EtOAc/cyclohexane) 
Yield: 50%, white solid. 
Smp > 130 oC 
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1H-NMR spectra of tweezer 247 in CDCl3 
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31P-NMR spectra of tweezer 247 in CDCl3 
 
1H-NMR (500MHz, CDCl3): δ [ppm] = 2.38, 2.43 (m, 8H, H-23, H-26, H-24, H-25), 2.85 (s, 
3H, H-31), 3.25 (dd, 6H, H-27, H-28), 3.36 (d, 3H, H-29), 4.03, 4.06 (s, 1H, 3H, H-5, H-11, H-
16, H-22), 4.16, 4.33 (m, 2H, H-30), 4.36 (m, 4H, H-7, H-9, H-18, H-20), 6.72 (m, 4H, H-2, H-3, 
H-13, H-14), 6.94-7.03 (m, 4H, H-1, H-15, H-4, H-12), 7.16, 7.21, 7.23 (s, d, s, 1H, 2H, 1H, H-6, 
H-10, H-17, H-21). 
 
13C-NMR (125.7MHz, CDCl3): δ [ppm] = 48.6, 51.1, 51.5, 54.8, 55.2, 64.1, 68.0, 69.0, 116.9, 
117.2, 120.8, 121.3, 124.6, 124.9, 136.2, 142.1, 146.7, 146.9, 147.8, 150.8, 167.6.  
 
31P-NMR (202MHz, CDCl3): δ [ppm] = -4.68 ppm and -3.81 ppm. 
 
HR-MS (ESI pos., MeOH): m/z [M+Na]+:  cal. 863.2145, obs. 863.2146. 
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5.2.3.3 Synthesis of the tweezer 248 
 
246
O
O
P
O O
O
P N
O
O
O
P
O O
O
P
O
CH3CN, RT, 6 h
Tetrazole, 3A MS
1.
2. t-BuOOH
0o C to RT, 6 h
          50 %
248
HO
O
O
 
 
25 mg (0.0299 mmol) of intermediate phosphoramidite 246 were dissolved in 3.0 ml dry 
acetonitrile and 5 beads of 3Ǻ molecular sieves were added to the solution. To this clear solution 
7 μl (0.0897 mmol) of 3-butyn-1-ol and 332 μl (0.149 mmol) of tetrazole solution (0.45 M 
solution in CH3CN) were added and the reaction mixture stirred at RT. After 3 hour, TLC 
indicated conversion of starting material. The reaction mixture was cooled to 0oC and 11 μl 
(0.0598 mmol) of anhydrous TBHP solution (5.5 M in octane) was added. The resulting reaction 
mixture was stirred from 0oC to RT for 6 hour and then 10 ml saturated NaHCO3 solution were 
added and extracted with dichloromethane (3×10 ml). The resulting organic phase was washed 
with dist water and dried over Na2SO4. The solvent removed on rotary evaporator and residue 
purified by column chromatography using EtOAc/cyclohexane (1:1) eluent. Thus 12 mg pure 
white solid of the tweezer 248 were obtained. 
 
Rf: 0.22 (1:1, EtOAc/cyclohexane) 
Yield: 48 % 
Smp > 130 oC 
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1H-NMR spectra of tweezer 248 in CDCl3 
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31P-NMR spectra of tweezer 248 in CDCl3 
 
1H-NMR (500MHz, CDCl3): δ [ppm] = 1.47-1.50 (m, 2H, H-31), 1.96 (t, 1H, H-32), 2.39, 2.44 
(m, 8H, H-23, H-26, H-24, H-25), 2.69, 3.31 (m, 2H, H-30), 3.15 (dd, 6H, H-27, H-28), 3.44 (d, 
3H, H-29), 4.07 (m, 4H, H-5, H-11, H-16, H-22), 4.33, 4.36, 4.44 (m, 1H, 2H, 1H, H-7, H-9, H-
18, H-20), 6.70, 6.75 (m, 2H, 2H, H-2, H-3, H-13, H-14), 6.99, 7.03, 7.12 (m, 1H, 2H, 1H, H-1, 
H-15, H-4, H-12), 7.22, 7.25, 7.33 (s, 2H, 1H, 1H, H-6, H-10, H-17, H-21). 
 
13C-NMR (125.7MHz, CDCl3): δ [ppm] = 20.4, 48.6, 51.2, 54.9, 66.0, 67.9, 68.5, 70.2, 117.1, 
117.5, 120.9, 121.1, 121.6, 124.7, 136.4, 142.2, 146.8, 147.8, 150.9.  
 
31P-NMR (202MHz, CDCl3): δ [ppm] = -5.09 ppm and -3.81 ppm. 
 
HR-MS (ESI pos., MeOH): m/z [M+Na]+:  cal. 843.2247, obs. 843.2237. 
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5.3 NMR titration 
 
Receptor 161 MR [g/mol] 770.78 
Solvent Phosphate buffer mR [mg] 1.13 
T[oC] 25 V0 [ml] 2.3 
Substrate Itself [R]0 [mM] 1.13 
S
O
O
O
O
O
2NaSO
O
O
2
1
3
4
5
26
22
21
6
20
7
25
14
13
12
15
11
1623
10
17
9
18
24
8
19
161  
   
   
   
   
 
[R][mM] δobs[ppm]   δmonomer- calc - δobs = ∆δcalc[ppm]   
1.13 6.212 0.707 
0.565 6.419 0.500 
0.282 6.624 0.295 
0.141 6.733 0.186 
0.0706 6.836 0.083 
0.0353 6.858 0.061 
 
 
 
 
Kdm[M-1]  = 370 ± 80 
∆δmax [ppm]  = 2.0219  
δmonomer-calc [ppm]  = 6.919  
 
 
 
 
 
 
 
 
 
 
 
 
[R]0 [mol/L]
0,0000 0,0002 0,0004 0,0006 0,0008 0,0010 0,0012
δ o
bs
[p
pm
]
6,0
6,2
6,4
6,6
6,8
7,0
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[R][mol/l]
0,0000 0,0002 0,0004 0,0006 0,0008 0,0010 0,0012 0,0014 0,0016
Δδ
[p
pm
]
0,0
0,1
0,2
0,3
0,4
Receptor 161 MR [g/mol 770.78 
Solvent Phosphate buffer MS [g/mol] 238.7 
T[oC] 25 mR [mg] 0.672 
Substrate AcLysOMe mS [mg] 0.410 
OCH3
O
HN
O
CH3
H3N
X
2
3
4
5
6
 
X⎯: HPO42- 
δ0 (2-H) [ppm] = 4.398 V0 [ml] 3.0 
δ0 (6-H) [ppm] = 2.999 [S0][mM] 0.5725 
δ0 (-NAc) [ppm] = 2.050   
δ0 (-CO2Me) [ppm] = 3.770   
  
V [ml] [R][mM] δ (2-H) [ppm] Δδobs [ppm] Δδcalc [ppm]
0.60 1.4548 4.0313 0.3670 0.3667 
0.66 1.3225 4.0332 0.3651 0.3658 
0.72 1.2123 4.0340 0.3643 0.3648 
0.78 1.1191 4.0340 0.3643 0.3637 
0.84 1.0391 4.0359 0.3624 0.3624 
0.90 0.9699 4.0367 0.3616 0.3609 
0.96 0.9093 4.0374 0.3609 0.3592 
1.02 0.8558 4.0405 0.3578 0.3572 
1.08 0.8082 4.0443 0.3540 0.3549 
1.18 0.7397 4.0501 0.3482 0.3500 
1.28 0.6819 4.0570 0.3413 0.3436 
1.40 0.6235 4.0689 0.3294 0.3337 
1.50 0.5819 4.0761 0.3222 0.3235 
1.70 0.5135 4.0898 0.3085 0.2997 
0.00 0.0000 4.3983 0.0000 0.0000 
 
 
 
 
 
 
Ka[M-1] = 79536 ± 8889  
Kd [µM] = 12 ± 11 % 
Δδmax (2-H) [ppm] = 0.3719 
Δδmax (6-H) [ppm] = 3.749 
 
 
 
 
 
 
* Limit of 95% - confidence interval from the nonlinear regression of the signals of the Protons 2-H. 
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Receptor 161 MR [g/mol] 770.78 
Solvent Phosphate buffer MS [g/mol] 266.7 
T[oC] 25 mR [mg] 0.800 
Substrate AcArgOMe mS [mg] 0.511 
N
H
OCH3
O
HN
O
CH3
C
X
2
3
4
5
H2N
NH2
 
X⎯: HPO42- 
δ0 (2-H) [ppm] = 4.421 V0 [ml] 3.42 
δ0 (5-H) [ppm] = 3.226 
δ0 (4-H) [ppm] = 1.663 
[S]0 [mM] 0.5602 
δ0 (-NAc) [ppm] = 2.052   
δ0 (-CO2Me) [ppm] = 3.775   
  
V [ml] [R] [mM] δ (5-H) [ppm] Δδobs [ppm] Δδcalc [ppm]
0.60 1.7298 -0.3837 3.6096 3.6009 
0.65 1.5968 -0.3578 3.5837 3.5719 
0.70 1.4827 -0.3216 3.5475 3.5416 
0.75 1.3839 -0.2950 3.5209 3.5101 
0.80 1.2974 -0.2534 3.4793 3.4773 
0.85 1.2211 -0.2227 3.4486 3.4433 
0.90 1.1532 -0.1865 3.4124 3.4079 
0.95 1.0925 -0.1410 3.3669 3.3714 
1.00 1.0379 -0.0926 3.3185 3.3338 
1.10 0.9436 -0.0113 3.2372 3.2553 
1.20 0.8649 0.0957 3.1302 3.1729 
1.30 0.7984 0.1700 3.0559 3.0876 
1.40 0.7414 0.2620 2.9639 3.0004 
1.50 0.6919 0.2955 2.9304 2.9119 
1.70 0.6105 0.4491 2.7768 2.7358 
1.90 0.5463 0.6097 2.6162 2.5658 
0.00 0.0000 3.2259 0.0000 0.0000 
 
 
 
 
 
 
 
Ka [M-1] = 11342 ± 561  
Δδmax (5-H) [ppm] = 3.86 
Δδmax (4-H) [ppm] = 2.51 
 
 
* Limit of 95% - confidence interval from the nonlinear regression of the signals of the Protons 5-H. 
 
 
 
 
 
[R][mol/l]
0,0000 0,0002 0,0004 0,0006 0,0008 0,0010 0,0012 0,0014 0,0016 0,0018 0,0020
Δδ
[pp
m
]
0
1
2
3
4
148 
Receptor 133 MR [g/mol] 770.78 
Solvent Phosphate buffer MS [g/mol] 266.7 
T[oC] 25 mR [mg] 0.800 
Substrate AcArgOMe mS [mg] 0.511 
N
H
OCH3
O
HN
O
CH3
C
X
2
3
4
5
H2N
NH2
 
X⎯: HPO42- 
δ0 (2-H) [ppm] = 4.421 
δ0 (5-H) [ppm] = 3.226 
δ0 (4-H) [ppm] = 1.663 
δ0 (-NAc) [ppm] = 2.052   
δ0 (-CO2Me) [ppm] = 3.775   
  
[R]0[mM] [S]0[mM] δ (5-H) [ppm] Δδobs [ppm] Δδcalc [ppm]
3.0 3.0 ‐0.198  3.424 3.442 
1.5 1.5 ‐0.113  3.338 3.323 
0.75 0.75 0.058  3.168 3.162 
0.375 0.375 0.274 2.952 2.947 
0.188 1.88 0.563  2.663 2.671 
 
 
 
 
 
 
Ka [M-1] = 45939 ± 2065  
Δδmax (5-H) [ppm] = 3.748 ± 0.16 
Δδmax (4-H) [ppm] = 2.540 ± 0.005 
Δδmax (3-H) [ppm] = 1.229 ± 0.007 
Δδmax (2-H) [ppm] = 0.630 ± 0.002 
 
 
 
 
* Limit of 95% - confidence interval from the nonlinear regression of the signals of the Protons 5-H. 
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5.4 Fluorescence titrations 
5.4.1 Fluorescence titrations of the phosphate tweezer 133 
 
Fluorescence titration of the tweezer 133 with AcLysOMe in phosphate buffer (10mM, pH 
7.6) 
 
λexc  = 285 nm 
λem  = 334 nm 
Receptor 
133 
Guest 
AcLysOMe · HCl 
Amount [mg]: 
Volume [mL]:  
Concentration [mol/L]: 
0.225  
10.710  
2.579 · 10-05  
0.263  
0.780 
4.573 · 10-04 
 
 
Guest 
V (µL) 
Receptor 
V (µL) 
[Receptor] 
[mol/L] 
[Guest] 
[mol/L] 
[Guest]/ 
[Receptor]
F·I· 
(I334 nm) 
∆Iobs ∆Icalc 
0 700 2.58E-05 0.00E+00 0.00 594.451 0.000 0.000 
10 710 2.58E-05 6.44E-06 0.25 550.838 43.613 42.321 
20 720 2.58E-05 1.27E-05 0.49 515.279 79.172 78.336 
30 730 2.58E-05 1.88E-05 0.73 483.590 110.861 107.795 
40 740 2.58E-05 2.47E-05 0.96 459.677 134.774 131.058 
60 760 2.58E-05 3.61E-05 1.40 433.532 160.919 162.749
80 780 2.58E-05 4.69E-05 1.82 416.212 178.239 181.512 
100 800 2.58E-05 5.72E-05 2.22 403.594 190.857 193.191 
140 840 2.58E-05 7.62E-05 2.95 389.476 204.975 206.378 
180 880 2.58E-05 9.35E-05 3.63 382.237 212.214 213.434 
240 940 2.58E-05 1.17E-04 4.53 373.044 221.407 219.364 
300 1000 2.58E-05 1.37E-04 5.32 369.385 225.066 222.793 
 
 
λ [nm   ]
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 Ka [M-1] = 113000 ± 6 %,  
 Kd[µM] = 9 ±  6 %, 
  ΔImax = 240  
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Fluorescence titration of the tweezer 133 with AcArgOMe in phosphate buffer (10mM, pH 
7.6) 
 
 
λexc  = 285 nm 
λem  = 334 nm 
Receptor 
133 
Guest 
AcArgOMe · HCl 
Amount [mg]: 
Volume [mL]:  
Concentration [mol/L]: 
0.225  
10.710  
2.579 · 10-05  
0.101  
0.828 
4.573 · 10-04 
 
 
Guest 
V (µL) 
Receptor 
V (µL) 
[Receptor] 
[mol/L] 
[Guest] 
[mol/L] 
[Guest]/ 
[Receptor]
F·I· 
(I334 nm) 
∆Iobs ∆Icalc 
0 700 2.58E-05 0.00E+00 0.00 593.577 0.000 0.000 
10 710 2.58E-05 6.44E-06 0.25 556.958 36.619 37.456 
20 720 2.58E-05 1.27E-05 0.49 525.313 68.264 69.073 
30 730 2.58E-05 1.88E-05 0.73 493.808 99.769 95.421 
40 740 2.58E-05 2.47E-05 0.96 473.990 119.587 117.216 
60 760 2.58E-05 3.61E-05 1.40 443.240 150.337 150.075 
80 780 2.58E-05 4.69E-05 1.82 421.906 171.671 172.777 
100 800 2.58E-05 5.72E-05 2.22 405.990 187.587 188.925 
140 840 2.58E-05 7.62E-05 2.96 386.727 206.850 209.801 
180 880 2.58E-05 9.35E-05 3.63 373.825 219.752 222.433 
240 940 2.58E-05 1.17E-04 4.53 359.004 234.573 233.984 
340 1040 2.58E-05 1.50E-04 5.80 345.525 248.052 244.467 
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       Ka [M-1] = 50600 ± 5 % 
Kd [µM] = 20 ± 5 % 
       ΔImax = 282  
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Fluorescence titration of the tweezer 133 with AcArgOMe in phosphate buffer (200mM, pH 
7.6) 
 
 
λexc  = 285 nm 
λem  = 335 nm 
Receptor 
133 
Guest 
AcArgOMe · HCl 
Amount [mg]: 
Volume [mL]:  
Concentration [mol/L]: 
0.170  
8.96 
2.33 · 10-05  
0.364  
0.535 
2.55 · 10-03 
 
 
Guest 
V (µL) 
Receptor 
V (µL) 
[Receptor] 
[mol/L] 
[Guest] 
[mol/L] 
[Guest]/ 
[Receptor]
F·I· 
(I335 nm) 
∆Iobs ∆Icalc 
0 700 2.33E-05 0.00E+00 0.00 973.832 0.000 0.000 
10 710 2.33E-05 3.59E-05 1.54 842.941 130.891 128.837 
20 720 2.33E-05 7.09E-05 3.04 775.363 198.469 199.554 
30 730 2.33E-05 1.05E-04 4.50 732.780 241.052 242.139 
40 740 2.33E-05 1.38E-04 5.92 700.879 272.953 270.041 
60 760 2.33E-05 2.01E-04 8.64 669.874 303.958 303.919 
80 780 2.33E-05 2.62E-04 11.23 653.089 320.743 323.546 
100 800 2.33E-05 3.19E-04 13.68 638.677 335.155 336.290 
120 820 2.33E-05 3.73E-04 16.02 631.899 341.933 345.214 
150 850 2.33E-05 4.50E-04 19.32 616.878 356.954 354.492 
180 880 2.33E-05 5.22E-04 22.39 610.332 363.500 360.880 
220 920 2.33E-05 6.10E-04 26.18 608.956 364.876 366.829 
260 960 2.33E-05 6.91E-04 29.65 602.008 371.824 371.029 
300 1000 2.33E-05 7.65E-04 32.84 598.502 375.330 374.151 
 
 
 
 
  
 
 
 
 
Ka [M-1] = 16400 ± 2 % 
Kd [µM] = 61 ± 2 % 
ΔImax = 405  
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Fluorescence titration of the tweezer 133 with AcLysOMe in methanol 
 
 
λexc  = 285 nm 
λem  = 322 nm 
Receptor 
133 
Guest 
AcLysOMe · HCl 
Amount [mg]: 
Volume [mL]:  
Concentration [mol/L]: 
0.120 
6.00 
2.46 · 10-05  
0.382 
1.00 
1.60 · 10-03 
 
 
Guest 
V (µL) 
Receptor 
V (µL) 
[Receptor] 
[mol/L] 
[Guest] 
[mol/L] 
[Guest]/ 
[Receptor]
F·I· 
(I322) 
-∆Iobs -∆Icalc 
0 700 2.46E-05 0.00E+00 0.00 608.731 0.000 0.000 
10 710 2.46E-05 2.25E-05 0.92 615.971 7.240 7.651 
20 720 2.46E-05 4.45E-05 1.81 621.386 12.655 12.889 
30 730 2.46E-05 6.58E-05 2.68 625.740 17.009 16.594 
40 740 2.46E-05 8.65E-05 3.52 626.250 17.519 19.308 
60 760 2.46E-05 1.26E-04 5.15 632.937 24.206 22.964 
100 800 2.46E-05 2.00E-04 8.15 636.981 28.250 26.873 
180 880 2.46E-05 3.27E-04 13.33 639.343 30.612 30.135 
220 920 2.46E-05 3.83E-04 15.59 638.661 29.930 30.962 
260 960 2.46E-05 4.33E-04 17.65 639.838 31.107 31.555 
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Ka [M-1] = 15200 ± 11 % 
Kd [µM] = 66 ± 11 % 
ΔImax = -37 
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Fluorescence titration of the tweezer 133 with IAPP (1-7) in phosphate buffer (10mM, pH 
7.6) 
 
 
λexc  = 285 nm 
λem  = 334 nm 
Receptor 
133
Guest 
IAPP (1-7) 
Amount [mg]: 
Volume [mL]:  
Concentration [mol/L]: 
0.225  
10.710  
2.579 · 10-05  
0.263  
0.780 
4.573 · 10-04 
 
 
Guest 
V (µL) 
Receptor 
V (µL) 
[Receptor] 
[mol/L] 
[Guest] 
[mol/L] 
[Guest]/ 
[Receptor]
F·I· 
(I334 nm) 
∆Iobs ∆Icalc 
0 700 2.58E-05 0.00E+00 0.00 612.158 0.000 0.000 
10 710 2.58E-05 6.44E-06 0.25 569.172 42.986 47.290 
20 720 2.58E-05 1.27E-05 0.49 530.430 81.728 87.553 
30 730 2.58E-05 1.88E-05 0.73 492.028 120.130 120.483 
40 740 2.58E-05 2.47E-05 0.96 463.046 149.112 146.461 
60 760 2.58E-05 3.61E-05 1.40 427.225 184.933 181.757 
80 780 2.58E-05 4.69E-05 1.82 409.022 203.136 202.571 
100 800 2.58E-05 5.72E-05 2.22 396.970 215.188 215.482 
140 840 2.58E-05 7.62E-05 2.95 383.541 228.617 230.017 
180 880 2.58E-05 9.35E-05 3.63 375.852 236.306 237.774 
240 940 2.58E-05 1.17E-04 4.53 367.371 244.787 244.284 
300 1000 2.58E-05 1.37E-04 5.32 362.955 249.203 248.044 
 
 
 
 
 Ka [M-1] = 115000 ± 6 % 
 Kd [µM] = 9 ± 6 % 
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Fluorescence titration of the tweezer 133 with IAPP (2-14) in phosphate buffer (10mM, pH 
7.6) 
 
 
λexc  = 285 nm 
λem  = 334 nm 
Receptor 
133
Guest 
IAPP (2-14) 
Amount [mg]: 
Volume [mL]:  
Concentration [mol/L]: 
0.225  
10.710  
2.579 · 10-05  
0.549  
0.880 
4.575 · 10-04 
 
 
Guest 
V (µL) 
Receptor 
V (µL) 
[Receptor] 
[mol/L] 
[Guest] 
[mol/L] 
[Guest]/ 
[Receptor]
F·I· 
(I334 nm) 
∆Iobs ∆Icalc 
0 700 2.58E-05 0.00E+00 0.00 596.576 0.000 0.000 
10 710 2.58E-05 6.44E-06 0.25 580.210 16.366 17.418 
20 720 2.58E-05 1.27E-05 0.49 564.679 31.897 33.094 
30 730 2.58E-05 1.88E-05 0.73 553.575 43.001 47.254 
40 740 2.58E-05 2.47E-05 0.96 537.644 58.932 60.086 
60 760 2.58E-05 3.61E-05 1.40 510.046 86.530 82.404 
80 780 2.58E-05 4.69E-05 1.82 496.676 99.900 101.094 
100 800 2.58E-05 5.72E-05 2.22 481.567 115.009 116.932 
140 840 2.58E-05 7.63E-05 2.96 450.962 145.614 142.223 
180 880 2.58E-05 9.36E-05 3.63 434.443 162.133 161.446 
240 940 2.58E-05 1.17E-04 4.53 412.349 184.227 182.862 
300 1000 2.58E-05 1.37E-04 5.32 398.538 198.038 198.498 
400 1100 2.58E-05 1.66E-04 6.45 382.369 214.207 216.847 
600 1300 2.58E-05 2.11E-04 8.19 359.076 237.500 238.599 
700 1400 2.58E-05 2.29E-04 8.87 349.319 247.257 245.559 
 
 
 
            
 Ka [M-1] = 9540 ± 4 % 
 Kd [µM] = 104 ± 4 % 
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5.4.2 Fluorescence titrations of the sulfate tweezer 161 
 
Fluorescence titration of the tweezer 161 with AcLysOMe . HCl in phosphate buffer (200 
mM, pH 7.6) 
 
 
λexc  = 285 nm 
Receptor 
161 
Guest 
AcLysOMe · HCl 
Amount [mg]: 
Volume [mL]:  
Concentration [mol/L]: 
0.156  
8.69  
2.33 · 10-05  
0.410  
0.673  
2.55 · 10-03  
 
 
Guest 
V (µL) 
Receptor 
V (µL) 
[Receptor] 
[mol/L] 
[Guest] 
[mol/L] 
[Guest]/ 
[Receptor]
F·I· 
(I337) 
∆Iobs ∆Icalc 
0 700 2.33E-05 0.00E+00 0.00 918.114 0.000 0 
10 710 2.33E-05 3.59E-05 1.54 725.153 192.961 193.3159 
20 720 2.33E-05 7.09E-05 3.04 642.548 275.566 272.2011
30 730 2.33E-05 1.05E-04 4.50 611.539 306.575 309.9996 
40 740 2.33E-05 1.38E-04 5.92 584.480 333.634 331.4145 
60 760 2.33E-05 2.01E-04 8.65 565.857 352.257 354.424 
80 780 2.33E-05 2.62E-04 11.23 551.001 367.113 366.4685 
100 800 2.33E-05 3.19E-04 13.69 548.189 369.925 373.8478 
120 820 2.33E-05 3.73E-04 16.03 541.879 376.235 378.8253 
150 850 2.33E-05 4.50E-04 19.33 532.487 385.627 383.8455 
180 880 2.33E-05 5.22E-04 22.40 527.754 390.360 387.2144 
220 920 2.33E-05 6.10E-04 26.19 526.147 391.967 390.2914 
260 960 2.33E-05 6.91E-04 29.66 525.849 392.265 392.4293 
300 1000 2.33E-05 7.66E-04 32.86 524.197 393.917 394.0008 
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0 5 10 15 20 25 30 35
ΔΙ
0
100
200
300
400
500
 
 
 
 
 
 
Ka [M-1] = 36000 ± 2 % 
Kd [µM] = 28 ± 2 % 
ΔImax = 409  
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Fluorescence titration of the tweezer 161 with AcArgOMe . HCl in phosphate buffer (200 
mM, pH 7.6) 
 
 
λexc  = 285 nm 
Receptor 
161 
Guest 
AcArgOMe · HCl 
Amount [mg]: 
Volume [mL]:  
Concentration [mol/L]: 
0.156  
8.69  
2.33 · 10-05  
0.340  
0.499  
2.55 · 10-03  
 
 
Guest 
V (µL) 
Receptor 
V (µL) 
[Receptor] 
[mol/L] 
[Guest] 
[mol/L] 
[Guest]/ 
[Receptor]
F·I· 
(I337) 
∆Iobs ∆Icalc 
0 700 2.33E-05 0.00E+00 0.00 921.704 0.000 0.000 
10 710 2.33E-05 3.60E-05 1.54 863.162 58.542 56.863 
20 720 2.33E-05 7.10E-05 3.05 825.328 96.376 98.541 
30 730 2.33E-05 1.05E-04 4.51 795.250 126.454 130.157 
40 740 2.33E-05 1.38E-04 5.93 765.497 156.207 154.846 
60 760 2.33E-05 2.02E-04 8.66 723.468 198.236 190.741 
80 780 2.33E-05 2.62E-04 11.24 703.545 218.159 215.465 
100 800 2.33E-05 3.19E-04 13.70 691.642 230.062 233.478 
120 820 2.33E-05 3.74E-04 16.04 675.124 246.580 247.162 
150 850 2.33E-05 4.51E-04 19.35 662.666 259.038 262.445 
180 880 2.33E-05 5.23E-04 22.42 654.232 267.472 273.656 
220 920 2.33E-05 6.11E-04 26.22 638.021 283.683 284.648 
260 960 2.33E-05 6.92E-04 29.69 625.181 296.523 292.749 
300 1000 2.33E-05 7.66E-04 32.89 619.139 302.565 298.964 
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Ka [M-1] = 5600 ± 4 % 
Kd [µM] = 178 ± 4 % 
ΔImax = 370  
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Fluorescence titration of the tweezer 161 with AcLysOMe . HCl in phosphate buffer (10mM, 
pH 6.2) 
 
 
λexc  = 285 nm 
Receptor 
161 
Guest 
AcLysOMe · HCl 
Amount [mg]: 
Volume [mL]:  
Concentration [mol/L]: 
0.109  
6.068  
2.33 · 10-05  
0.372  
0.611  
2.55 · 10-03  
 
 
Guest 
V (µL) 
Receptor 
V (µL) 
[Receptor] 
[mol/L] 
[Guest] 
[mol/L] 
[Guest]/ 
[Receptor]
F·I· 
(I338) 
∆Iobs ∆Icalc 
0 700 2.33E-05 0.00E+00 0.00 909.488 0.000 0.000 
10 710 2.33E-05 3.59E-05 1.54 712.669 196.819 195.357 
20 720 2.33E-05 7.09E-05 3.04 653.965 255.523 258.245 
30 730 2.33E-05 1.05E-04 4.50 626.159 283.329 283.571 
40 740 2.33E-05 1.38E-04 5.92 610.490 298.998 296.686 
60 760 2.33E-05 2.01E-04 8.64 599.700 309.788 309.904 
80 780 2.33E-05 2.62E-04 11.23 596.310 313.178 316.500 
100 800 2.33E-05 3.19E-04 13.68 587.791 321.697 320.442 
120 820 2.33E-05 3.73E-04 16.02 582.066 327.422 323.060 
150 850 2.33E-05 4.50E-04 19.31 584.337 325.151 325.669 
180 880 2.33E-05 5.22E-04 22.39 582.969 326.519 327.403 
220 920 2.33E-05 6.10E-04 26.17 581.129 328.359 328.975 
260 960 2.33E-05 6.91E-04 29.64 581.089 328.399 330.061 
300 1000 2.33E-05 7.65E-04 32.83 577.771 331.717 330.856 
 
 
 
 
 
 
 
 
Ka [M-1] = 60900 ± 3% 
Kd [µM] = 16 ± 3 % 
ΔImax = 338  
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Fluorescence titration of the tweezer 161 with AcArgOMe . HCl in phosphate buffer 
(10mM, pH 6.2) 
 
 
λexc  = 285 nm 
Receptor 
161 
Guest 
AcArgOMe · HCl 
Amount [mg]: 
Volume [mL]:  
Concentration [mol/L]: 
0.109  
6.068  
2.33 · 10-05  
0.350  
0.514  
2.55 · 10-03  
 
 
Guest 
V (µL) 
Receptor 
V (µL) 
[Receptor] 
[mol/L] 
[Guest] 
[mol/L] 
[Guest]/ 
[Receptor]
F·I· 
(I338) 
∆Iobs ∆Icalc 
0 700 2.33E-05 0.00E+00 0.00 960.000  0.000  0.000 
10 710 2.33E-05 3.60E-05 1.54 872.883 87.117 82.937 
20 720 2.33E-05 7.09E-05 3.04 824.577 135.423 130.271 
30 730 2.33E-05 1.05E-04 4.50 800.783 159.217 159.662 
40 740 2.33E-05 1.38E-04 5.92 781.239 178.761 179.344 
60 760 2.33E-05 2.02E-04 8.65 760.417 199.583 203.734 
80 780 2.33E-05 2.62E-04 11.24 747.828 212.172 218.125 
100 800 2.33E-05 3.19E-04 13.69 736.247 223.753 227.574 
120 820 2.33E-05 3.74E-04 16.03 724.760 235.240 234.240 
150 850 2.33E-05 4.51E-04 19.33 721.904 238.096 241.215 
180 880 2.33E-05 5.22E-04 22.41 714.210 245.790 246.043 
220 920 2.33E-05 6.10E-04 26.19 704.210 255.790 250.559 
260 960 2.33E-05 6.91E-04 29.67 701.741 258.259 253.757 
300 1000 2.33E-05 7.66E-04 32.86 702.693 257.307 256.141 
 
 
  
  
  
  
 
 
  Ka [M-1] = 14500 ± 4% 
  Kd [µM] = 69 ± 4 % 
  ΔImax = 280  
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Fluorescence titration of the tweezer 161 with AcLysOMe . HCl in phosphate buffer (10mM, 
pH 7.2) 
 
 
λexc  = 285 nm 
Receptor 
161 
Guest 
AcLysOMe · HCl 
Amount [mg]: 
Volume [mL]:  
Concentration [mol/L]: 
0.100  
5.568  
2.33 · 10-05  
0.354  
0.581 
2.55 · 10-03  
 
 
Guest 
V (µL) 
Receptor 
V (µL) 
[Receptor] 
[mol/L] 
[Guest] 
[mol/L] 
[Guest]/ 
[Receptor]
F·I· 
(I338) 
∆Iobs ∆Icalc 
0 700 2.33E-05 0.00E+00 0.00 925.462 0.000 0.000 
10 710 2.33E-05 3.60E-05 1.54 702.801 222.661 222.446 
20 720 2.33E-05 7.09E-05 3.04 623.958 301.504 299.942 
30 730 2.33E-05 1.05E-04 4.50 591.476 333.986 332.975 
40 740 2.33E-05 1.38E-04 5.92 578.192 347.270 350.558 
60 760 2.33E-05 2.02E-04 8.65 559.736 365.726 368.613 
80 780 2.33E-05 2.62E-04 11.24 545.225 380.237 377.746 
100 800 2.33E-05 3.19E-04 13.69 544.797 380.665 383.242 
120 820 2.33E-05 3.74E-04 16.03 537.159 388.303 386.908 
150 850 2.33E-05 4.50E-04 19.33 532.127 393.335 390.573 
180 880 2.33E-05 5.22E-04 22.41 533.112 392.350 393.015 
220 920 2.33E-05 6.10E-04 26.20 530.630 394.832 395.234 
260 960 2.33E-05 6.91E-04 29.67 533.667 391.795 396.769 
300 1000 2.33E-05 7.66E-04 32.86 522.077 403.385 397.893 
  
   
 
         ∆λ ~ 10 nm, blue shift      Ka [M-1] = 51500 ± 3 % 
          Kd [µM] = 19 ± 3 % 
  ΔImax = 408  
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Fluorescence titration of the tweezer 161 with AcArgOMe . HCl in phosphate buffer 
(10mM. pH 7.2) 
 
 
λexc  = 285 nm 
Receptor 
161 
Guest 
AcArgOMe · HCl 
Amount [mg]: 
Volume [mL]:  
Concentration [mol/L]: 
0.100  
5.568  
2.33 · 10-05  
0.354  
0.520  
2.55 · 10-03  
 
 
Guest 
V (µL) 
Receptor 
V (µL) 
[Receptor] 
[mol/L] 
[Guest] 
[mol/L] 
[Guest]/ 
[Receptor]
F·I· 
(I338) 
∆Iobs ∆Icalc 
0 700 2.33E-05 0.00E+00 0.00 906.244 0.000 0.000 
10 710 2.33E-05 3.59E-05 1.54 827.374 78.870 76.058 
20 720 2.33E-05 7.09E-05 3.04 782.379 123.865 120.955 
30 730 2.33E-05 1.05E-04 4.50 753.140 153.104 149.585 
40 740 2.33E-05 1.38E-04 5.92 739.276 166.968 169.129 
60 760 2.33E-05 2.01E-04 8.65 713.500 192.744 193.803 
80 780 2.33E-05 2.62E-04 11.23 700.130 206.114 208.608 
100 800 2.33E-05 3.19E-04 13.69 691.374 214.870 218.432 
120 820 2.33E-05 3.74E-04 16.03 684.805 221.439 225.413 
150 850 2.33E-05 4.50E-04 19.33 679.489 226.755 232.761 
180 880 2.33E-05 5.22E-04 22.41 668.375 237.869 237.873 
220 920 2.33E-05 6.10E-04 26.19 662.402 243.842 242.675 
260 960 2.33E-05 6.91E-04 29.67 656.113 250.131 246.088 
300 1000 2.33E-05 7.66E-04 32.86 650.395 255.849 248.638 
 
 
  
 Ka [M-1] = 13000 ± 5 % 
 Kd [µM] = 77 ± 5 % 
 ΔImax = 274  
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Fluorescence titration of the tweezer 161 with AcLysOMe . HCl in phosphate buffer (10mM, 
pH 8.6) 
 
 
λexc  = 285 nm 
Receptor 
161 
Guest 
AcLysOMe · HCl 
Amount [mg]: 
Volume [mL]:  
Concentration [mol/L]: 
0.092  
5.124  
2.33 · 10-05  
0.380 
0.624  
2.55 · 10-03  
 
 
Guest 
V (µL) 
Receptor 
V (µL) 
[Receptor] 
[mol/L] 
[Guest] 
[mol/L] 
[Guest]/ 
[Receptor]
F·I· 
(I338) 
∆Iobs ∆Icalc 
0 700 2.33E-05 0.00E+00 0.00 647.758 0.000 0.000 
10 710 2.33E-05 3.59E-05 1.54 453.457 194.301 185.303 
20 720 2.33E-05 7.09E-05 3.04 400.921 246.837 248.519 
30 730 2.33E-05 1.05E-04 4.50 377.422 270.336 275.058 
40 740 2.33E-05 1.38E-04 5.92 363.845 283.913 289.077 
60 760 2.33E-05 2.01E-04 8.65 347.507 300.251 303.399 
80 780 2.33E-05 2.62E-04 11.23 341.385 306.373 310.616 
100 800 2.33E-05 3.19E-04 13.69 331.055 316.703 314.950 
120 820 2.33E-05 3.73E-04 16.03 332.507 315.251 317.838 
150 850 2.33E-05 4.50E-04 19.33 327.646 320.112 320.723 
180 880 2.33E-05 5.22E-04 22.40 322.389 325.369 322.643 
220 920 2.33E-05 6.10E-04 26.19 320.437 327.321 324.387 
260 960 2.33E-05 6.91E-04 29.66 317.721 330.037 325.592 
300 1000 2.33E-05 7.65E-04 32.86 318.211 329.547 326.476 
  
 
 
 
 
 
 
 
 
Ka [M-1] = 53900 ± 5 % 
Kd [µM] = 18 ± 5 % 
ΔImax = 335  
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Fluorescence titration of the tweezer 161 with AcArgOMe . HCl in phosphate buffer 
(10mM, pH 8.6) 
 
 
λexc  = 285 nm 
Receptor 
161 
Guest 
AcArgOMe · HCl 
Amount [mg]: 
Volume [mL]:  
Concentration [mol/L]: 
0.092  
5.124  
2.33 · 10-05  
0.382  
0.561  
2.55 · 10-03  
 
 
Guest 
V (µL) 
Receptor 
V (µL) 
[Receptor] 
[mol/L] 
[Guest] 
[mol/L] 
[Guest]/ 
[Receptor]
F·I· 
(I338) 
∆Iobs ∆Icalc 
0 700 2.33E-05 0.00E+00 0.00 620.606 0.000 0.000 
10 710 2.33E-05 3.60E-05 1.54 558.129 62.477 59.765 
20 720 2.33E-05 7.09E-05 3.04 519.910 100.696 96.577 
30 730 2.33E-05 1.05E-04 4.50 498.401 122.205 120.855 
40 740 2.33E-05 1.38E-04 5.92 482.759 137.847 137.847 
60 760 2.33E-05 2.02E-04 8.65 464.441 156.165 159.832 
80 780 2.33E-05 2.62E-04 11.24 450.309 170.297 173.329 
100 800 2.33E-05 3.19E-04 13.70 438.258 182.348 182.417 
120 820 2.33E-05 3.74E-04 16.04 434.110 186.496 188.940 
150 850 2.33E-05 4.51E-04 19.34 428.968 191.638 195.865 
180 880 2.33E-05 5.22E-04 22.42 423.093 197.513 200.719 
220 920 2.33E-05 6.10E-04 26.21 414.712 205.894 205.306 
260 960 2.33E-05 6.91E-04 29.68 409.409 211.197 208.581 
300 1000 2.33E-05 7.66E-04 32.88 401.665 218.941 211.037 
 
 
   
 
 
 
 
 
 
Ka [M-1] = 11300 ± 5 % 
Kd [µM] = 88 ± 5 % 
ΔImax = 236  
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Fluorescence titration of the tweezer 161 with HLysOH in phosphate buffer (10mM, pH 7.6) 
 
 
λexc  = 285 nm 
λem  = 338 nm 
Receptor 
161 
Guest 
HLysOH · HCl 
Amount [mg]: 
Volume [mL]:  
Concentration [mol/L]: 
0.154  
8.58  
2.33 · 10-05  
0.282  
0.607 
2.54 · 10-03 
 
 
Guest 
V (µL) 
Receptor 
V (µL) 
[Receptor] 
[mol/L] 
[Guest] 
[mol/L] 
[Guest]/ 
[Receptor]
F·I· 
(I338) 
∆Iobs ∆Icalc 
0 700 2.33E-05 0.00E+00 0.00 668.101 0.000 0.000 
10 710 2.33E-05 3.58E-05 1.54 624.460 43.641 37.471 
20 720 2.33E-05 7.06E-05 3.03 600.417 67.684 66.272 
30 730 2.33E-05 1.05E-04 4.49 571.074 97.027 88.995 
40 740 2.33E-05 1.37E-04 5.90 565.345 102.756 107.324 
60 760 2.33E-05 2.01E-04 8.62 539.165 128.936 134.979 
80 780 2.33E-05 2.61E-04 11.19 516.322 151.779 154.784 
100 800 2.33E-05 3.18E-04 13.64 495.840 172.261 169.631 
140 840 2.33E-05 4.24E-04 18.19 478.098 190.003 190.359 
180 880 2.33E-05 5.20E-04 22.32 465.560 202.541 204.114 
240 940 2.33E-05 6.49E-04 27.86 451.082 217.019 217.799 
300 1000 2.33E-05 7.63E-04 32.74 437.507 230.594 226.874 
 
 
 
 
 
 
Ka [M-1] = 4410 ± 6 % 
Kd [µM] = 227 ± 6 % 
ΔImax =296  
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Fluorescence titration of the tweezer 161 with HLysOH in phosphate buffer (10mM. pH 6.2) 
 
 
λexc  = 285 nm 
λem  = 336 nm 
Receptor 
161 
Guest 
HLysOH 
Amount [mg]: 
Volume [mL]:  
Concentration [mol/L]: 
0.190 
11.310 
2.18 · 10-05  
0.192 
1.400 
7.51 · 10-04 
 
 
Guest 
V (µL) 
Receptor 
V (µL) 
[Receptor] 
[mol/L] 
[Guest] 
[mol/L] 
[Guest]/ 
[Receptor] 
F·I· 
(I334 nm) 
∆Iobs ∆Icalc 
0 700 2.18E-05 0.00E+00 0.00 615.594 0.000 0.000 
10 710 2.18E-05 1.06E-05 0.49 606.248 9.346 13.338 
20 720 2.18E-05 2.09E-05 0.96 591.587 24.007 25.074 
30 730 2.18E-05 3.08E-05 1.42 577.498 38.096 35.465 
40 740 2.18E-05 4.06E-05 1.86 565.311 50.283 44.718 
60 760 2.18E-05 5.93E-05 2.72 558.092 57.502 60.453 
80 780 2.18E-05 7.70E-05 3.53 544.148 71.446 73.303 
100 800 2.18E-05 9.38E-05 4.31 529.922 85.672 83.973 
140 840 2.18E-05 1.25E-04 5.74 514.226 101.368 100.631 
180 880 2.18E-05 1.54E-04 7.04 509.955 105.639 113.005 
240 940 2.18E-05 1.92E-04 8.79 482.395 133.199 126.529 
300 1000 2.18E-05 2.25E-04 10.33 475.508 140.086 141.332 
 
0 2 4 6 8 10 12
ΔΙ
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[H Lys OH]/[161]  
  
 Ka [M-1] = 5790 ± 15 % 
 Kd [µM] = 173 ± 15 % 
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Fluorescence titration of the tweezer 161 with HArgOH in phosphate buffer (10mM, pH 
7.6) 
 
 
λexc  = 285 nm 
λem  = 338 nm 
Receptor 
161 
Guest 
HArgOH · HCl 
Amount [mg]: 
Volume [mL]:  
Concentration [mol/L]: 
0.154  
8.58  
2.33 · 10-05  
0.282  
0.607 
2.54 · 10-03 
 
 
Guest 
V (µL) 
Receptor 
V (µL) 
[Receptor] 
[mol/L] 
[Guest] 
[mol/L] 
[Guest]/ 
[Receptor]
F·I· 
(I338) 
∆Iobs ∆Icalc 
0 700 2.33E-05 0.00E+00 0.00 663.928 0.000 0.000 
10 710 2.33E-05 3.58E-05 1.54 651.777 12.151 10.660 
20 720 2.33E-05 7.07E-05 3.03 640.915 23.013 20.121 
30 730 2.33E-05 1.05E-04 4.49 633.350 30.578 28.573 
40 740 2.33E-05 1.38E-04 5.90 629.736 34.192 36.168 
60 760 2.33E-05 2.01E-04 8.62 609.553 54.375 49.252 
80 780 2.33E-05 2.61E-04 11.20 602.310 61.618 60.118 
100 800 2.33E-05 3.18E-04 13.65 595.105 68.823 69.282 
140 840 2.33E-05 4.24E-04 18.20 587.086 76.842 83.879 
180 880 2.33E-05 5.21E-04 22.34 573.167 90.761 94.982 
240 940 2.33E-05 6.50E-04 27.88 555.393 108.535 107.403 
300 1000 2.33E-05 7.63E-04 32.76 543.114 120.814 116.533 
 
 
 
 
 
 
 
Ka [M-1] = 1430 ± 15 % 
Kd [µM] = 699 ± 2 % 
ΔImax =225  
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Fluorescence titration of the tweezer 161 with HArgOMe in phosphate buffer (10mM, pH 
7.6) 
 
 
λexc  = 285 nm 
λem  = 338 nm 
Receptor 
161 
Guest 
HArgOMe · 2HCl 
Amount [mg]: 
Volume [mL]:  
Concentration [mol/L]: 
0.154  
8.575 
2.33 · 10-05  
0.429  
0.644 
2.55 · 10-03 
 
 
Guest 
V (µL) 
Receptor 
V (µL) 
[Receptor] 
[mol/L] 
[Guest] 
[mol/L] 
[Guest]/ 
[Receptor]
F·I· 
(I338 nm) 
∆Iobs ∆Icalc 
0 700 2,33E-05 0,00E+00 0,00 668,334 0,000 0,000 
10 710 2,33E-05 3,59E-05 1,54 608,912 59,422 51,408 
20 720 2,33E-05 7,09E-05 3,04 571,524 96,810 88,201 
30 730 2,33E-05 1,05E-04 4,50 552,344 115,990 115,571 
40 740 2,33E-05 1,38E-04 5,92 536,594 131,740 136,610 
60 760 2,33E-05 2,01E-04 8,64 505,163 163,171 166,659 
80 780 2,33E-05 2,62E-04 11,23 482,611 185,723 186,984 
100 800 2,33E-05 3,19E-04 13,68 470,043 198,291 201,600 
140 840 2,33E-05 4,25E-04 18,25 451,324 217,010 221,160 
180 880 2,33E-05 5,22E-04 22,39 435,475 232,859 233,623 
240 940 2,33E-05 6,51E-04 27,95 418,363 249,971 245,633 
300 1000 2,33E-05 7,65E-04 32,84 411,150 257,184 253,393 
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Ka [M-1] = 6260 ± 6 % 
Kd [µM] = 160 ± 6 % 
ΔImax = 308  
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Fluorescence titration of the tweezer 161 with peptide KAA in phosphate buffer (10mM, pH 
7.6) 
 
 
λexc  = 285 nm 
λem  = 338 nm 
Receptor 
161 
Guest 
KAA 
Amount [mg]: 
Volume [mL]:  
Concentration [mol/L]: 
0.154  
8.58  
2.33 · 10-05  
0.37  
0.503 
2.55 · 10-03 
 
 
Guest 
V (µL) 
Receptor 
V (µL) 
[Receptor] 
[mol/L] 
[Guest] 
[mol/L] 
[Guest]/ 
[Receptor]
F·I· 
(I338) 
∆Iobs ∆Icalc 
0 700 2.33E-05 0.00E+00 0.00 671.428 0.000 0.000 
10 710 2.33E-05 3.59E-05 1.54 644.313 27.115 32.063 
20 720 2.33E-05 7.09E-05 3.04 606.546 64.882 57.917 
30 730 2.33E-05 1.05E-04 4.50 595.503 75.925 79.153 
40 740 2.33E-05 1.38E-04 5.92 575.253 96.175 96.878 
60 760 2.33E-05 2.01E-04 8.64 544.662 126.766 124.722 
80 780 2.33E-05 2.62E-04 11.23 525.733 145.695 145.552 
100 800 2.33E-05 3.19E-04 13.69 514.004 157.424 161.693 
140 840 2.33E-05 4.25E-04 18.25 484.077 187.351 185.041 
180 880 2.33E-05 5.22E-04 22.39 469.864 201.564 201.088 
240 940 2.33E-05 6.51E-04 27.95 451.425 220.003 217.517 
300 1000 2.33E-05 7.65E-04 32.85 445.244 226.184 228.679 
 
 
   
 
 
 
 
 
 
Ka [M-1] = 3300 ± 5 % 
Kd [µM] = 303 ± 5 % 
ΔImax =321 
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Fluorescence titration of the tweezer 161 with KAA in phosphate buffer (10mM. pH 6.2) 
 
 
λexc  = 285 nm 
λem  = 336 nm 
Receptor 
161 
Guest 
KAA 
Amount [mg]: 
Volume [mL]:  
Concentration [mol/L]: 
0.190 
11.310 
2.18 · 10-05  
0.260 
1.202 
7.5 · 10-04 
 
 
Guest 
V (µL) 
Receptor 
V (µL) 
[Receptor] 
[mol/L] 
[Guest] 
[mol/L] 
[Guest]/ 
[Receptor] 
F·I· 
(I334 nm) 
∆Iobs ∆Icalc 
0 700 2.18E-05 0.00E+00 0.00 618.074 0.000 0.000 
10 710 2.18E-05 1.06E-05 0.48 607.968 10.106 12.009 
20 720 2.18E-05 2.08E-05 0.96 598.678 19.396 22.630 
30 730 2.18E-05 3.08E-05 1.41 581.431 36.643 32.080 
40 740 2.18E-05 4.05E-05 1.86 576.712 41.362 40.533 
60 760 2.18E-05 5.92E-05 2.72 559.753 58.321 54.994 
80 780 2.18E-05 7.69E-05 3.53 550.712 67.362 66.889 
100 800 2.18E-05 9.38E-05 4.30 543.848 74.226 76.827 
140 840 2.18E-05 1.25E-04 5.74 528.168 89.906 92.459 
180 880 2.18E-05 1.53E-04 7.04 514.292 103.782 104.167 
240 940 2.18E-05 1.92E-04 8.79 501.664 116.410 117.060 
300 1000 2.18E-05 2.25E-04 10.33 484.849 133.225 131.295 
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[KAA]/[161]  
  
 Ka [M-1] = 5440 ± 12 % 
 Kd [µM] = 184 ± 12 % 
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Fluorescence titration of the tweezer 161 with peptide KLVFF in phosphate buffer (10mM, 
pH 7.6) 
 
 
λexc  = 285 nm 
λem  = 338 nm 
Receptor 
161 
Guest 
KLVFF 
Amount [mg]: 
Volume [mL]:  
Concentration [mol/L]: 
0.113  
6.724 
2.18 · 10-05  
0.355 
0.725 
7.5 · 10-04 
 
 
Guest 
V (µL) 
Receptor 
V (µL) 
[Receptor] 
[mol/L] 
[Guest] 
[mol/L] 
[Guest]/ 
[Receptor]
F·I· 
(I338) 
∆Iobs ∆Icalc 
0 700 2.18E-05 0.00E+00 0.00 644.084 0.000 0.000 
10 710 2.18E-05 1.06E-05 0.48 629.776 14.308 16.276 
20 720 2.18E-05 2.08E-05 0.96 613.787 30.297 28.826 
30 730 2.18E-05 3.08E-05 1.41 605.562 38.522 38.553 
40 740 2.18E-05 4.05E-05 1.86 599.635 44.449 46.180 
60 760 2.18E-05 5.92E-05 2.72 588.012 56.072 57.153 
80 780 2.18E-05 7.69E-05 3.53 580.781 63.303 64.522 
100 800 2.18E-05 9.38E-05 4.30 571.938 72.146 69.743 
140 840 2.18E-05 1.25E-04 5.73 565.785 78.299 76.576 
180 880 2.18E-05 1.53E-04 7.04 561.215 82.869 80.811 
240 940 2.18E-05 1.92E-04 8.78 556.559 87.525 84.792 
300 1000 2.18E-05 2.25E-04 10.32 562.350 81.734 87.306 
 
 
[KLVFF]/[161]
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              ∆λ ~ 20 nm, blue shift 
 
 
Ka [M-1] = 26200 ± 11 %  
Kd [µM] = 38 ± 11 % 
ΔImax =104 
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Fluorescence titration of the tweezer 161 with peptide IAPP (1-7) in phosphate buffer 
(10mM, pH 7.6) 
 
 
λexc  = 285 nm 
λem  = 338 nm 
Receptor 
161 
Guest 
IAPP (1-7) 
Amount [mg]: 
Volume [mL]:  
Concentration [mol/L]: 
0.113  
6.724 
2.18 · 10-05  
0.400 
0.700 
7.75 · 10-04 
 
 
Guest 
V (µL) 
Receptor 
V (µL) 
[Receptor] 
[mol/L] 
[Guest] 
[mol/L] 
[Guest]/ 
[Receptor]
F·I· 
(I338) 
∆Iobs ∆Icalc 
0 700 2.18E-05 0.00E+00 0.00 580.391 0.000 0.000 
10 710 2.18E-05 1.09E-05 0.50 563.471 16.920 18.683 
20 720 2.18E-05 2.15E-05 0.99 540.767 39.624 34.598 
30 730 2.18E-05 3.18E-05 1.46 531.674 48.717 48.268 
40 740 2.18E-05 4.19E-05 1.92 520.234 60.157 60.104 
60 760 2.18E-05 6.12E-05 2.81 500.379 80.012 79.501 
80 780 2.18E-05 7.95E-05 3.65 486.185 94.206 94.662 
100 800 2.18E-05 9.69E-05 4.44 473.604 106.787 106.792 
140 840 2.18E-05 1.29E-04 5.92 458.300 122.091 124.916 
180 880 2.18E-05 1.59E-04 7.27 444.470 135.921 137.757 
240 940 2.18E-05 1.98E-04 9.08 429.102 151.289 151.210 
300 1000 2.18E-05 2.32E-04 10.66 417.189 163.202 160.516 
 
 
[IAPP(1-7)]/[161]
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Ka [M-1] = 9080 ± 6 % 
         Kd [µM] = 110 ± 6 % 
         ΔImax =242 
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Fluorescence titration of the tweezer 161 with AcLysOMe in PBS buffer (10mM, pH 7.2, 
150 mM NaCl) 
 
 
λexc  = 285 nm 
λem  = 338 nm 
Receptor 
161 
Guest 
AcLysOMe · HCl 
Amount [mg]: 
Volume [mL]: 
Concentration [mol/L]: 
0.133 
7.517 
2.30 · 10-05 
0.435 
0.714 
2.55 · 10-03 
 
 
Guest 
V (µL) 
Receptor 
V (µL) 
[Receptor] 
[mol/L] 
[Guest] 
[mol/L] 
[Guest]/ 
[Receptor]
F·I· 
(I338 nm) 
∆Iobs ∆Icalc 
0 700 2.30E-05 0.00E+00 0.00 637.960 0.000 0.000 
10 710 2.30E-05 3.59E-05 1.57 477.957 160.003 159.909 
20 720 2.30E-05 7.09E-05 3.09 405.555 232.405 227.556 
30 730 2.30E-05 1.05E-04 4.57 376.727 261.233 260.956 
40 740 2.30E-05 1.38E-04 6.01 359.043 278.917 280.221 
60 760 2.30E-05 2.02E-04 8.78 339.784 298.176 301.216 
80 780 2.30E-05 2.62E-04 11.40 330.001 307.959 312.331 
100 800 2.30E-05 3.19E-04 13.90 323.139 314.821 319.182 
140 840 2.30E-05 4.25E-04 18.53 312.929 325.031 327.169 
180 880 2.30E-05 5.22E-04 22.74 306.314 331.646 331.674 
240 940 2.30E-05 6.52E-04 28.39 297.298 340.662 335.653 
300 1000 2.30E-05 7.66E-04 33.36 294.357 343.603 338.056 
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Ka [M-1] = 32600 ± 4 % 
Kd [µM] = 31 ± 4 % 
ΔImax = 352  
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Fluorescence titration of the tweezer 161 with peptide KAA in PBS (10mM, pH 7.2, 150 mM 
NaCl) 
 
 
λexc  = 285 nm 
λem  = 338 nm 
Receptor 
161 
Guest 
KAA · CH3COOH 
Amount [mg]: 
Volume [mL]:  
Concentration [mol/L]: 
0.133  
7.517  
2.30 · 10-05  
0.643  
0.875 
2.55 · 10-03 
 
 
Guest 
V (µL) 
Receptor 
V (µL) 
[Receptor] 
[mol/L] 
[Guest] 
[mol/L] 
[Guest]/ 
[Receptor]
F·I· 
(I338 nm) 
∆Iobs ∆Icalc 
0 700 2.30E-05 0.00E+00 0.00 620.053 0.000 0.000 
10 710 2.30E-05 3.59E-05 1.56 598.190 21.863 22.410 
20 720 2.30E-05 7.08E-05 3.08 576.260 43.793 41.169 
30 730 2.30E-05 1.05E-04 4.56 563.923 56.130 57.082 
40 740 2.30E-05 1.38E-04 6.00 548.533 71.520 70.737 
60 760 2.30E-05 2.01E-04 8.76 529.000 91.053 92.929 
80 780 2.30E-05 2.61E-04 11.39 508.270 111.783 110.168 
100 800 2.30E-05 3.19E-04 13.88 497.067 122.986 123.930 
140 840 2.30E-05 4.25E-04 18.50 477.125 142.928 144.499 
180 880 2.30E-05 5.21E-04 22.71 458.805 161.248 159.120 
240 940 2.30E-05 6.51E-04 28.35 446.819 173.234 174.519 
300 1000 2.30E-05 7.65E-04 33.31 434.113 185.940 185.242 
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Ka [M-1] = 2520 ± 3 % 
Kd [µM] = 397 ± 3 % 
ΔImax = 283  
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Fluorescence titration of the tweezer 161 with AcLysOMe in methanol 
 
 
λexc  = 285 nm 
λem  = 320 nm 
Receptor 
161 
Guest 
AcLysOMe 
Amount [mg]: 
Volume [mL]:  
Concentration [mol/L]: 
0.118  
7.000 
2.19 · 10-05  
0.459 
0.754 
2.55 · 10-03 
 
 
Guest 
V (µL) 
Receptor 
V (µL) 
[Receptor] 
[mol/L] 
[Guest] 
[mol/L] 
[Guest]/ 
[Receptor]
F·I· 
(I320) 
- ∆Iobs - ∆Icalc 
0 700 2.19E-05 0.00E+00 0.00 341.665 0.000 0.000 
10 710 2.19E-05 3.59E-05 1.64 491.668 150.003 147.138 
20 720 2.19E-05 7.08E-05 3.24 541.670 200.005 197.765 
30 730 2.19E-05 1.05E-04 4.79 558.559 216.894 219.535 
40 740 2.19E-05 1.38E-04 6.30 572.238 230.573 231.212 
60 760 2.19E-05 2.01E-04 9.21 580.712 239.047 243.285 
80 780 2.19E-05 2.62E-04 11.96 586.192 244.527 249.429 
100 800 2.19E-05 3.19E-04 14.58 593.864 252.199 253.137 
140 840 2.19E-05 4.25E-04 19.43 599.100 257.435 257.390 
180 880 2.19E-05 5.22E-04 23.85 604.290 262.625 259.757 
240 940 2.19E-05 6.51E-04 29.77 601.297 259.632 261.830 
300 1000 2.19E-05 7.65E-04 34.98 613.000 271.335 263.074 
 
 
[AcLysOMe]/[161]
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Ka [M-1] = 49800 ± 6 % 
Kd [µM] = 20 ± 6 % 
ΔImax = - 270 
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Fluorescence titration of the tweezer 161 with AcArgOMe in methanol 
 
 
λexc  = 285 nm 
λem  = 320 nm 
Receptor 
161 
Guest 
AcArgOMe 
Amount [mg]: 
Volume [mL]:  
Concentration [mol/L]: 
0.118  
7.000 
2.19 · 10-05  
0.484 
0.711 
2.55 · 10-03 
 
 
Guest 
V (µL) 
Receptor 
V (µL) 
[Receptor] 
[mol/L] 
[Guest] 
[mol/L] 
[Guest]/ 
[Receptor]
F·I· 
(I320) 
- ∆Iobs - ∆Icalc 
0 700 2.19E-05 0.00E+00 0.00 342.695 0.000 0.000 
10 710 2.19E-05 3.59E-05 1.64 351.154 8.459 9.834 
20 720 2.19E-05 7.09E-05 3.24 359.956 17.261 17.635 
30 730 2.19E-05 1.05E-04 4.80 369.160 26.465 23.956 
40 740 2.19E-05 1.38E-04 6.31 372.464 29.769 29.172 
60 760 2.19E-05 2.02E-04 9.21 379.892 37.197 37.254 
80 780 2.19E-05 2.62E-04 11.97 385.463 42.768 43.213 
100 800 2.19E-05 3.19E-04 14.59 387.707 45.012 47.780 
140 840 2.19E-05 4.25E-04 19.45 398.203 55.508 54.306 
180 880 2.19E-05 5.22E-04 23.87 401.469 58.774 58.740 
240 940 2.19E-05 6.52E-04 29.80 406.335 63.640 63.235 
300 1000 2.19E-05 7.66E-04 35.01 409.009 66.314 66.264 
 
 
[AcArgOMe]/[161]
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Ka [M-1] = 3620 ± 7 % 
Kd [µM] = 276 ± 7 % 
ΔImax = - 91 
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5.4.3 Fluorescence titration of the unsymmetrical tweezers 
5.4.3.1 Fluorescence titration of the acetoxy phosphate tweezer 193 
 
Fluorescence titration of the tweezer 193 with AcLysOMe in phosphate buffer (10mM, pH 
7.6) 
 
λexc  = 285 nm 
λem  = 336 nm 
Receptor 
193 
Guest 
AcLysOMe · HCl 
Amount [mg]: 
Volume [mL]:  
Concentration [mol/L]: 
0.133  
8.858  
2.18 · 10-05  
0.351  
1.0 
1.47 · 10-03 
 
 
Guest 
V (µL) 
Receptor 
V (µL) 
[Receptor] 
[mol/L] 
[Guest] 
[mol/L] 
[Guest]/ 
[Receptor]
F·I· 
(I336 nm) 
∆Iobs ∆Icalc 
0 700 2.180E-05 0.000E+00 0.00 590.348 0.000 0.000 
5 705 2.180E-05 1.043E-05 0.48 549.331 41.017 33.753 
10 710 2.180E-05 2.071E-05 0.95 523.016 67.332 59.898 
20 720 2.180E-05 4.085E-05 1.87 495.942 94.406 95.925 
40 740 2.180E-05 7.948E-05 3.65 459.793 130.555 133.326 
60 760 2.180E-05 1.161E-04 5.32 442.974 147.374 151.413 
80 780 2.180E-05 1.508E-04 6.92 431.023 159.325 161.809 
100 800 2.180E-05 1.838E-04 8.43 424.652 165.696 168.502 
140 840 2.180E-05 2.451E-04 11.24 416.324 174.024 176.568 
180 880 2.180E-05 3.008E-04 13.80 404.437 185.911 181.239 
240 940 2.180E-05 3.754E-04 17.22 399.988 190.360 185.434 
 
 
 
 
[AcLysOMe]/[193]
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Ka [M-1] = 29200 ± 10 % 
Kd [µM] = 34 ± 10 % 
ΔImax = 203  
 
 
 
 
 
176 
Fluorescence titration of the tweezer 193 with Ac-Arg-OMe in phosphate buffer (10mM, pH 
7.6) 
 
 
λexc  = 285 nm 
λem  = 336 nm 
Receptor 
193 
Guest 
AcArgOMe · HCl 
Amount [mg]: 
Volume [mL]:  
Concentration [mol/L]: 
0.133  
8.858  
2.18 · 10-05  
0.375  
0.956 
1.471 · 10-03 
 
 
Guest 
V (µL) 
Receptor 
V (µL) 
[Receptor] 
[mol/L] 
[Guest] 
[mol/L] 
[Guest]/ 
[Receptor]
F·I· 
(I336 nm) 
∆Iobs ∆Icalc 
0 700 2.180E-05 0.000E+00 0.00 599.607 0.000 0.000 
5 705 2.180E-05 1.043E-05 0.48 566.185 33.422 26.951 
10 710 2.180E-05 2.072E-05 0.95 544.781 54.826 48.343 
20 720 2.180E-05 4.086E-05 1.87 518.092 81.515 79.093 
30 730 2.180E-05 6.044E-05 2.77 501.274 98.333 99.400 
40 740 2.180E-05 7.950E-05 3.65 486.036 113.571 113.471 
60 760 2.180E-05 1.161E-04 5.33 475.263 124.344 131.341 
80 780 2.180E-05 1.509E-04 6.92 463.666 135.941 142.051 
100 800 2.180E-05 1.838E-04 8.43 454.836 144.771 149.129 
140 840 2.180E-05 2.451E-04 11.24 438.828 160.779 157.856 
180 880 2.180E-05 3.008E-04 13.80 428.066 171.541 163.010 
 
 
[AcArgOMe]/[193]
0 2 4 6 8 10 12 14 16
ΔΙ
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Ka [M-1] = 22840 ± 13 % 
Kd [µM] = 44 ± 13 % 
ΔImax = 188  
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Fluorescence titration of the tweezer 193 with KAA in phosphate buffer (10mM. pH 7.6) 
 
 
λexc  = 285 nm 
λem  = 336 nm 
Receptor 
193 
Guest 
KAA 
Amount [mg]: 
Volume [mL]:  
Concentration [mol/L]: 
0.143 
9.523 
2.18 · 10-05  
0.232 
1.073 
7.50 · 10-04 
 
 
Guest 
V (µL) 
Receptor 
V (µL) 
[Receptor] 
[mol/L] 
[Guest] 
[mol/L] 
[Guest]/ 
[Receptor] 
F·I· 
(I334 nm) 
∆Iobs ∆Icalc 
0 700 2.18E-05 0.00E+00 0.00 624.893 0.000 0.000 
10 710 2.18E-05 1.06E-05 0.48 605.406 19.487 20.312 
20 720 2.18E-05 2.08E-05 0.96 585.662 39.231 37.536 
30 730 2.18E-05 3.08E-05 1.41 573.879 51.014 52.264 
40 740 2.18E-05 4.05E-05 1.86 557.438 67.455 64.962 
60 760 2.18E-05 5.92E-05 2.72 534.839 90.054 85.650 
80 780 2.18E-05 7.69E-05 3.53 523.887 101.006 101.704 
100 800 2.18E-05 9.37E-05 4.30 512.650 112.243 114.471 
140 840 2.18E-05 1.25E-04 5.73 495.772 129.121 133.409 
180 880 2.18E-05 1.53E-04 7.04 478.560 146.333 146.721 
240 940 2.18E-05 1.91E-04 8.78 466.308 158.585 160.571 
300 1000 2.18E-05 2.25E-04 10.32 450.371 174.522 170.093 
                                        
      
0 2 4 6 8 10 12
ΔΙ
0
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40
60
80
100
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[KAA]/[193]   
   
 Ka [M-1] = 10000 ± 7 % 
 Kd [µM] = 100 ± 7 % 
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Fluorescence titration of the tweezer 193 with KLVFF in phosphate buffer (10mM. pH 7.6) 
 
 
λexc  = 285 nm 
λem  = 336 nm 
Receptor 
193 
Guest 
KLVFF 
Amount [mg]: 
Volume [mL]:  
Concentration [mol/L]: 
0.143 
9.523 
2.18 · 10-05  
0.328 
0.669 
7.51 · 10-04 
 
 
Guest 
V (µL) 
Receptor 
V (µL) 
[Receptor] 
[mol/L] 
[Guest] 
[mol/L] 
[Guest]/ 
[Receptor] 
F·I· 
(I334 nm) 
∆Iobs ∆Icalc 
0 700 2.18E-05 0.00E+00 0.00 601.226 0.000 0.000 
10 710 2.18E-05 1.06E-05 0.49 577.714 23.512 26.907 
20 720 2.18E-05 2.09E-05 0.96 550.459 50.767 47.965 
30 730 2.18E-05 3.09E-05 1.42 541.506 59.720 64.568 
40 740 2.18E-05 4.06E-05 1.86 523.536 77.690 77.811 
60 760 2.18E-05 5.93E-05 2.72 500.276 100.950 97.294 
80 780 2.18E-05 7.70E-05 3.53 489.437 111.789 110.716 
100 800 2.18E-05 9.39E-05 4.31 482.214 119.012 120.413 
140 840 2.18E-05 1.25E-04 5.74 463.563 137.663 133.358 
180 880 2.18E-05 1.54E-04 7.05 463.559 137.667 141.538 
240 940 2.18E-05 1.92E-04 8.80 454.119 147.107 149.336 
300 1000 2.18E-05 2.25E-04 10.33 445.093 156.133 154.318 
 
0 2 4 6 8 10 12
ΔΙ
0
20
40
60
80
100
120
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[KLVFF]/[193]   
  
 Ka [M-1] = 22500 ± 8 % 
 Kd [µM] = 44 ± 8 % 
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Fluorescence titration of the tweezer 193 with IAPP1-7 in phosphate buffer (10mM. pH 7.6) 
 
 
λexc  = 285 nm 
λem  = 336 nm 
Receptor 
193 
Guest 
IAPP1-7 
Amount [mg]: 
Volume [mL]:  
Concentration [mol/L]: 
0.099 
6.593 
2.18 · 10-05  
0.310 
0.560 
7.51 · 10-04 
 
 
Guest 
V (µL) 
Receptor 
V (µL) 
[Receptor] 
[mol/L] 
[Guest] 
[mol/L] 
[Guest]/ 
[Receptor] 
F·I· 
(I334 nm) 
∆Iobs ∆Icalc 
0 700 2.18E-05 0.00E+00 0.00 633.538 0.000 0.000 
10 710 2.18E-05 1.06E-05 0.49 592.929 40.609 33.451 
20 720 2.18E-05 2.09E-05 0.96 569.126 64.412 59.450 
30 730 2.18E-05 3.09E-05 1.42 552.716 80.822 79.789 
40 740 2.18E-05 4.06E-05 1.86 535.244 98.294 95.887 
60 760 2.18E-05 5.93E-05 2.72 517.558 115.980 119.329 
80 780 2.18E-05 7.70E-05 3.53 496.209 137.329 135.292 
100 800 2.18E-05 9.38E-05 4.30 492.579 140.959 146.722 
140 840 2.18E-05 1.25E-04 5.74 476.164 157.374 161.842 
180 880 2.18E-05 1.54E-04 7.04 469.739 163.799 171.312 
240 940 2.18E-05 1.92E-04 8.79 453.468 180.070 180.279 
300 1000 2.18E-05 2.25E-04 10.33 435.893 197.645 185.978 
 
0 2 4 6 8 10 12
ΔΙ
0
50
100
150
200
250
[IAPP1-7]/[193]  
  
 
 Ka [M-1] = 24100 ± 12 % 
 Kd [µM] = 41 ± 12 % 
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Fluorescence titration of the tweezer 193 with IAPP2-14 in phosphate buffer (10mM. pH 7.6) 
 
 
λexc  = 285 nm 
λem  = 336 nm 
Receptor 
193 
Guest 
IAPP2-14 
Amount [mg]: 
Volume [mL]:  
Concentration [mol/L]: 
0.199 
13.252 
2.18 · 10-05  
0.758 
0.741 
7.50 · 10-04 
 
 
Guest 
V (µL) 
Receptor 
V (µL) 
[Receptor] 
[mol/L] 
[Guest] 
[mol/L] 
[Guest]/ 
[Receptor] 
F·I· 
(I334 nm) 
∆Iobs ∆Icalc 
0 700 2.18E-05 0.00E+00 0.00 452.757 0.000 0.000 
10 710 2.18E-05 1.06E-05 0.48 437.479 15.278 16.095 
20 720 2.18E-05 2.08E-05 0.96 425.005 27.752 29.491 
30 730 2.18E-05 3.08E-05 1.41 406.789 45.968 40.742 
40 740 2.18E-05 4.05E-05 1.86 394.084 58.673 50.280 
60 760 2.18E-05 5.92E-05 2.72 384.079 68.678 65.480 
80 780 2.18E-05 7.69E-05 3.53 380.939 71.818 76.970 
100 800 2.18E-05 9.38E-05 4.30 370.615 82.142 85.912 
140 840 2.18E-05 1.25E-04 5.73 357.585 95.172 98.849 
180 880 2.18E-05 1.53E-04 7.04 352.933 99.824 107.709 
240 940 2.18E-05 1.92E-04 8.79 333.641 119.116 116.724 
300 1000 2.18E-05 2.25E-04 10.32 322.837 129.920 122.802 
 
0 2 4 6 8 10 12
ΔΙ
0
20
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60
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[IAPP2-14]/[193]  
  
 Ka [M-1] = 12200 ± 17 % 
 Kd [µM] = 82 ± 17 % 
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5.4.3.2 Fluorescence titrations of the ethoxycarboxymethyl phosphate tweezer 196 
 
Fluorescence titration of the tweezer 196 with AcLysOMe . HCl in phosphate buffer (10mM, 
pH 7.6) 
 
 
λexc  = 285 nm 
Receptor 
196 
Guest 
AcLysOMe · HCl 
Amount [mg]: 
Volume [mL]:  
Concentration [mol/L]: 
0.170  
8.996  
2.579 · 10-05  
0.190  
1.742 
4.57 · 10-04  
 
 
Guest 
V (µL) 
Receptor 
V (µL) 
[Receptor] 
[mol/L] 
[Guest] 
[mol/L] 
[Guest]/ 
[Receptor]
F·I· 
(I343) 
∆Iobs ∆Icalc 
0 700 2.579E-05 0.000E+00 0.00 591.106 0.000 0.000 
10 710 2.579E-05 6.437E-06 0.25 570.014 21.092 24.011 
20 720 2.579E-05 1.269E-05 0.49 546.695 44.411 44.747 
30 730 2.579E-05 1.878E-05 0.73 529.350 61.756 62.678 
40 740 2.579E-05 2.470E-05 0.96 515.369 75.737 78.225 
50 750 2.579E-05 3.047E-05 1.18 496.607 94.499 91.753 
60 760 2.579E-05 3.608E-05 1.40 484.978 106.128 103.574 
70 770 2.579E-05 4.155E-05 1.61 477.336 113.770 113.953 
80 780 2.579E-05 4.687E-05 1.82 466.028 125.078 123.109 
100 800 2.579E-05 5.713E-05 2.22 454.219 136.887 138.455 
140 840 2.579E-05 7.617E-05 2.95 430.803 160.303 160.746 
180 880 2.579E-05 9.348E-05 3.62 417.400 173.706 175.973 
240 940 2.579E-05 1.167E-04 4.52 399.394 191.712 191.344 
300 1000 2.579E-05 1.371E-04 5.32 388.433 202.673 201.601 
  
  
[AcLysOMe]/[196]
0 1 2 3 4 5 6
ΔΙ
0
50
100
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200
250
Ka [M-1] = 22600 ± 4 % 
Kd [µM] = 44 ± 4 % 
ΔImax = 277 
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Fluorescence titration of the tweezer 196 with AcArgOMe . HCl in phosphate buffer 
(10mM, pH 7.6) 
 
 
λexc  = 284 nm 
Receptor 
196 
Guest 
AcArgOMe · HCl 
Amount [mg]: 
Volume [mL]:  
Concentration [mol/L]: 
0.170  
8.996  
2.579 · 10-05 
0.145  
1.189 
4.57 · 10-04 
 
 
Guest 
V (µL) 
Receptor 
V (µL) 
[Receptor] 
[mol/L] 
[Guest] 
[mol/L] 
[Guest]/ 
[Receptor]
F·I· 
(I343) 
∆Iobs ∆Icalc 
0 700 2.579E-05 0.000E+00 0.00 561.433 0.000 0.000 
10 710 2.579E-05 6.440E-06 0.25 549.806 11.627 11.898 
20 720 2.579E-05 1.270E-05 0.49 536.256 25.177 22.538 
30 730 2.579E-05 1.879E-05 0.73 529.390 32.043 32.087 
40 740 2.579E-05 2.472E-05 0.96 518.275 43.158 40.689 
50 750 2.579E-05 3.048E-05 1.18 512.216 49.217 48.466 
60 760 2.579E-05 3.610E-05 1.40 506.225 55.208 55.521 
80 780 2.579E-05 4.690E-05 1.82 495.273 66.160 67.806 
100 800 2.579E-05 5.716E-05 2.22 484.497 76.936 78.114 
140 840 2.579E-05 7.621E-05 2.96 469.835 91.598 94.370 
180 880 2.579E-05 9.353E-05 3.63 453.226 108.207 106.548 
240 940 2.579E-05 1.167E-04 4.53 440.114 121.319 119.927 
300 1000 2.579E-05 1.372E-04 5.32 432.272 129.161 129.569 
 
 
[AcArgOMe]/[196]
0 1 2 3 4 5 6
ΔΙ
0
20
40
60
80
100
120
140
Ka [M-1] = 10900 ± 7 % 
Kd [µM] = 92 ± 7 % 
ΔImax = 227 
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Fluorescence titration of the tweezer 196 with KLVFF in phosphate buffer (10mM. pH 7.6) 
 
 
λexc  = 285 nm 
λem  = 343 nm 
Receptor 
196 
Guest 
KLVFF 
Amount [mg]: 
Volume [mL]:  
Concentration [mol/L]: 
0.153 
9.578 
2.18 · 10-05  
0.330 
0.674 
7.50 · 10-04 
 
 
Guest 
V (µL) 
Receptor 
V (µL) 
[Receptor] 
[mol/L] 
[Guest] 
[mol/L] 
[Guest]/ 
[Receptor] 
F·I· 
(I334 nm) 
∆Iobs ∆Icalc 
0 700 2.18E-05 0.00E+00 0.00 635.542 0.000 0.000 
10 710 2.18E-05 1.06E-05 0.48 615.693 19.849 13.354 
20 720 2.18E-05 2.08E-05 0.96 608.846 26.696 24.810 
30 730 2.18E-05 3.08E-05 1.41 604.937 30.605 34.713 
40 740 2.18E-05 4.05E-05 1.86 589.550 45.992 43.339 
60 760 2.18E-05 5.92E-05 2.72 575.477 60.065 57.583 
80 780 2.18E-05 7.69E-05 3.53 565.820 69.722 68.815 
100 800 2.18E-05 9.37E-05 4.30 564.477 71.065 77.868 
140 840 2.18E-05 1.25E-04 5.73 543.174 92.368 91.507 
180 880 2.18E-05 1.53E-04 7.04 533.346 102.196 101.257 
240 940 2.18E-05 1.91E-04 8.78 527.565 107.977 111.549 
300 1000 2.18E-05 2.25E-04 10.32 513.093 122.449 118.717 
 
0 2 4 6 8 10 12
ΔΙ
0
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[KLVFF]/[196]   
  
 Ka [M-1] = 8790 ± 14 % 
 Kd [µM] = 114 ± 14 % 
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Fluorescence titration of the tweezer 196 with IAPP1-7 in phosphate buffer (10mM. pH 7.6) 
 
 
λexc  = 285 nm 
λem  = 343 nm 
Receptor 
196 
Guest 
IAPP1-7 
Amount [mg]: 
Volume [mL]:  
Concentration [mol/L]: 
0.153 
9.578 
2.18 · 10-05  
0.393 
0.710 
7.51 · 10-04 
 
 
Guest 
V (µL) 
Receptor 
V (µL) 
[Receptor] 
[mol/L] 
[Guest] 
[mol/L] 
[Guest]/ 
[Receptor] 
F·I· 
(I334 nm) 
∆Iobs ∆Icalc 
0 700 2.18E-05 0.00E+00 0.00 636.672 0.000 0.000 
10 710 2.18E-05 1.06E-05 0.49 608.513 28.159 24.008 
20 720 2.18E-05 2.09E-05 0.96 596.917 39.755 44.672 
30 730 2.18E-05 3.09E-05 1.42 573.907 62.765 62.593 
40 740 2.18E-05 4.06E-05 1.86 561.312 75.360 78.247 
60 760 2.18E-05 5.93E-05 2.72 526.643 110.029 104.200 
80 780 2.18E-05 7.70E-05 3.53 512.296 124.376 124.760 
100 800 2.18E-05 9.38E-05 4.30 494.406 142.266 141.397 
140 840 2.18E-05 1.25E-04 5.74 472.700 163.972 166.580 
180 880 2.18E-05 1.54E-04 7.04 451.611 185.061 184.670 
240 940 2.18E-05 1.92E-04 8.79 434.884 201.788 203.851 
300 1000 2.18E-05 2.25E-04 10.33 417.406 219.266 217.262 
 
  
0 2 4 6 8 10 12
ΔΙ
0
50
100
150
200
250
[IAPP1-7]/[196]   
     
 Ka [M-1] = 8440 ± 6 % 
 Kd [µM] = 118 ± 6 % 
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Fluorescence titration of the tweezer 196 with IAPP2-14 in phosphate buffer (10mM. pH 7.6) 
 
 
λexc  = 285 nm 
λem  = 343 nm 
Receptor 
196 
Guest 
IAPP2-14 
Amount [mg]: 
Volume [mL]:  
Concentration [mol/L]: 
0.134 
3.388 
2.18 · 10-05  
0.713 
0.697 
7.50 · 10-04 
 
 
Guest 
V (µL) 
Receptor 
V (µL) 
[Receptor] 
[mol/L] 
[Guest] 
[mol/L] 
[Guest]/ 
[Receptor] 
F·I· 
(I334 nm) 
∆Iobs ∆Icalc 
0 700 2,18E-05 0,00E+00 0,00 574,307 0,000 0,000 
10 710 2,18E-05 1,06E-05 0,48 531,805 42,502 19,721 
20 720 2,18E-05 2,08E-05 0,96 513,578 60,729 36,388 
30 730 2,18E-05 3,08E-05 1,41 514,928 59,379 50,594 
40 740 2,18E-05 4,06E-05 1,86 504,512 69,795 62,805 
60 760 2,18E-05 5,92E-05 2,72 499,696 74,611 82,622 
80 780 2,18E-05 7,69E-05 3,53 488,894 85,413 97,929 
100 800 2,18E-05 9,38E-05 4,30 473,532 100,775 110,054 
140 840 2,18E-05 1,25E-04 5,73 459,571 114,736 127,959 
180 880 2,18E-05 1,53E-04 7,04 433,034 141,273 140,486 
240 940 2,18E-05 1,92E-04 8,79 422,963 151,344 153,465 
300 1000 2,18E-05 2,25E-04 10,32 395,952 178,355 162,356 
 
[IAPP2-14]/[196]
0 2 4 6 8 10 12
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 Ka [M-1] = 10400 ± 36 % 
 Kd [µM] = 96 ± 36 % 
 
 
 
 
 
 
 
 
 
 
186 
5.4.3.3 Fluorescence titration of the glycerol phosphate tweezer 198 
 
Fluorescence titration of the tweezer 198 with Ac-Lys-OMe . HCl in phosphate buffer 
(10mM, pH 7.6) 
 
 
λexc  = 285 nm 
Receptor 
198 
Guest 
Ac-Lys-OMe · HCl 
Amount [mg]: 
Volume [mL]:  
Concentration [mol/L]: 
0.092  
4.628  
2.579 · 10-05  
0.80  
0.733 
4.572 · 10-04  
 
 
Guest 
V (µL) 
Receptor 
V (µL) 
[Receptor] 
[mol/L] 
[Guest] 
[mol/L] 
[Guest]/ 
[Receptor]
F·I· 
(I341) 
∆Iobs ∆Icalc 
0 700 2.579E-05 0.000E+00 0.00 629.793 0.000 0.000 
10 710 2.579E-05 6.440E-06 0.25 626.381 3.412 6.137 
20 720 2.579E-05 1.270E-05 0.49 615.687 14.106 11.926 
30 730 2.579E-05 1.879E-05 0.73 610.584 19.209 17.396 
40 740 2.579E-05 2.472E-05 0.96 603.899 25.894 22.571 
50 750 2.579E-05 3.048E-05 1.18 603.652 26.141 27.475 
60 760 2.579E-05 3.610E-05 1.40 595.550 34.243 32.128 
80 780 2.579E-05 4.690E-05 1.82 588.319 41.474 40.753 
100 800 2.579E-05 5.715E-05 2.22 585.336 44.457 48.574 
140 840 2.579E-05 7.620E-05 2.95 569.057 60.736 62.215 
180 880 2.579E-05 9.352E-05 3.63 554.742 75.051 73.705 
240 940 2.579E-05 1.167E-04 4.53 543.420 86.373 87.897 
300 1000 2.579E-05 1.372E-04 5.32 528.916 100.877 99.365 
  
  
[AcLysOMe]/[198]
0 1 2 3 4 5 6
ΔΙ
0
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60
80
100
120
Ka [M-1] = 2760 ± 23 % 
Kd [µM] = 362 ± 23 % 
ΔImax = 375 
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Fluorescence titration of the tweezer 198 with Ac-Arg-OMe . HCl in phosphate buffer 
(10mM, pH 7.6) 
 
 
λexc  = 285 nm 
Receptor 
198 
Guest 
Ac-Arg-OMe · HCl 
Amount [mg]: 
Volume [mL]:  
Concentration [mol/L]: 
0.092  
4.628  
2.579 · 10-05  
0.70  
0.574 
4.573 · 10-04  
 
 
Guest 
V (µL) 
Receptor 
V (µL) 
[Receptor] 
[mol/L] 
[Guest] 
[mol/L] 
[Guest]/ 
[Receptor]
F·I· 
(I341) 
∆Iobs ∆Icalc 
0 700 2.579E-05 0.000E+00 0.00 571.170 0.000 0.000 
10 710 2.579E-05 6.440E-06 0.25 567.731 3.439 4.317 
20 720 2.579E-05 1.270E-05 0.49 560.881 10.289 8.436 
30 730 2.579E-05 1.879E-05 0.73 554.084 17.086 12.370 
40 740 2.579E-05 2.472E-05 0.96 555.087 16.083 16.132 
50 750 2.579E-05 3.048E-05 1.18 550.623 20.547 19.732 
60 760 2.579E-05 3.610E-05 1.40 545.689 25.481 23.181 
80 780 2.579E-05 4.690E-05 1.82 545.687 25.483 29.661 
100 800 2.579E-05 5.716E-05 2.22 537.385 33.785 35.638 
140 840 2.579E-05 7.621E-05 2.95 525.274 45.896 46.299 
180 880 2.579E-05 9.353E-05 3.63 514.754 56.416 55.525 
240 940 2.579E-05 1.167E-04 4.53 504.183 66.987 67.248 
300 1000 2.579E-05 1.372E-04 5.32 493.678 77.492 76.999 
  
  
[AcArgOMe]/[198]
0 1 2 3 4 5 6
ΔΙ
0
20
40
60
80
100
Ka [M-] = 1620 ± 42 % 
Kd [µM] = 617 ± 42 % 
ΔImax = 437 
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5.5 Isothermal titration calorimetry (ITC) studies of the tweezers 133 and 
161 complexes  
5.5.1 ITC experiments of the phosphate tweezer 133 complexes  
 
ITC titration of the tweezer 133 (0.1 mM) with AcLysOMe (1.0 mM) in phosphate buffer (10 
mM, pH 7.6) 
 
Nr. Ka [M-1] n H[kcal/mol] -T S[kcal/mol] G[kcal/mol] 
1 69300 ± 3700 0.679 ± 0.009 -5.552 ± 0.101 -1.05 -6.60 
2 67900 ± 3200 0.648 ± 0.008 -5.609 ± 0.095 -0.99 -6.60 
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ITC titration of the tweezer 133 (0.1 mM) with AcArgOMe (1.0 mM) in phosphate buffer (10 
mM, pH 7.6) 
 
Nr. Ka [M-1] n H[kcal/mol] -T S[kcal/mol] G[kcal/mol] 
1 31700 ± 1100 0.625 ± 0.010 -6.805 ± 0.145 0.67 -6.14 
2 27500 ± 1700 0.613 ± 0.020 -7.249 ± 0.305 1.19 -6.06 
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ITC titration of the tweezer 133 (0.1 mM) with KLVFF (0.65 mM) in phosphate buffer (10 mM, 
pH 7.6) 
 
Nr. Ka [M-1] n H[kcal/mol] -T S[kcal/mol] G[kcal/mol] 
1 65800 ± 2600 1.02 ± 0.005 -6.293 ± 0.055 -0.28 -6.57 
2 65300 ± 3300 0.983 ± 0.007 -6.466 ± 0.084 -0.10 -6.57 
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ITC titration of the tweezer 133 (0.1 mM) with IAPP1-7 (0.65 mM) in phosphate buffer (10 mM, 
pH 7.6) 
 
Nr. Ka [M-1] n H[kcal/mol] -T S[kcal/mol] G[kcal/mol] 
1 168000 ± 5300 1.21 ± 0.003 -6.442 ± 0.024 -0.69 -7.13 
2 151000 ± 5300 1.16 ± 0.004 -6.366 ± 0.03 -0.70 -7.07 
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ITC titration of the tweezer 133 (0.1 mM) with IAPP2-14 (0.65 mM) in phosphate buffer (10 mM, 
pH 7.6) 
 
Nr. Ka [M-1] n H[kcal/mol] -T S[kcal/mol] G[kcal/mol] 
1 6360 ± 1630 1.00 ± 0.18 -5.378 ± 1.63 0.19 -5.19 
2 6980 ± 2600 1.42 ± 0.11 -4.756 ± 1.08 -0.49 -5.25 
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ITC titration of the tweezer 133 (0.1 mM) with AcLysOMe (1.0 mM) in methanol 
 
Nr. Ka [M-1] n H[kcal/mol] -T S[kcal/mol] G[kcal/mol] 
1 7510 ± 900 1.49 ± 0.064 7.985 ± 0.643 -13.28 -5.30 
2 5820 ± 1000 1.25 ± 0.13 10.150 ± 1.64 -15.31 -5.16 
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5.5.2 ITC experiments of the sulfate tweezer 161 complexes 
  
ITC titration of the tweezer 161 (0.1 mM) with AcLysOMe (1.0 mM) in phosphate buffer (10 
mM, pH 7.6) 
 
Nr. Ka [M-1] n H[kcal/mol] -T S[kcal/mol] G[kcal/mol] 
1 36200 ± 1600 0.823 ± 0.011 -8.171 ± 0.159 1.96 -6.21 
2 33000 ± 1800 0.782 ± 0.015 -8.403 ± 0.226 2.24 -6.16 
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The ITC titration of the tweezer 161 (0.1 mM) with AcArgOMe (1.0 mM) in phosphate buffer (10 
mM, pH 7.6) 
 
Nr. Ka [M-1] n H[kcal/mol] -T S[kcal/mol] G[kcal/mol]
1. 11300 ± 1000 0.904 ± 0.048 -5.92 ± 0.045 0.387 -5.53 
2. 9490 ± 1100 0.816 ± 0.071 -6.75 ± 0.796 1.317 -5.43 
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5.6 Crystal structure 
5.6.1 Crystal structure of dimethoxy phosphate octyl tweezer 182 
 
The crystals of the tweezer 182 were obtained by dissolving 10 mg of the tweezer 182 in 3 ml 
methanol/n-pentane mixture (5:1) and allowing the solution to stand at room temperature for 3-5 
days. The crystal structure was solved on an X-ray diffractometer by Dr. Christöph Wolper at 
University of Duisburg-Essen.  
 
 
 
5.6.1.1 Crystal data and structure refinement for the tweezer 182 
 
Identification code sd_182p1 
Empirical formula C52 H51 O5 P * C H4 O 
Formula weight 818.94 Da 
Density (calculated) 1.261 g cm-3 
F(000) 1744 
Temperature  100(1) K 
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Crystal size 0.32 x 0.12 x 0.07 mm 
Crystal color colourless 
Crystal description needle 
Wavelength 0.71073 Å 
Crystal system monoclinic 
Space group P21/c 
Unit cell dimensions a  = 14.804(3) Å α  = 90° 
 b  = 18.391(3) Å β = 103.622(8)° 
 c  = 16.298(3) Å γ = 90° 
Volume 4312.7(12) Å3 
Z 4 
Cell measurement reflections used 9887 
Cell measurement theta min/max 2.39° to 27.08° 
Diffractometer control software Bruker AXS APEX 2 Vers.3.0/2009 
Diffractometer measurement device Bruker D8 KAPPA series II  with 
 APEX II area detector system  
Diffractometer measurement method Data collection strategy APEX 2/COSMO 
Theta range for data collection 1.80° to 27.11°  
Completeness to theta = 27.11° 99.3 %  
Index ranges -18<=h<=18, -23<=k<=23, -19<=l<=20 
Computing data reduction Bruker AXS APEX 2 Vers.3/2009 
Absorption coefficient 0.116 mm-1 
Absorption correction Semi-empirical from equivalents 
Empirical absorption correction Bruker AXS APEX 2 Vers.3/2009 
Max. / min. transmission 0.75 / 0.66  
R(merg) before/after correction 0.0777 / 0.0394 
Computing structure solution Bruker AXS SHELXTL Vers. 2008/4/(c) 2008 
Computing structure refinement Bruker AXS SHELXTL Vers. 2008/4/(c) 2008 
Refinement method Full-matrix least-squares on F2 
Reflections collected 78132 
Independent reflections 9461 [R(int) = 0.0375] 
Data / restraints / parameters 7636 / 0 / 549 
Goodness-of-fit on F2 1.033 
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Weighting details w = 1/[2 (Fo2)+ (0.0597*P)2+2.6078*P] 
 where P = (Fo2+2Fc2)/3  
Final R indices [I>2sigma(I)] R1 = 0.0414, wR2 = 0.1067 
R indices (all data) R1 = 0.0573, wR2 = 0.1187 
Largest diff. peak and hole 0.358 and -0.418 eÅ-3 
Treatment of hydrogen atoms Riding model on idealized geometries 
 with the 1.2 fold isotropic displacement 
 parameters of the equivalent Uij of the 
 corresponding carbon atom. 
 The methyl groups are idealized with 
 tetrahedral angles in a combined 
 rotating and rigid group refinement 
 with the 1.5 fold isotropic displacement 
 parameters of the equivalent Uij of the 
 corresponding carbon atom. 
 Hydrogen atom position H(60) taken from 
 a Fourier-map and also refined as riding 
  group with the 1.5 fold isotropic 
  displacement parameters of the 
 equivalent Uij of the corresponding 
 oxygen atom. 
Disorder Octoxy carbon atoms  C(50, 51)  
 disordered over two sites with SOF 0.9 
 and 0.1 together with the riding hydrogen atoms 
 Methyl  hydrogen atoms H(52A to H52C) disordered  
 over  two sites with SOF 0.9 and 0.1 
 
Table 5.1 Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2 x 103) for sd_182p1. 
U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
____________________________________________________________________________  
 x y z U(eq) 
____________________________________________________________________________  
P(1) 1802(1) 6862(1) 4694(1) 18(1) 
O(1) 706(1) 6958(1) 4567(1) 15(1) 
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O(2) 2165(1) 6154(1) 5026(1) 25(1) 
O(3) 1932(1) 7008(1) 3791(1) 27(1) 
O(4) 2239(1) 7531(1) 5241(1) 25(1) 
O(5) -809(1) 7302(1) 7396(1) 18(1) 
C(1) 334(1) 7061(1) 5281(1) 13(1) 
C(2) 26(1) 8464(1) 4988(1) 14(1) 
C(3) 1609(1) 9185(1) 5565(1) 15(1) 
C(4) 3070(1) 9914(1) 6481(1) 18(1) 
C(5) 4363(1) 8951(1) 7181(1) 22(1) 
C(6) 4711(1) 8555(1) 7923(1) 28(1) 
C(7) 4338(1) 8639(1) 8622(1) 30(1) 
C(8) 3608(1) 9122(1) 8612(1) 26(1) 
C(9) 2474(1) 10057(1) 7640(1) 21(1) 
C(10) 862(1) 9403(1) 7016(1) 16(1) 
C(11) -593(1) 8684(1) 6116(1) 15(1) 
C(12) -474(1) 7290(1) 6679(1) 13(1) 
C(13) -258(1) 5862(1) 6885(1) 13(1) 
C(14) 1191(1) 5454(1) 8104(1) 14(1) 
C(15) 2821(1) 4988(1) 9036(1) 17(1) 
C(16) 3792(1) 6141(1) 9736(1) 22(1) 
C(17) 4482(1) 6630(1) 9644(1) 32(1) 
C(18) 4916(1) 6562(1) 8980(1) 35(1) 
C(19) 4668(1) 6007(1) 8382(1) 29(1) 
C(20) 3534(1) 4880(1) 7944(1) 20(1) 
C(21) 2080(1) 5282(1) 6730(1) 16(1) 
C(22) 432(1) 5677(1) 5788(1) 14(1) 
C(23) 10(1) 7737(1) 5443(1) 13(1) 
C(24) 732(1) 8932(1) 5597(1) 14(1) 
C(25) 2095(1) 9572(1) 6264(1) 16(1) 
C(26) 3644(1) 9431(1) 7171(1) 18(1) 
C(27) 3273(1) 9517(1) 7884(1) 20(1) 
C(28) 1730(1) 9667(1) 6980(1) 17(1) 
C(29) 360(1) 9051(1) 6300(1) 14(1) 
C(30) -388(1) 7862(1) 6139(1) 13(1) 
C(31) -187(1) 6606(1) 6476(1) 13(1) 
C(32) 733(1) 5609(1) 7275(1) 13(1) 
C(33) 2099(1) 5200(1) 8231(1) 15(1) 
C(34) 3556(1) 5588(1) 9156(1) 18(1) 
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C(35) 3994(1) 5519(1) 8480(1) 21(1) 
C(36) 2537(1) 5126(1) 7560(1) 16(1) 
C(37) 1164(1) 5510(1) 6600(1) 14(1) 
C(38) 221(1) 6488(1) 5799(1) 13(1) 
C(39) 2876(1) 10556(1) 7042(1) 23(1) 
C(40) -884(1) 8798(1) 5143(1) 16(1) 
C(41) -446(1) 5392(1) 6066(1) 16(1) 
C(42) 3350(1) 4387(1) 8666(1) 21(1) 
C(43) 1692(1) 7698(1) 3359(1) 33(1) 
C(44) 2650(2) 7474(1) 6141(1) 38(1) 
C(45) -1250(1) 7936(1) 7628(1) 17(1) 
C(46) -1600(1) 7726(1) 8397(1) 17(1) 
C(47) -2091(1) 8342(1) 8745(1) 21(1) 
C(48) -2390(1) 8113(1) 9540(1) 22(1) 
C(49) -2936(1) 8695(1) 9890(1) 22(1) 
C(50) -3093(1) 8514(1) 10756(1) 24(1) 
C(51) -3640(2) 7821(1) 10769(1) 31(1) 
C(50A) -3654(11) 8327(9) 10444(10) 18(3) 
C(51A) -3105(13) 7951(10) 11216(12) 27(4) 
C(52) -3924(1) 7688(1) 11608(1) 33(1) 
O(60) 4072(1) 8872(1) 949(1) 64(1) 
C(61) 4488(2) 9548(1) 920(1) 43(1) 
____________________________________________________________________________  
Table 5.2 Bond lengths [Å] and angles [°] for sd_182p1. 
_____________________________________________________  
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P(1)-O(2) 1.4626(12) 
P(1)-O(3) 1.5528(12) 
P(1)-O(4) 1.5662(12) 
P(1)-O(1) 1.5961(11) 
O(1)-C(1) 1.4118(17) 
O(3)-C(43) 1.453(2) 
O(4)-C(44) 1.453(2) 
O(5)-C(12) 1.3737(17) 
O(5)-C(45) 1.4291(17) 
C(1)-C(23) 1.380(2) 
C(1)-C(38) 1.385(2) 
C(2)-C(24) 1.527(2) 
C(2)-C(23) 1.5322(19) 
C(2)-C(40) 1.555(2) 
C(3)-C(25) 1.392(2) 
C(3)-C(24) 1.392(2) 
C(4)-C(26) 1.526(2) 
C(4)-C(25) 1.537(2) 
C(4)-C(39) 1.560(2) 
C(5)-C(26) 1.380(2) 
C(5)-C(6) 1.402(2) 
C(6)-C(7) 1.387(3) 
C(7)-C(8) 1.396(3) 
C(8)-C(27) 1.381(2) 
C(9)-C(27) 1.523(2) 
C(9)-C(28) 1.525(2) 
C(9)-C(39) 1.554(2) 
C(10)-C(29) 1.387(2) 
C(10)-C(28) 1.389(2) 
C(11)-C(29) 1.529(2) 
C(11)-C(30) 1.5413(19) 
C(11)-C(40) 1.556(2) 
C(12)-C(31) 1.393(2) 
C(12)-C(30) 1.396(2) 
C(13)-C(32) 1.5279(19) 
C(13)-C(31) 1.5351(19) 
C(13)-C(41) 1.5605(19) 
C(14)-C(32) 1.391(2) 
C(14)-C(33) 1.391(2) 
C(15)-C(34) 1.530(2) 
C(15)-C(33) 1.535(2) 
C(15)-C(42) 1.557(2) 
C(16)-C(34) 1.376(2) 
C(16)-C(17) 1.397(2) 
C(17)-C(18) 1.386(3) 
C(18)-C(19) 1.401(3) 
C(19)-C(35) 1.380(2) 
C(20)-C(35) 1.525(2) 
C(20)-C(36) 1.529(2) 
C(20)-C(42) 1.560(2) 
C(21)-C(37) 1.388(2) 
C(21)-C(36) 1.391(2) 
C(22)-C(38) 1.5239(19) 
C(22)-C(37) 1.531(2) 
C(22)-C(41) 1.563(2) 
C(23)-C(30) 1.414(2) 
C(24)-C(29) 1.401(2) 
C(25)-C(28) 1.406(2) 
C(26)-C(27) 1.407(2) 
C(31)-C(38) 1.395(2) 
C(32)-C(37) 1.407(2) 
C(33)-C(36) 1.403(2) 
C(34)-C(35) 1.410(2) 
C(45)-C(46) 1.514(2) 
C(46)-C(47) 1.526(2) 
C(47)-C(48) 1.524(2) 
C(48)-C(49) 1.531(2) 
C(49)-C(50) 1.520(2) 
C(49)-C(50A) 1.690(16) 
C(50)-C(51) 1.513(3) 
C(51)-C(52) 1.543(3) 
C(50A)-C(51A) 1.50(2) 
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C(51A)-C(52) 1.573(18) 
O(60)-C(61) 1.393(3) 
 
O(2)-P(1)-O(3) 112.79(7) 
O(2)-P(1)-O(4) 114.98(7) 
O(3)-P(1)-O(4) 106.03(7) 
O(2)-P(1)-O(1) 114.82(6) 
O(3)-P(1)-O(1) 101.95(6) 
O(4)-P(1)-O(1) 105.01(6) 
C(1)-O(1)-P(1) 119.31(9) 
C(43)-O(3)-P(1) 122.64(11) 
C(44)-O(4)-P(1) 122.38(11) 
C(12)-O(5)-C(45) 121.20(11) 
C(23)-C(1)-C(38) 118.13(13) 
C(23)-C(1)-O(1) 119.95(12) 
C(38)-C(1)-O(1) 121.77(12) 
C(24)-C(2)-C(23) 105.27(11) 
C(24)-C(2)-C(40) 99.03(11) 
C(23)-C(2)-C(40) 98.81(11) 
C(25)-C(3)-C(24) 116.60(13) 
C(26)-C(4)-C(25) 105.11(12) 
C(26)-C(4)-C(39) 98.97(12) 
C(25)-C(4)-C(39) 98.69(12) 
C(26)-C(5)-C(6) 117.96(15) 
C(7)-C(6)-C(5) 120.89(16) 
C(6)-C(7)-C(8) 121.27(16) 
C(27)-C(8)-C(7) 117.71(16) 
C(27)-C(9)-C(28) 105.32(12) 
C(27)-C(9)-C(39) 99.24(12) 
C(28)-C(9)-C(39) 98.87(12) 
C(29)-C(10)-C(28) 116.47(14) 
C(29)-C(11)-C(30) 105.11(11) 
C(29)-C(11)-C(40) 99.28(11) 
C(30)-C(11)-C(40) 99.35(11) 
O(5)-C(12)-C(31) 114.11(12) 
O(5)-C(12)-C(30) 128.99(13) 
C(31)-C(12)-C(30) 116.90(13) 
C(32)-C(13)-C(31) 107.15(11) 
C(32)-C(13)-C(41) 98.40(11) 
C(31)-C(13)-C(41) 97.98(11) 
C(32)-C(14)-C(33) 116.52(13) 
C(34)-C(15)-C(33) 104.93(12) 
C(34)-C(15)-C(42) 98.84(12) 
C(33)-C(15)-C(42) 99.33(12) 
C(34)-C(16)-C(17) 118.41(16) 
C(18)-C(17)-C(16) 120.74(16) 
C(17)-C(18)-C(19) 121.02(16) 
C(35)-C(19)-C(18) 118.13(16) 
C(35)-C(20)-C(36) 105.39(12) 
C(35)-C(20)-C(42) 98.61(12) 
C(36)-C(20)-C(42) 99.12(12) 
C(37)-C(21)-C(36) 116.40(13) 
C(38)-C(22)-C(37) 106.99(11) 
C(38)-C(22)-C(41) 97.98(11) 
C(37)-C(22)-C(41) 98.60(11) 
C(1)-C(23)-C(30) 121.96(13) 
C(1)-C(23)-C(2) 130.34(13) 
C(30)-C(23)-C(2) 107.66(12) 
C(3)-C(24)-C(29) 121.89(13) 
C(3)-C(24)-C(2) 131.76(13) 
C(29)-C(24)-C(2) 106.24(12) 
C(3)-C(25)-C(28) 121.13(13) 
C(3)-C(25)-C(4) 132.35(14) 
C(28)-C(25)-C(4) 106.37(12) 
C(5)-C(26)-C(27) 120.87(15) 
C(5)-C(26)-C(4) 132.50(14) 
C(27)-C(26)-C(4) 106.55(13) 
C(8)-C(27)-C(26) 121.29(15) 
C(8)-C(27)-C(9) 131.88(15) 
C(26)-C(27)-C(9) 106.75(13) 
C(10)-C(28)-C(25) 122.12(13) 
C(10)-C(28)-C(9) 131.03(14) 
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C(25)-C(28)-C(9) 106.79(13) 
C(10)-C(29)-C(24) 121.66(13) 
C(10)-C(29)-C(11) 131.15(13) 
C(24)-C(29)-C(11) 107.04(12) 
C(12)-C(30)-C(23) 120.02(13) 
C(12)-C(30)-C(11) 134.99(13) 
C(23)-C(30)-C(11) 104.93(12) 
C(12)-C(31)-C(38) 122.79(13) 
C(12)-C(31)-C(13) 130.21(13) 
C(38)-C(31)-C(13) 106.99(12) 
C(14)-C(32)-C(37) 121.71(13) 
C(14)-C(32)-C(13) 131.84(13) 
C(37)-C(32)-C(13) 106.39(12) 
C(14)-C(33)-C(36) 121.57(13) 
C(14)-C(33)-C(15) 131.77(13) 
C(36)-C(33)-C(15) 106.60(12) 
C(16)-C(34)-C(35) 120.98(15) 
C(16)-C(34)-C(15) 132.75(15) 
C(35)-C(34)-C(15) 106.19(13) 
C(19)-C(35)-C(34) 120.70(15) 
C(19)-C(35)-C(20) 132.25(15) 
C(34)-C(35)-C(20) 106.96(13) 
C(21)-C(36)-C(33) 121.96(13) 
C(21)-C(36)-C(20) 131.30(14) 
C(33)-C(36)-C(20) 106.71(12) 
C(21)-C(37)-C(32) 121.74(13) 
C(21)-C(37)-C(22) 131.31(13) 
C(32)-C(37)-C(22) 106.92(12) 
C(1)-C(38)-C(31) 120.07(13) 
C(1)-C(38)-C(22) 133.11(13) 
C(31)-C(38)-C(22) 106.79(12) 
C(9)-C(39)-C(4) 94.15(12) 
C(2)-C(40)-C(11) 94.06(11) 
C(13)-C(41)-C(22) 93.95(11) 
C(15)-C(42)-C(20) 94.10(11) 
O(5)-C(45)-C(46) 106.11(12) 
C(45)-C(46)-C(47) 113.76(12) 
C(48)-C(47)-C(46) 111.63(13) 
C(47)-C(48)-C(49) 114.10(13) 
C(50)-C(49)-C(48) 113.76(14) 
C(48)-C(49)-C(50A) 111.9(5) 
C(51)-C(50)-C(49) 113.34(15) 
C(50)-C(51)-C(52) 113.78(16) 
C(51A)-C(50A)-C(49) 110.4(12) 
C(50A)-C(51A)-C(52) 99.6(12) 
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Table 5.3 Anisotropic displacement parameters (Å2x 103) for sd_182p1. The anisotropic 
displacement factor exponent takes the form:  -22 [ h2 a*2 U11 + ...  + 2 h k a* b* U12 ] 
___________________________________________________________________________ 
 U11 U22  U33 U23 U13 U12 
___________________________________________________________________________ 
P(1) 20(1) 20(1) 16(1) 4(1) 8(1) 4(1) 
O(1) 19(1) 18(1) 10(1) 0(1) 5(1) 1(1) 
O(2) 28(1) 25(1) 25(1) 6(1) 13(1) 9(1) 
O(3) 34(1) 30(1) 22(1) 8(1) 18(1) 10(1) 
O(4) 23(1) 26(1) 25(1) 3(1) 4(1) -3(1) 
O(5) 23(1) 17(1) 15(1) 0(1) 10(1) 4(1) 
C(1) 13(1) 16(1) 9(1) -1(1) 3(1) -1(1) 
C(2) 16(1) 12(1) 13(1) 1(1) 2(1) 0(1) 
C(3) 19(1) 13(1) 13(1) 2(1) 4(1) 0(1) 
C(4) 18(1) 19(1) 17(1) -2(1) 4(1) -5(1) 
C(5) 17(1) 29(1) 19(1) -2(1) 3(1) -4(1) 
C(6) 19(1) 36(1) 28(1) 3(1) 2(1) 3(1) 
C(7) 25(1) 42(1) 20(1) 9(1) -1(1) -3(1) 
C(8) 22(1) 38(1) 16(1) -2(1) 4(1) -9(1) 
C(9) 20(1) 24(1) 20(1) -9(1) 5(1) -5(1) 
C(10) 19(1) 14(1) 17(1) -3(1) 6(1) 2(1) 
C(11) 16(1) 13(1) 16(1) 0(1) 4(1) 1(1) 
C(12) 12(1) 16(1) 11(1) -1(1) 2(1) 0(1) 
C(13) 16(1) 12(1) 12(1) 0(1) 4(1) 0(1) 
C(14) 17(1) 12(1) 14(1) -1(1) 5(1) -2(1) 
C(15) 18(1) 17(1) 15(1) 1(1) 3(1) 2(1) 
C(16) 21(1) 26(1) 18(1) 0(1) 1(1) -1(1) 
C(17) 31(1) 33(1) 28(1) -5(1) 0(1) -10(1) 
C(18) 27(1) 41(1) 36(1) 1(1) 5(1) -15(1) 
C(19) 20(1) 40(1) 26(1) 3(1) 7(1) -3(1) 
C(20) 19(1) 22(1) 18(1) 0(1) 5(1) 6(1) 
C(21) 21(1) 12(1) 15(1) -2(1) 7(1) 1(1) 
C(22) 18(1) 12(1) 12(1) -1(1) 4(1) 0(1) 
C(23) 13(1) 14(1) 12(1) 0(1) 1(1) -1(1) 
C(24) 18(1) 11(1) 14(1) 0(1) 2(1) 1(1) 
C(25) 16(1) 15(1) 17(1) 1(1) 3(1) -1(1) 
C(26) 16(1) 22(1) 16(1) -3(1) 3(1) -7(1) 
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C(27) 16(1) 26(1) 16(1) -5(1) 3(1) -8(1) 
C(28) 18(1) 15(1) 17(1) -4(1) 3(1) 0(1) 
C(29) 16(1) 11(1) 17(1) 1(1) 4(1) 2(1) 
C(30) 11(1) 14(1) 13(1) -2(1) 1(1) 0(1) 
C(31) 12(1) 15(1) 11(1) 1(1) 1(1) -1(1) 
C(32) 16(1) 9(1) 15(1) -1(1) 5(1) 0(1) 
C(33) 19(1) 12(1) 13(1) 0(1) 2(1) -1(1) 
C(34) 16(1) 20(1) 17(1) 3(1) 0(1) 3(1) 
C(35) 16(1) 26(1) 20(1) 2(1) 2(1) 4(1) 
C(36) 18(1) 13(1) 17(1) -2(1) 5(1) 2(1) 
C(37) 20(1) 9(1) 13(1) -1(1) 4(1) -1(1) 
C(38) 13(1) 13(1) 12(1) -2(1) 2(1) 0(1) 
C(39) 23(1) 20(1) 26(1) -5(1) 4(1) -6(1) 
C(40) 16(1) 15(1) 17(1) 2(1) 2(1) 2(1) 
C(41) 19(1) 14(1) 14(1) -1(1) 3(1) -2(1) 
C(42) 24(1) 18(1) 20(1) 1(1) 3(1) 5(1) 
C(43) 37(1) 37(1) 26(1) 16(1) 12(1) 6(1) 
C(44) 45(1) 36(1) 27(1) -2(1) -8(1) -1(1) 
C(45) 20(1) 16(1) 18(1) 0(1) 7(1) 5(1) 
C(46) 20(1) 18(1) 14(1) 1(1) 6(1) 3(1) 
C(47) 26(1) 20(1) 18(1) 2(1) 10(1) 5(1) 
C(48) 26(1) 24(1) 17(1) 1(1) 8(1) 7(1) 
C(49) 22(1) 24(1) 22(1) -2(1) 7(1) 4(1) 
C(50) 23(1) 28(1) 21(1) -7(1) 7(1) 0(1) 
C(51) 40(1) 32(1) 20(1) -4(1) 8(1) -6(1) 
C(52) 38(1) 35(1) 29(1) 1(1) 12(1) -5(1) 
O(60) 40(1) 52(1) 91(1) 21(1) -8(1) -10(1) 
C(61) 38(1) 51(1) 39(1) -1(1) 6(1) -10(1) 
__________________________________________________________________________
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Table 5.4 Hydrogen coordinates ( x 104 ) and i displacement parameters (Å2 x 103) for sd_182p1. 
___________________________________________________________________________
___  x y z U(eq) 
______________________________________________________________________     
H(2) 85 8442 4389 17 
H(3) 1863 9099 5090 18 
H(4) 3349 10041 5997 22 
H(5) 4613 8890 6699 26 
H(6) 5210 8224 7946 34 
H(7) 4584 8363 9117 36 
H(8) 3351 9178 9091 31 
H(9) 2266 10301 8112 25 
H(10) 624 9461 7505 19 
H(11) -1040 8857 6449 17 
H(13) -717 5820 7245 16 
H(14) 900 5519 8559 17 
H(15) 2579 4854 9539 20 
H(16) 3492 6189 10188 27 
H(17) 4656 7014 10039 38 
H(18) 5389 6898 8932 42 
H(19) 4956 5967 7921 34 
H(20) 3883 4658 7551 23 
H(21) 2380 5236 6278 19 
H(22) 546 5475 5252 16 
H(39A) 3448 10813 7336 28 
H(39B) 2414 10906 6728 28 
H(40A) -1446 8519 4870 20 
H(40B) -962 9317 4981 20 
H(41A) -1035 5519 5661 19 
H(41B) -421 4863 6183 19 
H(42A) 2956 3961 8453 25 
H(42B) 3929 4229 9066 25 
H(43A) 1047 7822 3355 49 
H(43B) 1759 7657 2777 49 
H(43C) 2107 8079 3653 49 
H(44A) 2430 7028 6360 58 
H(44B) 2467 7896 6431 58 
H(44C) 3328 7459 6238 58 
H(45A) -1774 8088 7161 21 
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H(45B) -802 8342 7764 21 
H(46A) -1067 7559 8846 20 
H(46B) -2035 7312 8248 20 
H(47A) -1668 8765 8875 25 
H(47B) -2645 8494 8309 25 
H(48A) -1829 7985 9980 26 
H(48B) -2779 7670 9413 26 
H(49A) -2595 9161 9927 27 
H(49B) -3547 8763 9490 27 
H(50A) -3420 8909 10941 28 
H(50B) -2501 8468 11150 28 
H(51A) -3273 7417 10662 37 
H(51B) -4191 7839 10319 37 
H(50C) -4060 7980 10101 22 
H(50D) -4030 8700 10608 22 
H(51C) -2683 8290 11596 33 
H(51D) -2743 7538 11072 33 
H(52A) -4267 7242 11576 50 
H(52B) -3376 7658 12060 50 
H(52C) -4304 8084 11713 50 
H(52D) -3672 7432 12125 50 
H(52E) -4273 8100 11723 50 
H(52F) -4324 7370 11218 50 
H(60) 3431 8857 562 97 
H(61A) 4090 9929 1065 65 
H(61B) 4573 9634 349 65 
H(61C) 5094 9556 1324 65 
___________________________________________________________________________ 
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